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Abstract 
Relationship ofHelicobacter pylori virulence to gastric pathobiology in the Western Cape. 

M Kidd. Gastrointestinal Clinic and Department of Medicine, University of Cape Town and Groote 

Schuur Hospital, Observatory 7925, South Africa. 

The work presented in this thesis investigated virulence in Helicobacter pylori isolates of the Western 
Cape and related this virulent fingerprint to alterations in gastric cell physiology and cell cycle events. 
Initially, the "virulence profile" of 109 isolates from 86 patients with a spectrum of clinically 
significant gastroduodenal diseases was investigated. The distribution of the vacuolating cytotoxin A 
(vacA) demonstrated that the low cytotoxic vacA sIb allele was found in all (100%) of the isolates 
from patients with peptic ulcer disease and gastric adenocarcinoma. The non-cytotoxic vacA s2 allele 
was found exclusively in patients with gastritis alone and may be an excellent negative marker. 
Different mid-regions of the gene, which are associated with gastric pathology, were also 
differentially distributed (m1 with disease and m2 with gastritis alone). These alleles did not, 
however, segregate absolutely with disease; 40% of patients with gastritis alone were vacA slbml. 
The gene cagA was identified in all isolates and examination of the 3'-region of this gene revealed 
alterations, both in length as well as in structure and potential tyrosine phosphorylation sites. This 
specifically identified one third of patients with gastric cancer (cagA 3'-long), and may be an 
important marker for disease. The "classically virulent" Type I strains (vacA sl!cagA+) were found in 
100% of both peptic ulcer disease and gastric adenocarcinoma isolates. The sensitivity for clinically 
significant disease of this fingerprint was 100%, but the specificity was, however, only 43%. The 
structure of the cag pathogenicity island was then examined and deletions in the 5'-region were found 
more consistently (-60%) in isolates from patients without clinically significant disease. These 
deletions were associated with the non-cytotoxic vacA s2m2 allele (90%). The two genotypes of the 
iceA gene were examined and although half of the isolates contained both genes, iceAl was identified 
more often in isolates from patients with gastric cancer (81 %). Variants of the iceA2 gene, which were 
shown to have differences in secondary and tertiary protein structure, delineated patients with gastritis 
alone (iceA2C, 62%) and peptic ulcer disease (iceA2D, 53%). Combination analysis of vacA and iceA 
status revealed statistically significant associations between disease isolates and vacA slb1iceAl. 
Nevertheless, one third of isolates from patients with gastritis alone had this virulence-associated 
genotype. The relationship between the virulence factors and genomic heterogeneity was thereafter 
examined using repetitive extragenic palindromic and random-amplified polymorphic DNA-PCR. 
Two clusters were produced for each method. A clustering of isolates from patients with peptic ulcer 
disease, with the vacA sImI genotype, a short cagA 3'-fragment, and REPllRAPD2 genomic 
fingerprints were identified. Isolates from patients with gastric adenocarcinoma and gastritis alone 
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clustered in a second, unrelated grouping, but tended to divide into separate sub-clusters (gastritis 
alone with vacA s2m2, and gastric adenocarcinoma with cagA 3'-long). These results suggest that 
South African isolates from the Western Cape are partially clonal in nature, and that a virulence­
associated clonal grouping for peptic ulcer disease occurs in our study population. The relationship 
between specific genes and gastric pathology was presented in the first half of the thesis. 
The second part of the study examined whether a virulence fingerprint was biologically relevant using 
in vitro model systems. We hypothesized that bacterial lipopolysaccharide was a mechanism by which 
"virulent" H pylori strains could alter cell physiology and pathobiology. The effects of a well­
characterized lipopolysaccharide (84-183) from a toxigenic Helicobacter pylori on the histamine 
secretory capacity and proliferative/apoptotic nature of the biologically important gastric 
neuroendocrine ECL cell were initially investigated. In contrast to lipopolysaccharide from E. coli 
which had no effect, LPS 84-183 stimulated both histamine secretion (-1.5 fold) as well as DNA 
synthesis (-2.5 fold) but did not cause cell death over the 24 hr experimental time period. These 
effects were not mediated by activation of the gastrinlCCK2 receptor but could be inhibited by 
somatostatin (-100%). Lipopolysaccharide from the same bacteria also stimulated DNA synthesis 
(-2.2 fold) in a model ECL cell tumor system. This appeared to be mediated by activation of 
polyamine synthesis and could be reversed by ornithine decarboxylase inhibition (-75% inhibition). 
This effect appeared to be specific to Helicobacter pylori and involved activation of the 
lipopolysaccharide receptor, CDI4. Inhibition oflipopolysaccharide binding to CD14 reversed DNA 
stimulatory effects. In addition, CD14 message appeared to be upregulated in tumor ECL cells 
compared to the naIve cell. The effects of 84-183 were also tested in a gastric cancer model system, 
the AGS cell line. DNA synthesis was stimulated (-4.5 fold), was mediated by binding to CDI4, and 
appeared to be mostly mediated by activation of stimulatory G-proteins (calcium influx [80%] and 
cyclic adenosine-5'-monophosphate production [95%]). Analysis also suggested that the lipid A 
portion of Helicobacter pylori LPS may be involved in specifically activating DNA synthesis. Cell 
cycle progression (S+G2M and the ratio ofgrowth to apoptosis) was stimulated by Helicobacter pylori 
lipopolysaccharide. This correlated with DNA synthesis. Finally, the effect of lipopolysaccharides 
from South African Helicobacter pylori isolates whose virulence fingerprint had been defined were 
examined in the AGS cell system. This indicated that organisms with the vacA slbml, an intact cag 
pathogenicity island, and a long cagA 3'-fragment were all associated with an increased DNA 
synthesis. The iceA genotype was not associated with any significant alterations. Cell cycle 
progression was stimulated by lipopolysaccharides from isolates with ail intact cag pathogenicity 
island, while apoptosis was stimulated by deletions in the cag pathogenicity island and the vacA s1m2 
fingerprints. Analysis of effects by disease process demonstrated that gastric adenocarcinoma isolates 
had the most profound stimulatory effect on DNA synthesis (-4.6 fold) and cell cycle progression and 
an inhibitory effect on apoptosis. The data presented in this thesis support the hypothesis that H 
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pylori virulence plays an important but not exclusive role in the pathogenesis of clinically significant 
gastroduodenal diseases. 
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Chapter 1. 
Introduction and Experimental Rationale 
Helicobacter pylori has dominated clinical and scientific gastroenterological research over 
the past two decades. Within the rubric of evolving and rapidly changing concepts, it has 
now become clear that the organism is the most common cause of gastritis, is associated 
with peptic ulcer disease, gastric lymphoma, neuroendocrine cell hyperplasia and is a 
candidate initiator for the development of gastric cancer in humans 1. This is, at least, the 
paradigm of the developed world. 
In Africa, the disparity between the occurrence of H. pylori infection (up to 80% 
prevalence) and the perceived low expression of clinically significant disease (other than 
gastritis) has led some to speculate that this organism does not playa major role in the 
etiology of upper gastrointestinal pathology in developing nations 2, It should, however, be 
acknowledged that our understanding of the epidemiology of gastroduodenal diseases in 
the African setting, with its generally poor medical infrastructure, is less than perfect. 
Preliminary investigations suggest that the prevalence of gastric adenocarcinoma may be 
as high as 8% in some African endoscopic studies 3. In Cape Town and environs, the 
prevalence of H. pylori infection ranges between 40% and 80% in subjects with dyspeptic 
symptoms, depending on the socio-economic status of the individual 4. In addition, both 
the increased risk for gastric adenocarcinoma (estimated prevalence: 3%) as well as the 
importance of chronic atrophic gastritis as a precursor lesion for this condition has been 
noted in a preliminary, screening study 5. 
In the West, it is accepted that, in spite of the fact that H. pylori infection is 
extremely common throughout the world, most infected people never develop ulceration or 
adenocarcinoma and remain asymptomatic in a milieu of long-term infection 1,6. 
Development of disease is thought to depend at least on host factors as well as on the 
virulence of the infecting strain 6, Like many bacterial pathogens, H. pylori produces and 
secretes proteinaceous toxins, These may play a role in H. pylori-mediated disease. 
Several non-conserved bacterial virulence factors with logical roles in pathogenesis have 
thus far been described (to be reviewed more fully in Chapter 4) 6. These include the 
following functionally linked genes: the various alleles encoding vacuolating cytotoxin 
activity (vacA), the cytotoxin associated gene (cag) pathogenicity island (including cagA 
and cagE), the iceA (induced by contact with epithelium) gene family, possibly the bab 
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genes> as well as the expression of the immune invading host Lewis X (LeX) and Y (LeY) in 
the cell walllipopolysaccharides 7-10. Data from Western studies demonstrate that there is 
an association between peptic ulcer disease and vacA subtype s 1 > and the CagA· protein 11. 
There is also some data implicating iceAl, and Lewis antigen expression in gastrointestinal 
disease 10,12, In addition, expression of the CagA protein has been postulated to be a 
marker for increased risk ofgastric atrophy and gastric adenocarcinoma 13,14. 
In the South African setting, however, no studies have attempted to determine 
systematically, whether differences in pathogenic strains are associated with alterations in 
gastric pathophysiology, including gastric cancer. The initial focus of this study was, 
therefore, to analyze, at a genetic level, possible virulence factors in H. pylori isolated 
from patients in the Western Cape with a spectrum of gastroduodenal disease (gastritis 
alone, peptic ulcer disease and gastric adenocarcinoma). The presence (or absence), 
structure, DNA sequence and predicted proteins of these factors would be analyzed and the 
relationship to disease type examined (Chapter 5-7). In addition, the relationship of 
genomic heterogeneity to virulence would be explored (Chapter 8). 
H. pylori infection results in gastric mucosal endocrine and exocrine perturbations, 
recruitment of inflammatory cells and alterations in cellular proliferation and apoptosis 
(reviewed in Chapters 3 and 4). A number of in vivo and in vitro systems have been 
established to try and examine these alterations, and include H. pylori infection in rodent 
models, or analysis of H. pylori products in gastrointestinal cel1lines 15-21. Investigations of 
the latter kind have analyzed either the effects of bacterial products on cells over different 
time points or have attempted to mimic the gastric environment with co-culture experiments. 
Both have their limitations. Contradictory results have been obtained in these in vitro studies . 
and no clear delineation of a particular effect apart from vacuolation 11 has thus far been 
established. Biologically relevant cells ofthe gastric mucosa include the following: 
i) The naive EeL cell 
The neuroendocrine histamine-secreting ECL cell is the primary link between gastrin and the 
production of gastric acid from the fundic parietal cell and is thus a critical interface between 
the peripheral and central regulation of acid secretion. In addition, this cell is activated by 
gastrin to proliferate, and may produce and secrete growth factors, particularly histamine and 
TGFa, during growth 22. Such a panoply of factors and responses may play some role in 
modulating gastric pathophysiology. 
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it) The transformed EeL cell 
A novel rodent model available for study of the neoplastic transformed ECL cell is the 
Mastomys (Praomys) natalensis. Use of acid inhibitory agents in this Southern African 
animal results in the rapid production of hypergastrinemia with a transformation from a 
normal ECL cell population to a hyperplastic state by two months and neoplastic lesions 
(benign neuroendocrine tumors) are evident in up to 80% of animals by four months 23,24. 
The hyperplastic ECL state is reversible at 8 weeks but by 16 weeks withdrawal ofthe gastrin 
stimulus fails to result in tumor regression 23. The use of the mastomys species has been 
useful in studying gastrin induced ECL cell proliferation and has enabled characterization of 
the pathobiology bfthe ECL cell tumor. 
iii) Gastric (AGS) cancer eel/line 
The gastric AGS cell line is derived from fragments of a gastric adenocarcinoma from a fifty­
, ­
four year old female Caucasian patient 25. It has an epithelial morphology and is tumorigenic 
in athymic BALB/c mice. It is also one of the two gastric cell systems most used in the study 
ofHpylori. 
H pylori alters both the physiology and the pathology of the gastric mucosa, often through 
undefined mechanisms. The second component of the study was undertaken in order to assess 
whether and by what mechanism H pylori could differentially affect the physiology of 
biologically relevant gastric cells. Investigators have thus far focused primarily on specific H 
pylori pathogenic factors including vacuolating cytotoxin, CagA, urease and heat shock 
proteins. In this study, lipopolysaccharide (LPS) was chosen as the bacterial product to 
investigate based on a number of observations. These included that LPS has known 
modulatory effects on gastric physiology, has mitogenic potential as well as apoptotic 
activity, and has been chemically analyzed. The possibility also exists that the structure of 
LPS may be related to the virulence fingerprint of H pylori and that it may therefore be a 
surrogate marker for virulence bfthe organism. This study initially investigated the effects of 
H pylori LPS ort naive and transformed ECL cells (cf. Chapters 9 & 10). These observations 
were then expanded to include effects on the model gastric epithelial AGS cell line (cf. 
Chapter 11) and to test whether LPS from a range of clinical isolates differentially affected 
the pathobiology of this cell line (cf. Chapter 12). 
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This thesis thus comprises two parts: Firstly, an analysis of H pylori virulence in clinical 
isolates and its relationship to gastroduodenal diseases in vivo and, secondly, an 
assessment of the effects of "virulence" on biologically relevant gastric cell lines in vitro. i)~'"i)'3Ul"lU  ~~_._, .. ~_,_. 1
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Chapter 2. 
The evolution of a genus 
2.1 The History ofHelicobacter pylori - its discovery and significance 
The association between gastric infection with Helicobacter pylori and the presence of 
polymorphonuclear leukocytes was re-discovered by Robin Warren in 1979. The organism 
was cultured at the Royal Perth Hospital, Western Australia in 1982, and the relationship 
between the organism, gastritis and ulceration was suggested by Barry Marshall in 1984. The 
latter also provided the enthusiasm and drive to cement this lin1e Historically, however, 
investigations of the gastric mucosa are at least a hundred years old 26 and it is probable that 
the identification of spiral gastric organisms could have been made by a number of 
individuals (Table 2.1). 
Table 2.1 The discovery ofH pylori 
Date Discovery 
1875 Bacteria were discovered in the floor and margins ofgastric ulcers by Bottcher and 
Letulle. First hypothesis that bacteria caused ulcer disease 27. 
1889 "Spiral" bacteria were found in gastric aspirations by Jaworski 28. 
1893 Spirochetes were noted by Bizzozero in the gastric mucosa (infiltrating gastric glands 
and found within the cytoplasm and vacuoles ofparietal cells) ofdogs 29. These 
organisms were named Helicobacter bizzozeroni i in 1996 30.. 
1896 Mice successfully infected with H bizzozeronii by Salomon 31. 
1906 Krienitz noted spirochetes in the gastric aspiration ofa stomach cancer patient 32. 
1921 Edkins (the discoverer ofgastrin in 1905) investigated the physiology ofHelicobacter 
felis in the cat 33. 
1938 The association between spirochetes and gastric inflammation was noted in the 
Macacus monkey and in man by Doenges 34. 
1940 Freedberg and Barron "confirmed" that this organism had no etiologic role in gastric 
disease in man 35. 
1940 The hypothesis that an "acidophilic bacteria" caused ulcer disease was first postulated 
by Gorham 35. 
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Table 2.1 The discovery ofH. pylori (continued) 
1979 
1982 
1985-87 
1994 
1994 
1997 
1999 
Campylobacter pylori was identified as a possible causative agent of human gastritis 
by Warren 36. 
C. pylori was cultured by Kosras and Royce 37. 

Ingestion of C. pylori was demonstrated to cause gastritis in human volunteers 38,39. 

NIH concludes that there is a strong association between H pylori and ulcer disease 

[http://www.cdc.gov/ncidodldbmdlmedia.htm#history]. 

The rARC, part of the WHO classifies H pylori as a group r carcinogen 40. 

Genome ofH pylori released by TIGR 41. 

Comparison of two H pylori genomes published 42 

Adapted from Kidd and Modlin, Digestion 1998; 59:1-15 26 
2.2 Molecular and biochemical characteristics ofH. pylori 
Helicobacter pylori was the sixth prokaryotic genome to be sequenced. The genome ·of the 
organism consists of 1.64 to 1.67 Mb pairs, with approximately 1495 to 1590 predicted 
coding sequences 41,42 (Table 2.2). 
Table 2.2 Comparative features of 2 unrelated virulent H. pylori genomes 
, H. pylori 26695 H. pylori J99 
Size (base pairs) 1,667,867 1,643,831 
(G+C) content (%) 39 39 
vacAgenotype slaml slbml 
cagA genotype Positive Positive 
Complete IS605 copie~ 5 0 
Partial IS605 copies 8 5 
Genes (ORFs)* 1,590 1,495 
Classified 875 895 
No function 275 290 
Strain specific ORFs 345 367 
ORFs* = open reading frames 
Adapted from Almet a1. Nature 1999; 397:176-180 42 
Features of specific importance of this genome include small size, the ability to establish a 
positive inside membrane potential, well-developed systems for motility, as well as a number 
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of specialized genetic factors, including regulation of gene expression (DNA restriction and 
modification), physiology and metabolism, iron acquisition and molecular mimicry 43,44. The 
limitations of the new sequence databases are highlighted by the fact that approximately one­
third of the 1590 predicted coding sequences from H. pylori 26695 were not even assigned 
putative identifications 41. Furthermore, for many of the 1091 sequence identifications, a 
biological role appears to have been assigned only on the basis of database matches of less 
than 50% similarity. Nevertheless, many putative adhesins, lipoproteins, and about 300 
membrane proteins have been identified which underscore the potential complexity of the 
host-pathogen interaction. Consistent with its restricted niche, H. pylori has few regulatory 
networks, and a limited metabolic repertoire and biosynthetic capacity 41. The organism 
contains enzymes for glucose metabolism, lacks p-galactosidase, has some of the enzymes of 
the Kreb's cycle, and also the urease operon encoding UreA and UreB (urease). Synthesis of 
urease is constitutive, accounting for as much as 15% of the organism's protein and is 
essential for the successful colonization of the gastric mucosa 45. The genome also encodes 
several outer membrane proteins (aMPs), some of which are porins, able to transport a 
variety of molecules into and out of the periplasmic space. The presence of homopolymeric 
tracts (polyC or polyG) and dinucleotide repeats (e.g. CT or AG) present in the genome 
suggests that H. pylori, like several other mucosal pathogens, uses recombination and 
slipped-strand mispairing within dinucleotide repeats as mechanisms for antigenic variation 
and adaptive evolution 41. 
2.3 Other Helicobacter species 
Over the past 20 years, research in mutually overlapping disciplines has demonstrated that 
Helicobacter pylori is only one member of a whole family of bacteria which infect the entire 
gastrointestinal tract of both humans and animals. To date, at least 7 urease positive 
microaerophilic Helicobacter species have been cultured from mammalian and avian 
stomachs. H. acinomyx is the natural cheetah gastric helicobacter, H. mustelae is adapted to 
the stomach of the ferret,and H. nemestrinae is found in the primate stomach. H. felis, 
bizzozeronii, salmon is and heilmannii do not have host species specificity and have been 
identified in a number of animal species including cats, dogs, pigs, lemurs and monkeys 46-51, 
Most of these gastric helicobacters appear to cause minimal disease in their hosts 52. 
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Genus-specific H. pylori probes, based on conserved sequences within the 16S 
ribosomal RNA gene, have revealed a wide-range of new Helicobacter species in a number 
ofanimals and birds 53. (Table 2.3). 
Table 2.3 Non-gastric helicobacters 
Helicobacter species Host Urease activity 
H. bilis Rodent 
H. canis Dog 
H. cholecystus Hamster 
H. cinaedi Hamster! gerbil 
H. fennelliae Hamster!gerbil. 
H. hepaticus Rodent 
H. muridarum Rodent 
H pametensis Bird/Swine 
Hpullorum Poultry 
H. rodentium Rodent 
H. trogontum Rodent 
Positive 

Negative 

Negative 

Negative 

Negative 

Positive 

Positive 

Negative 

Negative 

Negative 

Positive 

Adapted from Lee and Robertson, Kluwer Academic Publishers; 1998:3-12 30 
Urease is essential for the successful colonization of the gastric mucosa 45 and is central to 
the pathogenesis of H. pylori. Only some of the lower bowel organisms are urease-positive 
and it appears likely that gastric helicobacters may have evolved from the urease-positive 
lower bowel colonizers like H. muridarum 30. Some of these organisms, particularly if they 
trans locate from their normal niche to other parts of the gastrointestinal tract, may be 
important in disease processes. Evidence for this is provided by H pullorum which has been 
observed to cause inflammatory lesions in the livers of chickens, probably following 
translocation into the portal blood-stream and into this organ 54. In mice, translocation of H 
hepaticus from the lower bowel causes hepatitis which can progress to hepatocellular 
carcinoma in the livers of these animals 55. Of interest are the recent findings of a hepatic 
Helicobacter species identified in patients with chronic cholecystitis 56,57. These organisms 
have been suggested as possible risk factors for gall-bladder disease in populations with bile­
resistant Helicobacter species. It appears certain that the genus of Helicobacter will continue 
expanding, and that some ofthese organisms will playa role in human disease. 
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Chapter 3. 
Evidence implicating H. pylori as a gastric pathogen 
3.1 Introduction 
In 1965, Sir Austin Bradford Hill, Professor Emeritus of Medical Statistics set out a list of 
criteria to analyze, logically, a causal relationship between environmental agents and disease 
58. While this cannot provide a fonnal test of causality, it does provide the framework to 
generate a verdict of causation from an observed association. The variables, which are 
summarized in Table 3.1, are not mutually independent. 
Table 3.1 Hill's outline 
Variable 
Strength and specificity of association 
Consistency and coherence of the observed association 
Biological plausibility and experimental evidence 
Is there a temporal relationship? 
Is a biological gradient involved? 
Analogy 
Infection with H pylori is associated with functional effects (alterations in gastric physiology 
e.g. acid secretion) and epithelial effects (alterations in gastric mucosa e.g. gastritis). Hills' 
criteria were borne in mind when examining the evidence implicating the organism as a 
causative agent/gastric pathogen in this chapter. 
3.2 Functional effects ofH pylori 
Evidence relating H pylori infection to alterations m gastric physiology includes the 
following: 
3.2.1 Effect on gastrin 
Experimental evidence and clinical observations demonstrate that gastric mucosal 
colonization by H pylori results in increased basal serum gastrin levels and may result in 
increased post-prandial plasma gastrin· concentrations and increased gastrin responses to 
stimulation with GRP compared to H pylori-negative healthy volunteers 59-62. The G-17 
fonn of gastrin is the fonn selectively increased by infection, but the mechanisms responsible 
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for this remain unknown. One proposal for the alteration of gastrin release is the production 
of an alkaline microenvironment by acid-neutralizing ammonia catalyzed by the bacterial 
urease. This elevation of pH in the vicinity of the G-cells could potentially result in gastrin 
release. Although complete urease inhibition does not result in a decrease of gastrin secretion 
63,64, it has been noted that long-term exposure to ammonia results in hypergastrinemia 65. An 
alternative potential mechanism might be the production of gastrin-stimulating cytokines 
such as interleukin-1 ~ and tumor necrosis factor-a from T -lymphocytes and monocytes 
present in the inflammatory infiltrate engendered by H pylori 66,67. A third possibility is an 
increase in gastrin release consequent upon inhibition of somatostatin (SST) synthesis and 
release 68. In rare circumstances, H pylori infection can result in massive hypergastrinemia to 
an extent that may mimic Zollinger-Ellison syndrome (ZES) 69 or the entity of antral G-cell 
hyperfunction 70. 
3.2.2 Effect on acid secretion 
The data on the effects on acid secretion are not clear-cut. Observations, in early infection, 
suggest that acid secretion decreases (by 1980 there was a report concerning an "epidemic 
. .. 
gastritis associated with hypochlorhydria" 71). During the chronic phase of infection, it can be 
demonstrated that duodenal ulcer patients have, on the average, higher acid output than 
patients without duodenal ulcer 72,73. Counting the number of parietal cells has shown that 
duodenal ulcer patients have more parietal cells thus explaining the acid output data 74,75. 
There is also experimental evidence for at least two acid inhibitory substances which have 
been purified from H pylori, with one partially sequenced 76. This appears to represent a 
metabolic gene. 
3.2.3 Effect ofsite ofinfection 
The gastric effects ofH pylori appear to depend in part on the site of infection. In the case of 
antral infection, clinical observations suggest that there is a decrease of somatostatin or the 
D-cell population accompanied by hypergastrinemia 77. In the case of infection of the gastric 
corpus, there is often gastric atrophy with loss of the acid secreting cells; this could account 
for the reduced level of acid secretion observed in patients with gastric atrophy 75. 
Hypergastrinemia is thought to be trophic for parietal cells, thus accounting for the higher 
acid output in duodenal ulcer patients. 
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3.3 Gastritis 
In most people, gastritis is not associated with any obvious symptoms. Infection with H. 
pylori, however, is observed to result in a cellular infiltrate in the gastric mucosa termed 
chronic gastritis, and visible damage both to the superficial epithelial cells and to the cells 
that form the pits and glands of gastric mucosa 78. Attachment of the organism also releases a 
sequence of inflammatory changes which results in injury and altered function both to the 
superficial and glandular mucosa, including the oxyntic glands 79. Virtually all infected 
persons develop gastric inflammation that persists for the duration of the infection 80. 
Gastritis can be antral predominant or corpus predominant, or can affect both areas of the 
stomach (pangastritis) 77,81. The physical distribution of the organism is important because it 
may determine the physiological and pathological outcome of the gastritis although this has 
not been empirically proven. This is supported by evidence demonstrating that eradication of 
the organism leads to healing of the gastritis and· the return of mucosal histopathological 
appearances to normal. The causal role for the organism in gastritis has been accepted 82,83. 
H. pylori has been isolated from a patient with gastritis, purified and ingested. In both cases, a 
gastritis ofvarying degrees had developed in the human "guinea-pig" 38,39. Koch's postulates 
(Table 3.2) have therefore been fulfilled for gastritis 84. 
Table 3.2 Koch's postulates 
First 
postulate 
"The organism should always be found microscopically in the bodies of animals 
having the disease and in that disease only; it should occur in such numbers, and can 
be distributed in such a manner as to explain the lesions of the disease." 
Second 
postulate 
"The organism should be obtained from the diseased animal and grown outside the 
body" 
Third 
postulate 
"The inoculation of these organisms, In pure cultures, freed by successive 
transplantations from the smallest particle of matter taken from the original animal, 
should produce the same disease in a susceptible animal." 
Fourth 
postulate 
"The organisms should be found in the diseased areas so produced in the animal." 
3.4 H. pylori and Peptic Ulcer Disease 
There is substantial evidence associating H. pylori with peptic ulcer disease. This includes the 
following: H. pylori carriers appear to have an increased risk of developing peptic ulcer 
disease (about 3-50 fold) depending on the site of infection 85-88. The organism is present in 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
27 
90 to 95% of patients with duodenal ulcer and 60 to 80% of patients with gastric ulcer as 
compared to 25-30% incidences in asymptomatic control subjects 89-92. More recently, a 
surprisingly high incidence of H pylori negative patients with duodenal ulcer disease has 
been recorded in the USA 93. This, however, could simply be a statistical anomaly and be a 
reflection of NSAID usage 94, There is an association between gastric metaplasia in the 
duodenal cap and H. pylori which appears to confer a predisposition to ulcer disease. H 
pylori can colonize only gastric-type epithelia, and is not therefore found normally in the 
duodenum. Gastric metaplasia, the replacement of the columnar cells which normally cover 
the duodenal villi, by gastric type epithelium rich in neutral mucin, is present in up to 90% of 
patients with duodenal ulceration, and appears to allow the organism to colonize the duodenal 
bulb 95,96. The definitive link between the organism and this disease is provided by the 
unequivocal association between the eradication of H pylori infection and the cure of peptic 
, "" j • • 
ulcer disease 97-99.. 
3.5 Hpylori and Gastric cancer 
Although gastric cancer is a disease with a poorly understood pathogenesis 100, some 
evidence links H pylori with it. The effect of infection generated by the organism may result 
in three types of mucosal alterations: 1) The gastric mucosa regenerates;- 2) an adaptive, 
reparative process with the replacement of the normal functioning mucosa resulting in 
atrophy may occur or 3) intestinal metaplasia may develop. Mucosal atrophy is thought to be 
the key pathological change underlying the increased risk of gastric cancer in subjects with 
chronic gastritis 86,101 while the progression of intestinal metaplasia to colonic type intestinal 
metaplasia is a known risk factor for gastric cancer 102. IfH pylori is to be implicated as the 
starting point for a sequence of changes ultimately leading to cancer, it is necessary that the 
organism plays a defined role in the pathogenesis of these two processes. 
3.5.1 Atrophy 
Irreversible loss of functional structure or atrophy occurs when destroyed glands fail to 
regenerate and the space that they previously occupied in the lamina propria is replaced by 
fibroblasts and extracellular matrix 101. H. pylori appears to playa role in atrophy. The 
evidence supporting this includes the following. Data from all parts of the world indicate that 
H pylori infection is the major cause of chronic atrophic gastritis 103. One of the modes of 
cell death in glandular atrophy is apoptosis. Evidence for the induction of apoptosis by H. 
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pylori has been obtained recently from two types of study, namely the identification of 
apoptotic cells in tissue sections from H. pylori infected individuals, and the induction of 
apoptosis in cultured gastric epithelial cells in vitro. Several studies by independent groups 
have all shown that the H. pylori colonized stomach contains more apoptotic cells than 
normal 104-106. Furthermore, the increased number of apoptotic epithelial cells decreases to 
normal following eradication, suggesting that the bacterium or the associated inflammatory 
response is responsible for the increased apoptosis 104. It is not known, however, whether H. 
pylori induces a physiological, senescent type of cell death in normal but aging cells, or an 
altruistic apoptosis in response to cell damage 107. What is also not known, is whether the 
induction of apoptosis by H. pylori may be the stimulus for gastric mucosal proliferation 108, 
or whether apoptosis may be viewed as an at~empt to reduce tissue growth in response to 
hyperproliferation growth 17. It is not known whether apoptosis in this context is a damaging 
or protective effect. 
Direct injury to epithelial cells by bacterial products (cytotoxins, ammoma, 
phospholipases a~d others) is likely to be important for surface epithelia but is potentially less 
important with regard to glandular epithelia 79. Other likely mechanisms are host responses to 
infection. For H. pylori infection, the mucosal response to infection leans heavily towards 
that of the promotion of inflammation, autoantibody formation, and cell-mediated epithelial 
damage, all of which are classical Thl mediated responses 79. The link therefore betweenH. 
pylori and atrophy may be an indirect one that is thought to be modified by the ability of the 
host to mount appropriate autoimmune responses. Irrespective of the mechanisms involved, a 
recent study has demonstrated that eradication of the organism led to improvements in gastric 
atrophy in a prospective randomized study 109. This suggests that progression of pathologic 
changes in the gastric mucosa can be potentially inhibited. 
3.5.2 Metaplasia 
In cases of intestinal metaplasia, the specialized gastric glandular epithelial cells are replaced 
by an intestinal type epithelium containing goblet cells, intermediate/absorptive cells which 
in most cases is lined by a brush border. Both mucosal atrophy and intestinal metaplasia are 
putative precursors of gastric cancer 110. Once chronic changes (e.g. intestinal metaplasia) 
have been established in the gastric mucosa, there is no good evidence for a return of mucosa 
to normal (reversibility). The known association of distal gastric cancer (both the intestinal 
and diffuse types) with pre-existing gastritis has led a number of investigators to transfer the 
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association from gastritis to its cause, H. pylori infection 5,110,111. Data from all parts of the 
world demonstrate that H. pylori infection is associated with the presence of intestinal 
metaplasia 112, although the organism colonizes adjacent areas only. At least one study has 
shown that eradication of the organism leads to regression of intestinal metaplasia activity 
over a one year study period 109. 
3.5.3 Cellular role in gastric tumor formation 
Development of gastric cancer is a complex and poorly understood process involving 
alterations in the balance of gastric mucosal proliferation and apoptosis/atrophy. 
3.5.3.1 Alterations in proliferation 
Recently it has been reported that H. pylori· infection is associated with the increased 
proliferation of gastric epithelial cells in H. pylori positive hosts 113,114, and eradication of H. 
pylori significantly reduces gastric epithelial cell proliferation 113,115. Research into H. pylori 
has focussed attention on the importance of chronic inflammation and impaired host defense 
mechanisms as factors in the development of gastric cancer. It is apparent that H. pylori 
colonization in the gastric mucosa causes acute inflammatory cell infiltration and leads to 
chronic inflammation in all cases sustaining H. pylori infection 116. Following this, there are 
evidently differences in the severity of the inflammation of the gastric mucosa due to 
differences in the extent of the gastric atrophy 112. An association between antibody titer and 
the subsequent development of gastric cancer has been claimed, suggesting greater extents of 
inflammation leading to mutagenesis and gastric cancer 87. It is likely that H. pylori 
associated inflammation may interact with other causal factors such as environmental or 
hereditary factors related to gastric carcinogenesis and result in the intestinal type of early 
gastric cancer. Thus, at least the intestinal types of gastric carcinoma may be long-term 
sequelae ofH. pylori infection. 
The relationship between H. pylori infection and the diffuse type of gastric cancer 
seems to be different from that of intestinal cancer. In the case of diffuse-type gastric cancer, 
the sequence of H. pylori infection, atrophy of the gastric mucosa, intestinal metaplasia and 
development of gastric cancer does not seem to be relevant 102. Instead, DNA damage due to 
oxygen radicals induced by persistent inflammatory cell infiltration in the gastric mucosa 
based on H. pylori infection may lead to alterations of the gene and result in the development 
of diffuse-type gastric cancer 117. 
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A number of studies have attempted to identify whether H pylori or its products 
could directly influence either proliferation or the rate of proliferation of gastric epithelial 
cells. Table 3.3 and Figure 3.1 summarizes the results to date: 
Table 3.3 Experimental observations analyzing the effects ofH pylori on cell proliferation in 
vitro. 
Cell type 
AGS (gastric 
cancer line) 
Hpylori 
constituent 
Whole 
organIsm 
AGS (gastric 
cancer line) 
Whole 
organIsm 
AGS (gastric 
cancer line) 
Whole 
organIsm 
MKN28 
(gastric 
epithelial 
cell) 
IEC-6 (small 
intestine, 
epithelial) 
Dialyzed! 
undialyzed 
broth filtrates 
Water extract 
IEC-6 (small 
intestine, 
epithelial) 
Sonicates & 
water extracts 
Method 
FCM 
FCM 
Ki-67FCM 

andMTT 

assay 

? 

24hr 

incubation, 

3H-thymidine 

uptakefor 4 

hr 

24hr 

incubation, 

3H-thymidine 

uptake for 4 

hr 

Mechanism 
? 
? 
? 
? 
Receptor 
mediated? 
Receptor 
mediated? 
Results 
cag + > cag ­
cagA+ = 
cagA-
Increased, 
Hpylori> 
E. coli 
Decreased 
Increased, 
E. coli > 

Hpylori 

Increased, 
E. coli > 

Hpylori 

Reference 
21 
20 
15 
16 
18 
19 
FCM = flow cytometry; MTT = tetrazolium salt; ? = no mechanism suggested 
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H. pylori 
E. coli =H. pylori (?)cagPAI (intact) > cagPAI (partial) (?) 
(-)\ t/(+) 
<}-{>:·G··.. ,.... . •J: .. ":'1-: IsubG1 4' .... 
(+) 
H. pylori 
E. coli 
cagPAI (intact) > cagPAI (partial) C. jejuni
vacA 51> 52 
Figure 3.1 Compilation of in vitro data relating H pylori or its products to alterations in the 
cell cycle. H pylori (or its constituents) may inhibit entry into the S-phase or stimulate DNA 
synthesis and activate apoptosis (entry into sub-Gt}. Other gastrointestinal organisms inhibit 
entry into the G2M phase. 
These results reflect the difficulties inherent in this field. Studies in gastric carcinoma cell 
lines demonstrate either an increase 15,21 or a decrease 16,20 in cell proliferation ­
discrepancies which may be due to differences in the methodologies used. The two studies 
analyzing the effects of products of H pylori demonstrated an effect on proliferation but at 
levels less than that obtained from E. coli products 18,19. These experiments were conducted 
in a small intestinal cell line, which minimizes the relevance of the findings. It is obvious that 
a proliferative role for H pylori has not been clearly or adequately defined in vitro. 
3.5.3.2 Alterations in apoptosis 
Recent studies have shown that exposure of bacterial proteins and whole bacteria to gastric 
epithelial cells inhibits proliferation of gastric epithelial cells in vitro 17,20,76,118. In one study, 
soluble bacterial protein led to a decrease in epithelial cell proliferation that was detectable 
within 16 hrs. 76. In addition, protein synthesis was inhibited by exposure to bacterial 
proteins, which was seen initially 6 hours after exposure. The inhibitory effect was not caused 
by lytic activity (cell death) and was believed to be linked to a protein with an estimated 
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molecular weight of approx. 100 kDa. Proteins from knockout mutants without urease, the 
gene cagA, or VacA activity were shown to have the same effects 76. In other experiments, 
inhibition of cell proliferation could be induced by culture with bacteria (albeit at high 
concentrations: >100 organisms per cell) 20, soluble extracts and culture supernatant 17. This 
suggests that the factor originates· from the cytosol of the organism and is released into the 
culture medium. In addition, this factor was sensitive to trypsin digest and heating at 95°C, 
suggesting that it may be a protein 17. This protein also appeared to be present in all bacterial 
strains. Interestingly, this inhibitory protein appeared to be specific to H. pylori because C. 
jejuni was unable to affect gastric epithelial cell growth and apoptosis. A further study has 
suggested that cagA+ organisms are less effective than cagA- organisms in inducing apoptosis 
20. It should be pointed out that while this in vitro data suggest that inhibition of epithelial 
proliferation may be a general phenomenon ofall H. pylori, this may not directly translate to 
the in vivo scenario where it has been suggested that there are considerable strain-specific 
differences in gastritis and the il111l1une response 17. 
3.5.3.3 The neuroendocrine EeL cell 
The mucosal cells implicated in gastric tumorigenesis are unknown. The cellular origin of 
tumors may be potentially interesting because such knowledge may be important in 
understanding tumorigenesis itself, mechanisms for preventing tumor formation and also 
planning therapeutic approaches. Recently, some focus has been applied to the gastric ECL 
cell. Neuroendocrine differentiated tumor cells in malignant tumors of the gastrointestinal 
tract have been known for many decades 119,120. In tumors classified as adenocarcinomas due 
to a glandular growth pattern and mucin staining of malignant cells, the presence of 
neuroendocrine tumor cells was believed to represent dedifferentiation. The biological 
rationale for classification of tumors as carcinoids when the majority of the cells have a 
neuroendocrine marker and as adenocarcinomas when only few tumor cells have such 
markers remains to be empirically proven. An alternative view is that all these tumors could 
be of neuroendocrine origin with differing degrees of dedifferentiation. This suggests that 
tumors with the least neuroendocrine positive cells are the most dedifferentiated and therefore 
most malignant. A previous study has described neuroendocrine tumor cells of the ECL cell 
type in gastric carcinomas ofthe diffuse type, but not in tumors ofthe intestinal type 121. In a 
more recent prospective study of gastric tumors, it has been found that 27% of tumors had 
cells positive for chromogranin A reactivity (a marker for endocrine cells), and five (four 
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diffuse type, 1 intestinal type) of the 41 carcinomas analyzed required reclassification as 
neuroendocrine tumors 122. Among these tumors, the ECL cell was the most preponderant 
cell of origin. In addition, tumors of the diffuse type were most often reclassified as 
neuroendocrine carcinomas. Interestingly, it also appears that ECL cells may be implicated in 
the pathogenesis of spontaneous oxyntic mucosal adenocarcinomas found in inbred cotton 
rats 123. A role for ECL cells in gastric carcinoma formation has not, however, been proven. 
The direct effect of H pylori on the pathogenesis of ECL cell proliferation is not 
known, but there are a number of observations which implicate the bacterium in the process 
of disease. Micronodular pseudohyperplasia appears to be a passive process of endocrine cell 
clustering, which is a frequent finding in foci of gland atrophy occurring in H pylori gastritis 
124-126. To date, the phenomenon of endocrine, cell clustering appears to be restricted to 
patients with H pylori colonization but has not been demonstrated to progress beyond 
micronodular hyperplasia, which only occasionally has been of the pre-dysplastic 
adenomatoid type 125-127. Whether these phenomena are due to a direct mitogenic effect of 
the bacterium or are the result of perturbations in gastrin secretion is not known. It is of 
interest to note, however, that the effects of H pylori are more marked in fundic mucosal 
gastritis than in antral gastritis. ECL cell hyperplasia and the potential for neoplastic 
formation in a setting of Hpylori induced gastritis remain enigmatic; 
3.5.4 Experimental gastric adenocarcinoma in animal models 
The carcinogenicity of H pylori has been proven in the Mongolian gerbil 128. The animal 
(Meriones unguiculatus) is an appropriate animal in which various gastrointestinal diseases 
which mimic human H pylori infection have been studied 129-131. This animal model can be 
successfully infected with H pylori and short-term infection with Tox + (toxic, VacA +/CagA+) 
strains can result in severe gastritis, gastric ulceration and intestinal metaplasia. The long­
term effects of infection in this model (62 weeks) result in the formation of pyloric 
adenocarcinomas in a third of infected animals 128. The tumors originate deep in the gastric 
gland, but the progenitor cell type has not yet been identified. Significant changes consistent 
with chronic atrophic gastritis were also noted in the oxyntic mucosa of these achlorhydric 
animals 128. In addition, neuroendocrine ECL cell tumors, diagnosed by the presence of 
neuroendocrine nests were identified in 1 in 10 animals. Extending such studies to 80-100 
weeks demonstrated increases in serum gastrin levels, the increased prevalence of gastric 
carcinoids as well as well-differentiated intestinal-type gastric cancers 132,133. Such .results 
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fulfil Koch's postulates in these animals and also suggest strongly the link between H. pylori 
infection and both carcinoid and carcinoma in humans 134. 
3.5.5 H. pylori and Gastric MALT Lymphoma 
Mucosa-associated lymphoid tissue (MALT) in the stomach is primarily the consequence of 
an infection with H. pylori 135. Other agents may also result in gastric MALT, but it is 
believed that in more than 90% of the cases, infection with H. pylori is responsible for the 
induction of lymphoid tissue in the stomach. MALT is an immunologic defense system to 
control local infection caused by the organism. It is composed of H. pylori-reactive T cells, 
plasma cells, and other B-cells and mimics lymphoid follicles known from typical nodal 
tissue. Localization of MALT parallels the site of H. pylori infection, the antrum 136,137. In 
addition, the number of lymphoid follicles in the stomach correlates well with the grade ofH. 
pylori-induced inflammation 135. 
In 1991, data emerged to indicate that low-grade gastric MALT lymphomas are a 
result of genetic changes probably induced in B-cells clonally evolving from H. pylori-related 
chronic gastritis 138. Lymphomas arising from gastric MALT show specific features not 
present in other lymphoma entities. They arise from the marginal zone of the lymphoid 
follicle, they consist of centrocyte-like cells, and lympho-epitheliallesions must be present to 
establish the diagnosis of gastric MALT lymphoma 139,140. 
Wotherspoon et al. have observed that microscopically detectable MALT lymphomas 
associated with H. pylori infection responded to eradication ofH. pylori 140. Similar findings 
were reported by Rudolph 141, and Stolte 135 (Table 3.4). Roggero et al. recently stated that 
the cure of H. pylori infection in low-grade gastric MALT lymphoma should be considered 
standard therapy 142. 
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Table 3.4 of the induction in Low-Grade gastric lymphomas 
cure pylori 
N CR(%)* Year Reference 
10 60 
6 83 
69 
15 93 
84 80 
1992 
1993 
1995 
1995 
1996 
1997 
135 
140 
143 
144 
145 
146 
CR complete remission. 
Thiede et al. Gastroenterol 1997; 11 -S64 146 
H. pylori appears to m gastric MALT 
some authors speculated high grade 
to such treatment. sporadic cases of cure have been published 141,147; this is not 
recommended .,.....-,,.,,,.,,,, ... 
6 Cohort studies 
~..,.,_~. evidence pylori plays a role in stems 
3 sero-epidemiological case-control 
The 
nested within These 
odds ratios (OR) ",n"",,,,... 2.8 and 6.0 85-87 (Table 3.5). 4 nested case-
studies have yielded supporting 148 and less convincing results 149-151. In a more 
recent case-control study, which attempted to assess and control confounding bias 
by socio-economic an increased risk gastric cancer was observed 
seropositive individuals compared with seronegative subjects 1 association was 
in the antrum 6.94) and particularly the pyloric (OR = 15.1), then 
overall risk this study was 2.26. 
H. pylori seropositivity and subsequent 
adenocarcinoma development, however, was the cardia. finding 
that cardia and non-cardia cancers may be as separate Ul" .... u.;'''' 

profiles. 

LU..uUU.;:o (OR = body (OR = 
significant 
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the early 
"'-"'0"--­ neoplasm in 
Table 3.5 H. pylori antibody positivity cancer 
Patient OR* Reference 
8520129 (69%) 2.8 
8692/109 (84%) (66%) 3.6 
87103/109 (94%) 09 (76%) 6.0 
1521661208 (80%) 619/983 (63%) 2.26 
OR* Odds Ratio 
H. pylori IS implicated as a for diffuse gastric cancer. recent 
nested cru;;e-(:onno study from Norway has .......'H·t..."'t"'rl that the OR for both (OR 
= 4.1) cancer (OR = 5.18) was 

In 1994, exhaustively 
 the Working 
the International Agency for Research on ,-,cu,,,,",, in affiliation World 
Health u""'''''''VJLA. concluded that IIH:lell1 evidence from UY1UU,H ..,1,U'-'1'-'''' to 
establish the nTPI'Tlr\nof infection with pylori and that H. pylori IS 
carcinogenic to humans (group 1 carcinogen) mentioned, some 
position, have produced equivocal which may engender some 
7 ~D'lal:~mlOI()2 studies 
cancer IS 
provided by following epidemiological nnc'p,,! 
gastric cancer was the most common 
countries, since then rates (particularly distal cancer) have progressively declined in 
parallel with decline in the prevalence pylori 153. Data from show 
that 1 there has been an approximately 50% decrease in the 
gastric cancer which is associated a in H. pylori prevalence I Interestingly, 
as a decrease in distal 
'''''',nAn of a pylori infectionIndirect n"<'rr1J"O 
cancers, there has also been an in the 
gastric cancers 100. has also been to differences in 
development of the 
cardia is 
H. <+l"J""" 155; in the Oft;Sellce 
subjects 152, preliminary 
"f",'''''''''1';) suggest that stomach cancer may ranked as high as 
lower than in H. 
(making up 
3.4% all cancers) 156, and some enClOS;COPI studies suggest that 
U ....'1U""""''-' distal 
risk 
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of gastric adenocarcinoma in Cape-colored males as as 20.41110,000 
lifetime risk is ill people 3, It should acknowledged, however, our 
understanding of epidemiology of gastroduodenal is less than perfect. 
3.6 H. pylori in 
The relationship n"'T'''T''''~n pylori infection no"'...... " pathology in Africa is ""'1'lTr,... ,,,"r(11 
Several' authors su}:~ge:SLe:Q that there is no ""...,uvu between and any 
pathology apart gastritis 2,157, and that ue(;uon with the organism lU""',,","'" be 
protective against inter alia gastric cancer 158, evidence for these views is 
from sero-epidemiology studies in "asymptomatic" individuals combined anecdotal 
evidence about prevalence of various entities 2,157-160. More recently, results 
of a CID;e-{~On[ro suggest that there may no in the infection rates between 
patients with cancer and controls in South 161, TheseAU,""""A"'-1 
observations allow for, amongst others, a including a role pylori related 
virulence determining the outcome 
literature review the data published on pylori in Africa 
provide information that is at odds with time honored wisdom 3. This questioned the 
assumptions gastroduodenal in Africa. The difficulty with definitively 
a no~~enlc role to H. pylori African setting, is by a generally 
poor and by a paucity of appropriate directlyHlv'U,1",.,1.1 
investigating What seems to IS incidences the 1990s 
are based on information gathered twenty to thirty years ago 1 evaluation of 
the data that the organism's association with gastritis be as strong as in 
rest world. In addition, although flawed, data generated in era appear to 
infection is strongly associated with peptic ulcer u,.:>'.. <1.:>'..... and that this disease 
not be as rare as is commonly perceived (ulceration was noted in 26% of cases) 3, 
to be a of duodenal ulcer compared to gastric 
ulcer ......,,''''...,'''' these studies, of a relatively prevalence of gastric 
,",UIViLl,a (range 1-7%). This suggests that the between H. pylori 
and 1la!;trC)QUlOQ.enal disease in very similar to countries, 
the caveat that prospective, studies are clearly ","",u,",'". It is possible a 
low prevalence of pylori associated diseases .'n.'..u .... of a high H. pylori 
may possibly expression of Africa's medical infrastructure, as 
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evidenced by the "health for all indicators" of the World Health Organization's 1996 Report 
162. It is clear that the average life expectancy in Sub-Saharan Africa is much lower than in 
industrialized countries, the 1995 life expectancy being 53 years (range 40 to 71). This is of 
particular importance in diseases such as gastric cancer which typically involves the older 
patient. 
3.5 Conclusion 
This chapter has used Hill's criteria as a basis for evaluating the strength of evidence 
supporting the role of H. pylori as a gastric pathogen. 
In summary, the association between the organism and a host of endocrine and 
paracrine alterations suggests strongly that H. pylori affects gastric physiology, although 
direct experimental evidence is lacking. Nevertheless, a strong, consistent, and coherent 
association implicating H. pylori exists. For the entity of gastritis, associations are found in 
numerous studies and demonstrate strength, consistency, and specificity of association, as 
well as providing a biologically plausible, coherent causal relationship. The data for a causal 
relationship with peptic ulcer disease are supported by evidence of both specific and coherent 
observations and a biologically plausible relationship has been defined. Some questions, 
however, still relate to the strength and the consistency of an association. There is some 
experimental evidence linking the organism with neuroendocrine tumor formation in a 
susceptible animal model, but a strong and consistent association has not been proven in man. 
The summation of the data amassed on the relationship between H. pylori and gastric cancer 
cover associations with atrophy and intestinal metaplasia, epidemiological and cohort studies, 
and experimental evidence. It is clear, using Hill's criteria, that the data support a causative 
role for the organism. The fact that all individuals infected with H. pylori do not develop 
gastric cancer suggests strongly that modulatory factors (diet, host factors, differences in 
virulence) must, however, exist. A causal relationship between infection and clinically 
significant disease in Africa is proven for gastritis. It probably exists for peptic ulcer disease 
and gastric cancer in certain populations, but more research is required on this continent. 
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H. pylori and factors associated with disease expression 
4.1 Introduction 
Since its rediscovery and culture in 1 pylori has been investigated at 
metabolic and protein levels. .pylori is a complex organism, which displays 
both at a genomic and a cellular relationship between infection with 
and gastrointestinal complex and multifactorial. 
(including flagella, to colonize and evade host u"~"u,, a 
of '!Jr'""''"''' by the organism (vacA, may 
modulate the , ....:l'...,U"..., nro(:es:s. outline some of which may 
identify organisms that are as well as indicate how may potentially be 
relevant to the etiopathology processes. 
4.2 H. pylori heterogeneity a potentially misleading observation? 
H. pylori appears to be one of the most diverse so reported 
163, although the to arrive at these conclusions is dependency 
on either the nucleotide or on the sequencing of specific loci in different strains 
163,164. In spite limitations, the organism to be subject to the 
highest known rate bacterial recombination 165. panmictic structure of the 
H. pylori demonstrated 166, as has the possibility that it is clonal over short 
time periods .....,......... , .....u.~'u,..,.'u'vu 165 and there is a different "Asian" clonal 
grouping 1 crn'>"'t~'rI that such the bacteria's ancient 
ancestry, its human populations, colonized hosts, 
ability to mutate over decades of colonization within a ease with which it 
may exchange with other H. pylori strains 163,168. 
An viewpoint is presented by comparison. A recent 
report has that the overall genomic order and predicted proteins 
of two virulent H. pylori isolates may be quite similar 42, DNA-sequence 
differences 20%) between these two virulent were found mainly in the 
position (a site for synonymous substitutions - and the reason for the 
earlier 42,165). nucleotide variation does notenormous 
into a highly divergent nrl"l,rpnrn comparisons of H. pylori 26695 
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310 J99 demonstrated that whilst only eight genes had greater than 98% Uy,,,,,,,_,, ...,,,, 
proteins (41 of which had identity) had 98% amino-acid conservation 
such a genome a low level of gene -"..'......'lH.I:.' 
to have the same U""',","~'J& of gene 
divergence np'C"l?'pn study, however, rpr.".-t",t1 of 
strain-specific to the pathogenicity contain almost 
half of the genes unique to of the organisms and which may be in the disease 
process 42, 
Several have suggested that H. pylori may disease­
specific strains. Duodenal appear to be more homologous to than to 
strains from patients with 169, while cluster analysis of 
palindromic (REP) demonstrated that duodenal isolates, as a 
may be more similar to one different from gastritis ..."J ...."J-' 
USA 170, 
4.3 Strain heterogeneity 
number of techniques while there appears to be considerable 
H. pylori genomic intra-patient variability ranges 
172,178-180 to marked 171,180,181, colonization with H. pylori may 
in determining both and the response to antibiotic 
patient H. pylori genomic variability has been demonstrated by the 
nitroimidazole-sensitive and III infected patients 182,183 and by the 
demonstration of showing differences inA.."""'''' 
associated genes vacuolating A (vacA) and cytotoxin-associated 
(cagA) 184, The latter may as the distribution of 
particularly the of the gene 
both in peptic adenocarcinoma 13,14, while 
differences in virulence postulated to playa role in the infection L"''''"VJl'' 
Pathogenic factors 
While certain factors appear to host to infection by H. pylori 187, 
clearly possess a well-defined battery pathogenic factors which allows the organism to: (1) 
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gastric mucosa gene product, urease, flagella, acid inhibitory 
iron-acquisition and shock (2) host defense (by 
shedding surface proteins, superoxide catalase and poorly reactive 
lipopolysaccharide); and (3) damage host tissue (proteinaceous toxins). factors allow 
pylori to colonize and in the host, thus establishing a chronic infection. 
Many species secrete toxins which play an important 
III of numerous represent a 
that have evolved over millions for the specialized 
with eukaryotic cells 1 in strain pathogenicity can also achieved by the 
inheritance of a pathogenicity associated island (PAl), a large "alien" DNA 
which encodes virulence proteins 186. 
1988, epithelial vacuolation was following in vitro exposure to H. pylori 
culture supernatant 1 was 55% of and 
characterization suggested it was caused a high molecular protein. Following 
early observations, vacuolating cytotoxin (Vac A) has researched 
to its structure, effect on epithelial and its clinical 
A second protein, which is and immunodominant, IS CagA. 
which is a pathogenicity evokes a systemic antibody 
response in the human 190. Such a response identifies HU'v"''''''H with cag+ ""~'''''H'''. 
identification of and strains with a pathogenicity island led initially to 
of clinical into two broad type I and II 191. Type I et..",,"e 
CagA and exhibited activity and gastroduodenal 
",,",<A,,'''' models 192. II strains do not CagA or are not 
with disease. Such a classification, however, to be too it 
other potential pathogenic information including and/or deletions 
genes of the (e.g. cagE, cag 10), genes as well as genes in the 
identified plasticity zone. more focussed approach encompassing candidate virulence 
may suggest are not fully independent of importantly, are 
not absolutes but degrees 
4.4.1 Vacuolating Cytotoxin A (vacA) 
vacA gene (HP0887 strain 26695 in strain J99) is nrp';:Pn in all H. pylori 
':Hl'..>1.", but the toxin is ';:Pl'rPU'i1 in detectable amounts in only about of the isolates. 
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alleles are of any combination of sequence type a, sIb, sIc or and mid­
region (m 1, mIx or m2) 8. Initial studies in the USA QeInOlnStraU~Q that infection with strains 
with was to gastric inflammation, duodenal ulceration, vitro 
cytotoxin ",,...r,,,,1r,, v...,v..,",,,, of the cytotoxin-associated cagA, whilst s2 
strains apl0el:tr to have pathogenic 11. When from non-oriental world­
wide studies are combined (Table 4.2), vacA sl strains are also associated peptic 
link between the ability a to induce epithelial vacuolation 
in vitro ulceration in vivo is significant but does not aUl:Jt:l:Lr to be invariable 6. 
Table 4.2 World-wide relationships nPT""p"" vacA sequence (s) subtypes in different 
u,""vue,,", groups 11,1 193-196 
Disease 
NUD 
No. of vacAsl 
64% 
87% 
vacAs2 
GCa 143 98% 
= non-ulcer dyspepsia; n<lC'T.... ,.,peptic ulcer U''''''''''''''''', adenocarcinoma 
from Orient (China, and Korea) are somewhat at odds with this 
predict outcome 197­and suggest these regions, may not as 
have led some to suggest that gec)gr:apn in allele pv....r"" 
may associations 201. Such objections, however, to be 
and are by assuming disease are fully independent of each 
when they could reflect Alternatively, there is to suggest that 
from "non-Asian" strains may have as a separate clonal 
at the C-terminus (approx. kDa) 202. The remaining (traditional 
assembles into copies to form the holotoxin toxin 
protein is not HVIHV.lV Irnr.Ufn proteins and acts to form within its 
cells 203. vitro studies show the toxin is well to the environment it 
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is irreversibly activated by acid exposure 204. The purified toxin binds specifically to, and is 
then internalized by, cultured epithelial cells 205. It then acts on an undetennined target in the 
cytosol to interfere with membrane trafficking 206, resulting in the fonnation of post­
endosomal compartments (or vacuoles) which have both endosomal and lysosomal features 
207. Primary cultures of human gastric epithelial cells, when exposed to bacterial broth 
culture supernatant containing vacuolating cytotoxin activity, appear to be more sensitive to 
the vacuolating activity than established tumor cell lines such as AGS and Hela cells. Hela 
cells themselves do not appear to have a receptor for the subtype m2 allele and hence are not 
vacuolized by vacA toxins with this allele (Figure 4.1) 208. 
51. Signal 31·mid region 
sequence 
s1a 
s1b 
s2 
"-_...J 
m1 
m1a 
m2 
Figure 4.1 Structure of the vacA gene. The vacA sla1s1b/s1c encodes a protein which is Tox+ 
(cytotoxic). The vacA s2 product is non-toxic. The major vacA homology is present in the 3'-region 
(m1, m1a or m2) of the gene. Twelve protein combinations are possible. (adapted from Atherton et al. 
J BioI Chern 1997; 270: 17771-17777 8). 
4.4.2 cag Pathogenicity Island and cagA 
The cag pathogenicity associated island (P AI) is a region of approx. 40 kb associated with 
pathogenicity and encodes a functional bacterial type IV secretion system to export CagA, 
and induce interleukin IL-8, NF -KB activation, c-fos and c-jun induction in H. pylori 176,209­
213. The island has a significantly lower concentration of guanine and cytosine residues 
(35%) than the rest of the genome which indicates that it was acquired from a secondary 
source 176,186. It is possible that this island may be present in as much as 60-70% of 
organisms world-wide but this has not been systematically investigated in all populations 
7,202. It has been postulated that sub-populations of organisms with differences in virulence 
may have been generated following insertion of the designated insertion sequence 605 
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(1S605), and rearrangements and deletions within the P AI 176 but this also appears not to be a 
universal phenomenon. The cag P AI can be contiguous, separated into two distinct units 
(cagI and cagII) by an intervening chromosomal sequence of differing length, or consist of 
units with partial or complete deletion or inversions (Figure 4.2). 
I caglcagll 
•...1...•-+ +- ~ +-- ....-:+- --+ ....+-+- +-- , ..... ---l+­
567 10 13 15 16171 'T S Q M I H G E C A 
Figure 4.2 Schematic representation of the cagPAl. It may be divided into two sections (cagJJ and 
cagJ) by an insertion sequences (JS605) (x) . Genes in cagII are labeled from cag6 to cagS while genes 
in cagI are labeled from cagQ to cagA (Adapted from Tomb et al. Nature 1997; 388:539-547 41 ) . 
cagII encodes 15 ORFS including cag6,1 O,S and T. Inactivation of the genes cag6, 10 (the 
virD4 homolog), S and T (the virB7 homolog) differentially alter IL-8 secretion 214 ,215. 
Disruptions in genes of cagII are also associated with alterations in CagA phosphorylation 
and translocation 215. cagT also has a low level of similarity to the 42 kDa IPAC surface 
antigen of Shigella flexneri 176, and is a useful marker for the presence of cagII or a 
contiguous P AI 216. 
cagI encodes 15 open reading frames (ORFs) of different transcriptional polarity. 
Within cagI, the gene cagA (HP0547 in strain 26695 and JHP495 in strain J99) encodes a 
high-molecular-weight a tigenic protein (120 - 140 kDa) 7,202. Variability in the 3'-coding 
region of the cagA gene, which has been postulated to alter the immunogenicity of the 
protein, results in the differences in CagA size. The function of CagA has recently been 
elucidated 210-212 . Attachment of H. pylori results in the translocation and phosphorylation of 
CagA, with the resultant activation of signal transduction pathways (IL-8 secretion, NF-ill 
activation, c-fos and c-jun induction) 210,213. Its production is also a useful marker for the 
presence, but not the integrity, of the cagPAI. The majority of clinical studies have focussed 
on expression of the gene product (i.e. CagA), rather than the gene (i.e. cagA), per se. Such 
clinical studies have demonstrated that CagA-producing strains occur more frequently in 
patients with peptic ulceration than in patients with chronic gastritis alone 7,202,217, while 
recent evidence has shown an association between infection with CagA + strains and the 
development both of atrophic gastritis and of adenocarcinoma of the stomach 13 ,14. In 
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addition, 3'-region its protein appear to with 
VH""V''''' outcome vivo 193,218, 
nu"v"",.. proliferation, protein of an 
immunodominant region of cagA) demonstrated to specifically 
phytohemagglutinin-A (PHA)-driven proliferation 219, In addition, was 
also to inhibit the growth of GM-CSF stimulated THP-l monocytes and Kato-3 
suggested a 
epithelial However, the growth of even in the presence of growth medium­
._......"hcolony factor (GM-CSF) was ,","'."au,,", by this protein. These that 
may be anti-proliferative but modulatory effect this protein is the 
type, 
.... "..,'v_"u of cagA are a H~',H~''''' a"~,vv"a.,,,u with IL-8 The 
to be critical for in vitro IL-8 with a 
is similar to deletion lose the ability to .u.... ""..,,", release 209, The 
the ofAgrobacterium tumefaciens 176. 
insertion sequence 1S605, is an intervening sequence which the cagPA! 
into and cagI 176,220. It is between the (similar to the 
prepilin peptidase) (similar to the Erwinia chrysantemi 
PTS system PTBA I 1S605 encodes two transposases, 
(TnpA) and B and fun length or of this 
may also be present in the chromosome I a high 
level to 1S200 from while TnpB has a similarity to 
bacterium PS3 gene for transposase-like protein IS606 is a 
second pylori insertion sequence. It has the same arrangement and 95% DNA 
sequence identity to 1S605 41. Both are present as discrete about one-third 
ofH pylori strains 
intact, complete, cag associated with duodenal in H 
France and 21 I, although patients harbor 
strains partial or complete cag PAl which ""V'VU'JU" 
The cagPA! IS not, however, restricted to severe 
gastroduodenal disease; 53% of French, 90% of United Kingdom and 82% NUD 
have intact cagPAls 21 It is possible that the structure of the cag PAl 
may exhibit geographical differences. Although numbers of (89%), UK (90%) 
of 
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and Japanese (94%) isolates have intact cagPAls, significantly more (p < 0.05) UK isolates 
have the IS605 element (62% vs. 32% [Japan] and 17% [France]) 216,221,222. 
4.4.3 iceA 
A novel gene has been discovered recently, designated iceA (induced by contact with 
epithelium) 12,223. There are two main allelic variants of the gene: iceAl and iceA2. 
Functionally, the iceAl gene is a homolog of adenine methylase 12. In vitro, iceAl (HP1209 
in strain 26695) causes increased mucosal concentrations of IL-8 223, and the expression of 
the gene is up-regulated on contact between H. pylori and human epithelial cells 12. Sequence 
analysis has demonstrated that this is a 127 amino acid protein, but in-frame alterations may 
result in putative proteins of 47-130 amino acids 224. iceAl may be associated with peptic 
ulcer disease 185,223 but this is probably limited to non-Oriental countries 201. 
iceA2 (JHPl132 in strain J99) has no homology to known proteins, and occurs in a 
number of forms based on alterations in repeat structures 224. In its most common form, iceA2 
could encode a protein of 59 amino acids which can be divided into two conserved outer 
domains of 14 and 10 amino acids that flank 3 internal peptide domains of 13, 16, and 6 
amino acids respectively (Figure 4.3) 225. The 13 and 6 amino acid domains are highly 
conserved, but the 16 amino acid domain exists in one of two variants, 2B or 2C. Sequence 
analysis of multiple H. pylori iceA2 strains has recently revealed that this internal 35 amino 
acid cassette may be absent or repeated resulting in deduced proteins of 24, 59, 94 or129 
amino acids 224. Five distinct iceA2 subtypes have thus far been defined; subtypes 2B/C 
appear to be transcribed more readily than 2D 224. 
14 10 
2A (24aa) k " ?::i_ 
14 13 16 6 10 
2B/C (59aa) I :::~:::::~::_ 2B/2C 
-
20 (94 aa) •..•... 
2E (129aa) 1--------41x2 
Figure 4.3 Schematic representation of the iceA2 genotypes. The top figure represents 
iceA2A, the middle figure variants 2B and 2C, while the lower figures represents the form of 
iceA2 with an additional 13-16-6 repeat. The motif in 2D is typified by 162B-162c, which is 
repeated twice in 2E. 
I
I ::::::/mr:::::i
:u ; ::))::: m 2B/2C _ 
20 (94 aa) .' 
-l   
z - z  
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
47 
4.4.4 Urease 
On culturing H. pylori, Marshall and his thought the bacterium was urease 
negative It quickly became apparent, an extraordinarily high amount of 
urease, up to 10-15% 226 of total cell protein was produced the organism 227. Numerous 
established that urease is pathogenesis of H. pylori 
the enzyme is essential for gastric mucosa 
aminohydrolase urea to ammonia 
and latter decomposing to carbonic ammonia, with the net result of 
H. pylori is not acidophilic, and is to low pH (similarly to 
most pn1rPMIl' bacteria), it has been demonstrated that optimum for activity 
2 to 6, serves to protect the bacterium, at in vitro, through local acid 
are recognized to comprise the ure pylori. UreA and 
ureB ....ll'JV.... ' .... structural subunits of the enzyme of these 
genes of 26.5 and 60.3 kDa, respectively and 
are ,",VA,!':"',,,,,. encoding proteins that function to nickel ions, which 
are catalytic activity. The role of ureI which is not ess;en1tlal urease 
and apparent homologues in other urease 231 is ess;en'tlal H. 
pylori in vivo and for colonization 232. 
gated urea cytoplasmic urease Using filtration 
the to be 550 kDa in size and to contain equimolar 
It is generally accepted that there are six copies 
subunit in the and two nickel ions fill each active site of which are 
located within the subunit. 
In contrast to where ureases are entirely cytoplasmic, pylori 
urease can be cytoplasmic compartment and outside to 
surface the organism mechanism for urease extrusion appears to 
autolysis 236. A number studies have demonstrated a second function 
urease, and that is the m~Lml:enan(~e the proton motive force which is 
organism to It would appear that at 
than 6.5, the urease is vital protection and bacterial growth, 
while it has been urease is responsible for initiating autolysis at 
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close to neutral urease is critical allowing 
organism to metabolize between pH and 8 237. 
of the products of urease also play some role in damage. Direct 
injury to the epithelial occurs in vitro from 238,239. In animal studies, 
ammonia has been shown to the cell kinetics of the mucosa, and long-term 
exposure to mucosal atrophy 114, vitro studies have shown that ammonia to 
cancer cell lines a dose-dependent delay by LALA''''''''.'' 
an accumulation cycle 240,241, numbers 
DNA synthesizing in vivo, may in the of mutations which can lead to 
cancers 242, essential role for urease in gastric colonization confirmed using 
l;;)VJ;:.""lH'" mutants the nude mouse model 243. Studies also have shown that isogenic mutant 
H pylori strains without urease activity will not colonize gnotobiotic pigs, even when 
secretion is suppressed These show the critical role of the urease III 
pathogenic of this bacteria and also that the ammonia produced be a 
source synthesis ofproteins ne(:essar for adhesion. 
4.4.5 Flagella 
pylori produces polar sheathed flagella, are to be essential for the bacterial 
colonization of mucosa. The flagella of H pylori are constructed repeating 
protein (flagellin) having a molecular weight from kDa 246.248. The 
nucleotide sequence of the flagellin gene flaA has an open reading 1530 
'"'u'"'''~£u'''' a protein with a predicted molecular mass of 53.2 Sequence alignment this 
with flagellins a high degree similarity the amino-terminal and 
carboxy-terminal regions, but little in the domain is supported by 
that the flagella of H pylori are antigenically related to the flagella of C. jejuni 248, 
and to the antigens a diverse of gastrointestinal spiral 247 
suggests convergent a advantage this for gastrointestinal 
mucus motility. The flagella of H pylori are III membranes which contain 
lipopolysaccharides (LPS) and 250 appear to be important as organs 
primary attachment. 
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4.4.6 Heat Proteins (HSPs) 
HSPs playa the '"'a'!lv.""............"." immunology pylori infection. In 
bacteria, pylori a bicistron em:oOIng GroES-GroEL homologues. In H. pylori, 
proteins were designated HspA 10 homologue) (the Hsp60 homologue) 
251,252. While the HspB protein is similar to the and eukaryotic 
chaperonins, a unique structure found in the HspA The N-terminal domain 
corresponds to conventional 10 bacterial chaperon in, the C-terminal domain, that 
other homo logs lack, is a nickel-binding domain. presence of this highly 
charged suggests an role of the HspA cmtoeron for the or 
stabilization of the urease/nickel complex in an acid environment. HspB IS 
immunogenic in infected patients while only 30% of patients develop antibodies to 
Interestingly, however, HspA has successfully shown to protect against pylori 
infection the H. felts mouse model 
4.4.7 Lipopolysaccharides 
Bacterial endotoxins exhibit and diverse biological properties and In 
higher organisms, they elicit a broad spectrum of harmful effects that contribute to the 
pathogenic potential of the The chronic, infection associated with H. 
has to many investigators the organism evolved to 
immunological reSOOllse H. pylori, "''''1"1''''''' by electron 
.....";.....,,,........ 
typical trilaminar cell of Gram-negative of which the outermost 
layer is the outer membrane membrane consists a lipid bilayer, and outermost 
leaflet the lipid bilayer is ""T"' ...."" of lipopolysaccharide (LPS). Inserted into this lipid 
are outer membrane Porin proteins embedded in this act as 
",""'44"'""",,, to allow molecules to migrate into the cell, and urease is associated with the cell 
general structure is a glycolipid of a core lipid, and a 
polysaccharide region, containing the O-specific chain. Generally, the immunomodulating 
and immunostimulating ofLPS is provided by lipid A 257, Structural comparisons 
lipid A reveal that it has less phosphate and fewer fatty acids than E. coli 
lipid length of acid chain is, however, increased in H. pylori and additional 
has been by fatty acid phosphate substitutions 258. This 
maybe altered biological 
253 
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The O-specific IS a composed of repeating units of a certain 
number of which is to is that these repeating 
in some strains H. pylori .HF,V"..... expressed on erythrocytes and in the 
gastric mucosa. Some strains express LewisY , whilst a third 
group both mimicry may induce autoantibodies which 
could cause cross-linking of CD15 by 
pylori induced ..." ..r'-.,... recruitment 
Attachment H. pylori to O<;lct.... l" mucosa is mediated by blood group antigens 
expressed on the gastric epithelium 261. ;onresPolndlug UUl''''''''1''' must therefore be present on 
the H pylori cell identified as the Lewisx antigens 
similar to the human blood - which is expressed on gastric epithelial ....n-·.. 
Interestingly, purification a 1 ,3-fucosyltransferase and PI ,4-galactosyltransferase 
and elucidation of their "~..,,,~"".. that these were the same as those 
mammals to is actively secreted into the culture medium 263 it 
has been suggested that it enter the gastric tissue 262. The structure 
mediates attachment gastric epithelial cells at specific sites with reciprocal 
blood group U1n1M""U'" on pylori initiates an immune response in the host 262 and may 
therefore pylori induced autoantibodies which cross react VA'J>""'U 
with the patients 264. This autoimmune mechanism 
lead to cell injury development of gastritis. H. pylori LeX may also 
involved in the ao'wn-regRlanon T-cell immune response encountered in 
patients 'I""",,,,tl,,,,,,,. with the low pro-inflammatory activity of H pylori 
ensure 
persistence 
The biological activity LPS has been reported in a 
ranging from induction to LPS-LPS binding 
studies a proportionately lower 
LPS to activate mC)llCfCVl:eS '"'''''''1-'' .... from other organisms. The bacterial 
LPS is transduced via an binding receptor. The best studied of 
receptors is CD14, a glycoprotein expressed on the surface 0 f 
macrophages, tracheal epithelial cells 265-269. Activation of this rp""",nrnr 
been associated with or synthesis cytokines, interleukins, oxygen radicals and 
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tracheal-specific antibiotic peptide 265-269. These responses are modulated by either tyrosine 
kinase activity or redistribution of intracellular G-proteins 269. 
Two studies have identified a putative role for H. pylori LPS as a pathogenic factor in 
gastric disease. Such studies have demonstrated that intragastric administration of H. pylori 
LPS at doses ranging from 50 to 200 ).ig in rats results in stomach mucosal inflammatory 
responses typical of gastritis. Infiltration of the lamina propria with lymphocytes and plasma 
cells, edema, hyperemia and hemorrhage extending from the lamina propria to the surface 
mucosa, were noted in these experiments. Such changes were associated also with marked 
increases in epithelial apoptotic indices both in the superficial epithelium as well as deeper in 
the glands 270,27J. These results suggest that LPS may be a pathogenic factor responsible for 
the induction of gastric epithelial cell apoptosis by H. pylori. It should be noted that the 
dosage administered to the rats was high, in the order of 1-5 x 10-4 M, which complicates the 
physiological interpretation of these observations. In addition, no studies were performed on 
LPS from other bacterial species. 
In a second series of investigations, conducted with guinea pig stomachs in Ussing 
chambers, H. pylori LPS at high concentrations (0.25mg/ml) selectively stimulated gastric 
mucosal pepsinogen secretion in comparison to E. coli LPS at the same concentration 272. 
This release was not due to chief cell damage by LPS. Later studies suggested that this effect 
may be virulence dependent; H. pylori LPS mediated pepsinogen release was higher from 
duodenal ulcer patients compared to non-ulcer subjects 272. 
The apparent LPS concentration to which the human gastric mucosa may be exposed 
in vivo is not known. 
4.4.8 babA 
The blood-group antigen-binding adhesin (BabA) mediates adherence of H. pylori to human 
Lewisb blood group antigens on gastric epithelial cells 261,273. It is a 78 kDA protein 273, and 
recently, the two genes encoding BabA have been cloned 9, Only the babA2 gene, which 
differs by the addition of a 10 bp insert, is functionally active 9, The clinical relevance of this 
gene has been suggested in one recent study 274. 
4.4.9 Lipase and Protease 
Lipase and protease secreted by H. pylori can degrade gastric mucus, shown by the loss of 
protective qualities of mucus 275. H. pylori protease activity leads to the disintegration of the 
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polymeric structure mucin, whereas elaborated LAI-'''''''''''' and phospholipase in particular 
result in mucous lipid degradation, loss mucosal surface hydrophobicity and 
lysophospholipid The lytic the resulting lysophospholipids is 
detrimental to mucous and to cell It is possible that 
pylori has the ability to disrupt the layer at the of the 
mucous cells through phospholipase activity 278-280. 
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Chapter 
Analysis of vacuolating cytotoxin A heterogeneity in 
Helicobacter pylori and its relationship to gastroduodenal 
5.1 Introduction 
The structure and of has been described in Chapter 4.4.1. Results from 
conducted in developed suggest that development of clinically significant ",u"",",,,,,,,,, IS 
associated with "pathogenic" strains are known as type I 
as to II strains 191, and have the ability to 
vacuolating ""."<Trl,.. vitro, CagA, and activate neutrophils 
6,7,215,281 
The link """r,,,,,,,,"" of a strain to induce epithelial vacuolation in vitro and 
peptic ulceration in vivo is but not invariable 6. In the USA with 
with the vacA sla linked to gastric inflammation and ...v,",,,,,,,,... ulceration, 
whilst vacA least pathogenic potential II. postulated that 
specific alleles as populations, would 
in the African 
5.2 Material and Methods 
5.2, J Patients, sampling and cultivation ofH. pylori strains 
All human approved by the Ethics and (University of 
informed consent for the procedure. hundred and nine H. 
patients undergoing upper gastrointestinal endoscopy were 
percent of the patients were 20% were black 
and 8% were with a predominant male sex ratio of and a median age of forty­
seven Sixty-four patients had a isolated from the 
antrum, 21 from two anatomical fundus) and one 
patient had (duodenum, antrum and and histological 
diagnoses were all patients. In no endoscopic 
pathology was but histology confirmed the "rp·cpt,,..p .. tn'...,n', .. active gastritis, 
twenty-eight had duodenal ulcers and nineteen Gastric 
biopsies obtained from the antrum of all patients were _U as described 99.\JUL...... 
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Briefly, biopsies were transported in a jar under micro-aerobic conditions (Oxoid Gas 
Generating BR38, Basingstoke, Hampshire, UK). The specimen was cultured on tryptose 
blood agar (CM 233; Oxoid Ltd.) containing lysed horse blood (10% vol/vol) at 37 C in a0 
micro-aerobic atmosphere (12% C02, 88% air (6% C02), 95% humidity) for a minimum of 
seven days. H. pylori were identified by colony morphology and positive urease reaction 
(Christensen's urea slope). The strains were numbered, and all analyses were performed 
without prior knowledge of the clinical diagnosis. Reference strains 26695 41 and J99 42 were 
used in this study. 
5.2.2 Preparation ofsamples for PCR amplification 
Genomic DNA was isolated from each colony utilizing the High PCR (polymerase chain 
reaction) purification kit from Roche Diagnostics (Johannesburg, South Africa) 282. Briefly, 
bacterial cells were resuspended in PBS (phosphate buffered saline), and lysozyme (10 
mg/ml) added. Thereafter, cells were further digested by proteinase K and the DNA was 
isolated/purified by chaotropic salt/glass fiber methodology. Approximately 10 ug DNA was 
obtained from 106 bacterial cells. 
5.2.3 PCR amplification and detection ofamplified DNA products 
For vacA, primers VAIF and VAIR were used to amplify the signal sequence 8. 
Amplification fragments of 259 bp for genotype s1 and 286 bp for genotype s2 were 
expected (Table 5.1). Further analysis of the sl genotype was performed using SS IF and 
VAIR for sla and SS3F and VAIR for sl b. The vacA mid region was amplified with primers 
V AGF and V AGR, resulting in fragments of 570 bp for m 1 and 645 bp for m2 respectively 8. 
Table 5.1 Primers used to identify vacA alleles 
Region Allele Primer Primer Sequence Size (bp) Ref 
Mid- ml or m2 VAG-F 5' -CAA TCT GTC CAA TCA AGC CAG-3' ml = 570 8 
region VAG-R 5'-GCG TCA AAA TAA TIC CAA GG-3' m2 = 645 
Signal 
sequence 
sl or s2 VAI-F 
VAI-R 
5'-ATG GAA ATA CAA CAA ACA CAC-3' 
5'-CTG CTI GAA TGC GCC AAC-3' 
sl = 259 
s2 = 286 
8 
sla SSl-F'" 5'-GTe AGC ATC ACA CCG CAA C-3' sla = 190 8·201 
slb SS3-F* 5'-AGC GCC ATA CCG CAA GAG-3' slb= 187 
sIc SlC-F* 5'-CTY GCT TIA GTR GGG YTA-3' sIc = 213 
'" Used m comb matI on WIth pnmer VAI-R 
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PCR amplification vacA was performed as previously described 8. samples 
were incubated buffer including MgCh [15mM], nucleotides (200uM), 
primers (O.2uM) polymerase as per the manufacturer's 
Diagnostics), and Following initial denaturation, 94°C for 1 
reaction consisted denaturation at 94 "C for 1 min., ......t.• ..,,,. 
for 2 min. and final ext,enSlOn at "C 10 min. Annealing .....u,'O-'v. were set at "C 
for VAlF, IR, SI VAGR, and 59°C for VAIR, 
was subjected to gel electrophoresis on 1 
a 100 bp DNA ladder was used as a size marker. 
5.2.4 UH"H.,tl'L-U< TTlPI'TUlil" 
Data (n 109) were analyzed using the chi-squared test or 
exact test as "nT'.rnr,,.., mUltiple regression, the data were summarized into two-way 
rows and columns for vacA genotype and disease status. 
Of(~SellCe or !lr!l/~rpr was binarily coded, present = 1, absent O. All 
analyses were ...."''"'i".....rl'Y'l with ST A TISTICA © software (Gaithersburg, Maryland, 
Probability levels < 0.05 were considered statistically significant. 
5.3 Results 
5.3.1 Determination 
The vacA was pylori isolates. By using the primers F and 
VAIR to amplify bp 
genotype s 1 was strains as well as 
the two strains yielded the 286 bp amplicon (s2). 
None of any other size. Further analysis of the eighty­
nine strains with that 88 (99%) were vacA sIb and 1 (l%) was 
sla. No l"'UU'"'_''' sIc allele. Strain 26695 was vacA sia while J99 was vacA sIb. 
All 109 the two reference strains contained DNA was 
amplifiable by resulting in fragments of 570 bp (m I) in 73 (67%) 
26695 and (m2) in 36 (33%) respectively. None had DNA <CU"I-''''1''',,", 
sets of primers or other than predicted. Among one 
nine isolates studied, 5 6 possible combinations of vacA signal and mid reg:lOIlS were 
identified. The slaJml V""UVA...."V" was found in one (1%), slb/ml in 69 (63%), s 
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18 (17%), s2/m1 in 3 (3%), and s2/m2 III 17 (17%). The sla/m2 combination was not 
detected. 
5.3.2 Relationship ofvacA genotypes to gastrointestinal disease 
All patients with peptic ulceration were infected with vacA s 1 strains (36, 100%), compared 
with only 27 (57%) of 47 strains from subjects with gastritis alone (p < 0.00001) (Figure 
5.1). 
* * 
s1a s1b s2 m1 m2 
vacA alleles 
100 
90 
* 80 
.-. 70~ 0
-­en 60Q) 
....... 
CO 500 
en 
Q) 40 
> 
....... 
en 30 
0 
0... 20 
10 
0 
D Gastritis alone Peptic ulceration Gastric adenocarcinoma 
Figure 5.1 Relationship between vacA alleles and disease states. *p < 0.05 vs. gastritis, **p 
< 0.05 vs. PUD or GCa. 
All of the 26 strains (100%) isolated from patients with gastric cancer were sIb (p = 0.0002). 
The vacA s 1 blm 1 genotype was found more often in strains from patients with peptic 
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(83%, p = 0.0007) and was more commonly with strains from gastric 
adenocarcinoma (76%, p < 0.003) than gastritis (40%). The strong relationship 
nPTl,"PF'n the vacA s 1 allele and disease was confirmed by "'''''''.VB analysis (Table 5.2). In 
the vacA s2 genotype was isolated ...",..,,,.... ,;;,. strains from patients with gastritis 
was not found in peptic ulceration (0%) or 
(0%) (both p < 0.0002 vs. alone). In addition, the vacA s2m2 
C'fpr\",n,....", was found exclusively in alone (36%). This was 
significantly higher than in strains with ulceration (0%, p < 
0.0001) or gastric adenocarcinoma (0%, p < 0.001). 
1J'::1'1,",11L;) 
Analysis of the vacA midregion demonstrated that they were not 
distributed in patients with gastroduodenal vacA ml genotype was, 
found more often in strains from with peptic ulceration (83%, p < 0.001) and 
adenocarcinoma (77%, p < 0.02) than in strains from gastritis alone (49%). 
analysis demonstrated a statistically ."'".u"'....... relationship between vacA ml 
disease in these isolates (Table 
Table 5.2 Relationship between and clinically significant (both PUD and 
disease 
p-valuer 
vacA sl +0.469*0.469 < 0.0001 
vacA mt +0.238*0.238 0.049 
PUD = peptic ulcer 1,,11;)'....";)'.... , adenocarcinoma 
* = significant ~ 
5.3.3 Predictive value ofvacA strains 
The sensitivity of vacA as a marker for gastric disease (either GCa or is 100% based 
on the data generated in study (Table 5.3), while the specificity of vacA as a marker is 
43%. The predictive for strains range between 49-57%. 
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Table 5.3 value of vacA s 1 for clinically disease 
Diagnosis SE SP 
PUD 0.57 1.0 1.0 0.43 
GCa 0.49 1 1.0 0.43 
PUD ulcer disease, GCa adenocarcinoma 
PPV = positive predictive value, 
specificity. 
= negative predictive value, SE = sensitivity, SP = 
5.4 Discussion 
In the present study, the results demonstrate a high prevalence of the vacA allele and 
confirm low prevalence of the vacA sia allele previously found in a smaller sample 283, 
....."',.,".;,,., groups that the sIb allele was found consistently 
(1 00%) ~tr'.l"n~ from \..11<)'1.<0.<)'1.<. In contrast to isolated from 
patients peptic ulcer the USA are nr,,·rI,..,·tnl1.. ~n a 6, no vacA 
s 1 a <<1>\,,.,,,.:> were present in any South African strains associated with the ,,u.:>'.... ,,.:>'v. In the USA, 
vacA s 1 b strains appeared to be intermediately ulcerogenic and vacA with this signal 
were found to be cytotoxic in vitro than vacA s 1 a strains 8, II. South African 
to produce of in vitro activity in vacA 
epithelial (Hela) Our n'tp'rrlT'ptp'r! as being compatible 
with, and perhaps supportive of the "African enigma" concept. As has noted, however, 
the assumption on which the "low p evalence" ofy,..".......,'" in Africa is can be questioned 
• .).,;.,).).,;.()v In addition, a high prevalence of vacA is not limited to South Africa; vacA sIb 
un,"""., are also highly Brazil 195 Portugal 194, where reported prevalences of 
ulceration and adenocarcinoma aoo,ear to higher. In study, 
allele was found exclusively in the of individuals no 
pathology other than keeping with observations suggesting that vacA s2 strains 
are minimally or and potentially non-pathogenic 6,8, II. 
The vacA middle type also to be associated with the occurrence 
disease. ""vu;u,_<) had the vacA ml mid-region whilst the 
III n~'tlpnt<' is keeping awas found more 
was more correlatedstudy which demonstrated that the 
epithelial injury (epithelial degeneration, mucus depletion and microscopic erosions) than 
mid-region m2 II, 
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The association between vaeA genotypes and gastric adenocarcinoma has not 
previously been studied in the African setting. Twenty of the 26 strains in the patients in this 
study were vaeA genotype s 1 blm1. All of the strains were vaeA sIb+. One may hypothesize 
that infection with vaeA m I strains, and the associated potential damage to the antral and 
corpus mucosa may play a role in the etiology of gastric adenocarcinoma in our study 
population. 
The temptation of over-interpreting these results is recognized. Both peptic ulcer 
disease and gastric adenocarcinoma are multifactorial diseases, and it is probable that factors 
other than the virulence of the organism plays a role in the etiology of the disease. The 
findings would support the postulate, however, that disease is more likely to be associated 
with specific H. pylori strains. It is apparent that these studies are limited by the timing of 
invasive clinical investigations and, furthermore, that it is only those organisms present in the 
gastric milieu at the time of biopsy which have been analyzed. The resultant is that our data 
can only demonstrate that at a particular time in the natural history of infection, certain strains 
are more likely to be associated with pathology. 
5.5 Conclusion 
The high prevalence of vaeA sIb alleles in H. pylori strains isolated from South African 
individuals with peptic ulceration and gastric cancer has been noted. While, in general, 
attention has been focussed on the positive correlation with disease, the segregation of vaeA 
s2 alleles with "non-pathogenic" strains may be an excellent negative marker. 
These studies suggest that a number of the associations established between H. pylori 
virulence factors and disease in other parts of the world apply to the South African setting. 
Cytotoxic strains (vaeA sImI) are associated with disease while less cytotoxic strains (vaeA 
s2m2) are found exclusively in patients with gastritis alone. There are, however, some 
interesting differences. The prevalence of vaeA sIb is extremely high, while that of the highly 
cytotoxic vaeA subtype Ia is very low. The widespread prevalence of a low cytotoxic vaeA 
sIb allele, however, may have important ramifications and requires further study. 
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Chapter 6. 

Analysis of cytotoxin associated gene pathogenicity island 
ofHelicobacter pylori in relationship to gastroduodenal disease 
6.1 Introduction 
The structure of the eag pathogenicity and genes therein have 
been 4.4.2. The production of protein and presence of 
majority of pathogenicity has been associated with 
clinically gastroduodenal disease not 
13,14,200,201 structural subtype of eagA with gastric carcinoma 
and atrophy 8, while an intact, complete, is highly associated with duodenal 
ulceration pylori from France . Patients with disease 
however, harbor with partial or complete ..... '-'"'-',, ..... u"' the PAl 216,221. 
however, is known about the structure of the island in with gastric adenocarcinoma. 
structure of the eagPAI in South ",va,,"..:> has not previously been studied. 
In we that H. pylori .u'V....,,'u different clinical diseases would 
exhibit eagPAI and that there would an association between the 
vaeA allele. The organization 
were therefore and by means 
of chain reaction (PCR) functionally important 
cagE, and the eag] region, and two genes, eagT and,u",u,",-" 
Strains which were "PCR-negative" for these genes were analyzed for 
(which virD4 homologue) as as the downstream eag13 
addition, of the eagPAI was tested by analyzing the presence of 
amplicons. ]S605 (tnpAIB) was tested for as a potential insertion between eag] 
of]S606was 
Materials and Methods 
and DNA 
DNA 109 H. pylori isolates "1",,""'-"'''' patients (Cf. "'''"''''''''" 1.) was 
to presence of the eagA in the 3'-region of 
1 
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and for analysis of the cag P AI. Reference strains 26695 41 and J99 42 were used in this 
study. 
6.2.2 peR amplification and detection ofamplified DNA products 
Oligonucleotide primers used for PCR are listed in Table 6.1. Two sets of primers were used 
for each gene examined. PCR amplification was performed as previously described (cf. 
Chapter 5.2.3) 283,284. Following initial denaturation, 94 C for I min, each reaction0 
consisted of 35 cycles of denaturation at 94 C for 1 min., annealing and extension for 2-3 0 
min. and final extension at 72 C for 10 min. Annealing temperatures were set at 50 C for 0 0 
cag2/cag4, picBFIR, 53°C for cag7/I2, cag8/9, caglO/II, cag13/I4, cag9/IO, cag7/10, 
cagIlI12 and 55 °C for Fl, Bl, FB2F, RB3R, cagMF, cagMR, cag6-7F, cag 6-7R 
10,193,216,220,221. Twenty microliters of each PCR mixture was subjected to gel electrophoresis 
on 1 % agarose gels and a 100 bp DNA ladder (Roche Diagnostics, South Africa) was used as 
a size marker. Long-distance PCR was performed with the Expand™ PCR System (Roche 
Diagnostics) as recommended by the supplier 289. Briefly, samples were incubated in Tris­
reaction buffer including MgCh [22.5mM], detergents (Tween-20 and Nonidet P40 [0.5% 
v/vJ), nucleotides (500uM) and the enzyme Pwo/Taq mix, and subjected to PCR. Following 
initial denaturation, 92 ° C for 2 min, each reaction consisted of 35 cycles of denaturation at 
92 C for 30 s, annealing for 1 min., and extension for 24 min. and final extension at 68 C0 0 
for 10 min. Annealing temperatures were as for standard PCR. Twenty microliters of each 
PCR mixture was subjected to gel electrophoresis on 0.8% agarose gels and a 564-23,130 bp 
DNA ladder (Roche Diagnostics, South Africa) was used as a size marker. 
 
 
-
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
62 
Table 6.1 IJM,rn<>,r", to cagPAI genes. 
Gene HP Primer 
cagA 5' 
Primer Sequence Location Ref 
*/+ 
5' -GATAACAGGCAAGCTITTGAGGGA 19119 202 
5'-CTGCAAAAGA TTGTTTGGCAGA 19468 
5' -GGAACCCT AGTCGGT AATG 21498 
21 
1335 
193 
5'-ATCTTTGAGCTTGTCTATCG 

5' -TGTTTGGTTTCCCTG 
 10 
5' -ACGCA TTCCTT AACG 
5'-TCTATAAAGAGAGAGGTGTT 
5'-GGCTAA TCTTTGGT AATCAG 
5'-ATGCTTGCAAAAATTGTITT 
5'-CT A TTCAAAGGGA TTA TTCT 
5'-ACAAATACAAAAAAGAAAAAGAGGC 
5' -ATfTITCAACAAGTTAGAAAAAGCC 
221 
2217772 1130 
5' -GCAATCA TTGAGAAGAGTITTCGC 
5'-TTTGGTTGGTAATGGTITTGGTAGC 
5' -GTTTGCTCAGTGGTAAGTGA 
5'-ATGCTTCCTACTAAAACACG 
5' -TCT AAAAAGATTACGCTCATAGGCG 
5' -CTTTGGCTTGCATGTTCAAGTTGCC 
5' -ATGAAAGTGAGAGCAAGTGT 221 
5'-TCACTTACCACTGAGCAAAC 
5' -GCT AGAGAAAAGGCTGTTGC 
5' -TGGCGTT AAT AGTGGCAA T A 
5' -ATGGCAACATGGAGA TGGTT 
5'-TTAGTTTCCTITTTITTCAG 
5'-ACATITTGGCTAAAT AAACGCTG 
402 
885 
221 
221 
5' -TGGGTTCAAGCGAACTGTGA 
5'-ATC AGT CCA AAA AGT TTT TIC TTT CC 
5'-TAA GGG GGT ATA TTT CAA CCAACC G 
5' -CGC TCT CCC TAA ATI CAA AGA GGG C 
5'-AGCTAG GGAAAAATCTGTCTA TGCC 
5'-GGA GGG TAG TTG ATA AGC AAA TC 1070 
5'-GTT TAG ACT TTA ACA CCC TAC GG 
# = HP numbers fromH. pylori strain 26695 (GenBank Accession No. AE000511) 
*/+ Location on H. Accession No. U60176 or 
ofthe cagA gene 
was amplified using primers The twelve South African 
extracted (QIAEX n gel Cape Town, 
South Africa) on an ABI PRISM 377 automated (ABI, Foster City, 
California, the ABI PRISM TM BigDye ™ sequencing reagent 
kit with DNA polymerase FS (PE Biosystems, South Africa) as 
290 PCR and direct sequencing were ,..<>,'1-",."",,·11 at least twice to 
determine DNA each strain. 
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6.2.4 Computer analysis 
DNA and protein sequences were analyzed using the National Center for Biotechnology 
Information (NCBI) server (USA) and META Predict Protein (which includes the JPRED, 
NetPhos, TopPred and DAS servers [Columbia University, USA]) 291-294. JPRED is a consensus 
method for protein and secondary structure prediction, NetPhos is a neural network-based 
method for predicting potential phosphorylation sites at serine, threonine and tyrosine residues, 
TopPred predicts the location and orientation of transmembrane sequences using hydrophobicity 
patterns by applying the "positive-inside" rule and DAS predicts the location of transmembrane 
using hydrophobicity patterns. Internet-based searches were preformed at NCBI, The Institute for 
Genome Research (TIGR, Maryland, USA) and Astra-Zeneca (Boston, USA). 
6.2.5 Statistical methods 
Data from non-identical strains (n = 109) were analyzed using the chi-squared test or Fisher's 
exact test as appropriate. For multiple regression analysis, the typing data were summarized into 
two-way tables. Each table had 109 rows and a column for the vacA genotype, cagPAI status and 
pathology. The presence or absence of each character was binarily coded, present = 1, absent = O. 
All analyses were performed with ST ATISTICA © software (Gaithersburg, Maryland, USA). 
Probability levels of < 0.05 were considered statistically significant. 
6.3 Results 
6.3.1 Prevalence ofthe gene cagA in 109 H. pylori isolates 
One hundred and six (97%) of 109 strains and the two reference strains were cagA+ utilizing 
primers F liB I to identify a 349 bp conserved amplicon from the 5' -region of the gene. The 
gene cagA was present in 35 (97%) of 36 strains isolated from patients with peptic ulceration 
and 45 (96%) of 47 strains from patients with gastritis alone. All 26 isolates from patients 
with gastric adenocarcinoma were cagA+. One hundred and six (97%) of 109 strains had 
identifiable PCR products with primer set cag2/cag4. All three of the strains which did not 
have an amplifiable conserved 5' -cagA region, had identifiable amplicons with this second 
primer set. This demonstrates that cagA was present in all isolates. 
6.3.2 Analysis ofsequence variation in the 3 '-region ofthe gene cagA. 
PCR fragments of differing length (approximately 450-750 bp) from twelve different South 
African isolates were sequenced, the amino acid composition determined, and compared to 
HP547 from strain 26695 and JHP495 from strain J99 (Figure 6.1). The conformation and 
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number of m this part of the protein were analyzed usmg previously described 
methods 21 is diagrammatically illustrated Figure 6.2. 
Figure acid sequences an segment of the 
ofcagA. 
HP0547: 
JHP495: 
142: 
175: 
188: 
192 : 
442: 
464da: 
464li: 
Ca54: 
Ca84: 
Ca102: 
Ca1507: 
Ca17: 
HP0547: 
JHP495; 
142: 
175; 
188: 
192 : 
442: 
464da: 
4641i: 
Ca54: 
Ca84: 
Ca102: 
Ca1507: 
Ca17 
HP0547: 
JHP495: 
142: 
175: 
188: 
192: 
442: 
464da: 
464li : 
Ca54: 
Ca84: 
Ca102: 
Ca1507: 
Ca17: 
NEK*FKNFNNNNN**GLKNS*****TEPIYA 
NAKL*GNFNNNNNN*GLENS*****TEPIYT 
NEK*FKNFNNNNNN*GLKNG*****GEPIYA 
NEK*FKNFNNNNNN*GLKNG*****GEPIYA 
NEK*FKNFNNNNNN*GLKN*******EPIYA 
NEK*FKNFNNNNNN*GLKNGKDKGPEEPIYA 
NEK*FKNFNNNNN**GLKNS*****TEPIYA 
EAKL*GNFNNNNNNNGLKNS*****TEPITA 
EAKL*GNFNNNNNNNGLKNS*****TEPITA 
NEK*FKNFNNNNNN*GLKNGKDKGPEEPIYA 
NAKL*GNFNNNNNN*GLKN*******EPIYA 
NAKL*GNFNNNNNN*GLKN*******EPIYA EPIYA 
NEK*FKNFNNNNN**GLKN*******EPIYA 
NEK* FKNF~* *pLKNS * * * * * TIE PIyAj 
Ro 
QVAKKVNAKIDRLNQIA* 
QVAKKVKAKIDRLDQIA* 
QVAKKVNAKIDRLNQIA* 
QVAKKVTQKIDQLNQAA* 
QVAKKVNAKIDRLNQAA* 
* 
QVAKKVNAKIDRLNQIA*SGLGGVGQAAGFP 
KVNKKKTGQVASPE EPIYT 
************** ***** 
KVNKKKTGQAASPE EPIYT 
QVNKKKTGQVASPE EPIYA 
KVNKKKTGQVASPE EPIYT 
QVNKKKTGQVASPE EPIYV 
KVNKKKTGQAASLE EPIYA 
EPITT 
KVNKNKTGQVASPE EPITT 
KVNKKKAGQAASPE EPIYA 
KINKKKAGQAASLE EPIYT 
LKRHDKVDDLSKVGLSASP*EPIYA 
LKRHDKVDDLSKVGLSANH*EPIYA 
LKKHDKVDDLSKVGRSVSP*EPIYA 
LKRHDKVEDLSKVGRSVSP*EPIYA 
LKRHDKVDDLSKVGLSASH*EPIYA 
LKRHDKVEDLSKVGRSVSPEEPIYA 
LKKHDKVDDLSKVGRSVSP*EPIYA 
************************* 
LKRHDKVDDFSKVGLSASP*EPIYA 
LKRHDKVEDLSKVGRSVSP*EPIYA 
LKKHDKVDDLSKVGRSVAL*EPIYA 
LKRHDKVDDLSKVGRRVSP*EPIYA 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
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HP0547: 
JHP495: 
142 : 
175: 
188: 
192 : 
442 : 
464da: 
4641i: 
Ca54: 
Ca84: 
Ca102: 
Ca1507: 
Ca17: 
HP0547: 
JHP495: 
142: 
175: 
188: 
192: 
442: 
464da: 
4641i: 
Ca54: 
Ca84: 
Ca102: 
Ca1507: 
Ca17: 
HP0547: 
JHP495: 
142: 
175: 
188: 
192: 
442: 
464da: 
4641i: 
Ca54: 
Ca84: 
Ca102: 
Ca1507: 
Ca17: 
TIDDLGGPFP L*KRHDKVDDLSKVGRS*********************************** 
TIDDLGGPFP L*KRHDKVDDLSKVGLS*********************************** 
TIDDLGGPFP L*KRHDKVDDLSKVGLS*********************************** 
TIDDLGGSFP L*RRSAKVEDLSKVGLS*********************************** 
TIDDLGGPFP L*KRHDKVDDLSKVGLS*********************************** 
TIDDLGGSFP L*RRSAKVEDLSKVGLS*********************************** 
TIDDLGGPFP L*KRHDKVDDLSKVGLS*********************************** 
********FP L*KRHDKVDDLSKVGLS*********************************** 
TIDDLGGPFP L*KRHDKVDDLSKVGLS*********************************** 
TIDDLGGPFP LLKRHDKVDDLSKVGRS*********************************** 
TIDDLGGPFP L*KRHDKVDNLSKVGLS*********************************** 
TIDDLGGPFP L*KRHDKVDDLSKVGRS*********************************** 
TIDDLGGPFP L*KKHDKVEDLSKVGLSASPEIEPIY'Ij IQVAKKVTQKIDRNLNQIASGLGGVGj 
ITIDDLVGPFPI !L*KRHDKVDDLSKVGLls** * * * * ***** * * **** *** *** *** * *** * **** 
R5 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
********************************************************* 
**********************VSPEPIYA TIDDLGGPFP LKRHDKVDDLSKVGR 
**********************VSPEPIYA TIDDLGGPFP LKRHDKVDDLSKVGR 
********************************************************* 
* * * * * * * * * * * * * * * * * * * * * *VSpIEPIyAj tI'IDDLGGPFPI ILNRHDNVDDLSKVG~ 
IQAAGFPI ILKKHDKVEDLSKVG8* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
********************************************************* 
*RNQELAQKIDNLN*QAVSEAKAGFFGNL 
*REQKLTQKIDNLN*QAVSEAKASHFDNL 
*RNQELAQKIDNLS* QAVSEAKAGFFANL 
*RERELTQKIDSLS*QAVSEAKAGFFGNL 
*RNQELAQKIDNLS* QAVSEAKAGHFANL 
*RGQELTQKIDSLS*QAVSEAKAGFFANL 
*RERELAQKIDNLN*QAVSEAKAGFFANL 
*RNQKLAQKIDNLN*QAVSEAKAGFFANL 
*RNQKLAQEIDNLN*QAVSEAKAGFFGNL 
SRDQELAQKIDNLS*QAVSEAKAGFF*NL 
*REQQLKQKIDNLN*QAVSEAKAGFFANL 
*RN*QELAQKIDSLSQAVSEAKAGFFRNL 
SRNQNLAQKIDNLN*QAVSEAKAGFFGNL 
*RNRELAQKIDNLN*QAVSEAKAGFFGN8 
R6 
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Figure 6.2 Diagrammatic representation of the variability in the 3'-region with predicted 
protein size and peR products (bp). 
HP0547 
JHP495 
142 
175 
188 
192 
442 
4641i 
464da 
Ca54 
Ca84 
Ca102 
• 
Protein peR product 
185 554 
167 500 
186 557 

185 554 

185 554 

185 554 

185 554 
220 659 

153 494 

239 716 

185 554 

217 650 

Ca1507 
Ca17 
239 716 
_~11111 239 716 
O RO IR1 R2 R3!L...----JI R4 []I R5 • R6 
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I 
I 
in size between 5 7 Asn repeats. wasThe multi-asparagine region (Ro)I 
followed an EPIY(AlTN) which is similar to III 
strain 26695 but not to JHP495 the O""",'-'H.U are deleted. All ''''V'''H'~''' 
exhibited an an ~ region a third EPIY A except ."'v" ...,,~ 464da in 
latter two were deleted. Alteration latter half of including additional 
..,,,,v'v..... 
R2/EPIYA and EPIY AlR3~ or EPIY AlR5~ were 1"\.."'<'An in five (42%) of 12 
South isolates. These and truncations in predicted 
varying 153 to 239 with predicted fragment lengths 
from 494 to 716 bp. DNA more homology 
from the strains (HP0547 JHP495; 73-94% 75-95% positivity) 
with four Japanese strains (GenBank number AF043487; 
identity), (GenBank number AF043489; 33-44%), JK269 
Accession No. AAC02084; 38-44%) JK271 (GenBank number AF043488; 
43%). confirm that cagA is "non-Asian" 
and that these ",t...,,, .... ,,, will po'tenltlaH more 
with """,1"\p<.n strains 216,222 than ......, ...>A......,'" strains 221 . 
of the putative secondary structures topology and 
phosphorylation sites are given in 
Table 6.2 characteristics -variants 
5 HP547 88 J 
18 
I 
54 Ca84 CaJ02 CaJ507 Cal7 
Amino acids (n) 167 185 
#Proline (%) 3.0 
'Pbospbo-S (n) 4 
'Pbospbo-T (n) 2 
'Pbospbo-Y (n) 2 
TP *PTM (n) None 
+Position 
D PTM(n) None 
Position, 
#Helix (%) 42.0 
#Sbeet ("I,,) 0.8 
5.4 
6 
3 
One 
54-74 
(0.606) 
One 
60-66 
40.3 
3.4 
5.3 
5 
3 
One 
56-76 
One 
61-67 
30.7 
8.7 
185 
4,7 4.7 5.1 
9 4 9 
2 2 
3 3 3 
None None One 
60-80 
None One None 
62-65 
36.2 34.5 34.6 
4.7 5.4 10.9 
6,9 
9 
2 
4 
One 
53-73 
(0.606) 
One 
62-63 
28.0 
4.8 
4.0 
4 
3 
None 
None 
44.6 
1.4 
#Otber(%) 57.2 56.4 60.7 59.1 60.1 54.5 67.2 I 54.0 
217 239 239 
6.1 
9 
2 
4 
Two 
52-72 
142-162 
(0.684) 
None 
26.5 
12.2 
61.3 
5.5 6.4 
8 7 
4 5 
None None 
None None 
38.1 35.5 
1.0 1.0 
60.9 63.5 ! 
= upPrcd, D = DAS, # = identified using JPRED, ' identified using 
*PTM putative transmembrane "''''F,'''''''', +Position amino acid position 
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from 3.0-~7.0%. 
This was 
Cysteines were absent in all samples per'cerlta~~e of proline 
III number 
of potential immunogenic surface peaks. In 
the differences in 
upn ...",. the greater the 
number of transmembrane segments and surface exposure. correlated with the 
residues (p < 0.02). 
the longer the 3 
longer (which were invariably 
""F,UU.,''''UJlH differences pOl:elll[lal number 
phosphorylatable tyrosine residues < 0.02) but not serine or thy,"'n.... vi)l'UU~ji) compared 
to short Similar 
cancer patients) from 
topology, and in potential number of 
phosphorylatable tyrosine residues but not or threonine were noted in the 
Japanese JK269 (Strain C) which has been positively associated with gastric cancer 
218 
6.3.3 a/size variation in the 
variation in the 106 ,+ isolates are shown 6.3. Based on 
sequence (cf. Chapter could be divided groups of differing 
fragment of < 600 bp, 600-700 bp and > 700 bp. Amplicons than 600 bp were 
found more frequently in H. pylori isolated from patients with alone (43 of 45 
[96%]) patients with peptic ulceration (27 of35 [77%J, p < 0.02) and in those from 
The 
6 [61 %]; p < 0.003) 6.3). 
No. length of cagA 3'-amplicon 
< 600 bp 600 -700 bp > 700 bp 
Gastritis alone 
Table , and disease 
did not have 3'-amplicons 
peptic bCompared with cCompared with 
43 (96%)a, 2 (4%) 0(0%) 
(n 
5 (14%) 3 (8%) 
(n 
Adenocarcinoma 8 l%t,d 
26) 
p-value 0.02 
16 (61 %) 2 (8%) 
p=NS 0.0002 
0.04 
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I of 600-700 bp were not differentially between peR 
.....F>""vu,.'" of> 700 bp were found more often in patients with adenocarcinoma (8 of 
26 [31 %]) than in patients with gastritis alone (0 45 [0%], p < 0.0002) and from 
with peptic ulceration (3 of35 [8%]; p 0.037). 
6.3.4 Predictive value 
Type 1 (vacAs1+cagA+) was in all peptic disease (36 strains (p < 0.00001 
vs. gastritis and in all adenocarcinoma (26 26) strains (p < 0.00002 vs. 
to 57% (27 47) of strains clinically 
significant disease (gastritis alone). The of type I as a marker gastric 
disease or PUD) is 100% based on data generated this study 
while the specificity of type I as a marker is The predictive values for 
strains between 49-57%. 
",tr'll""'" (vacAs1+cagA+) for clinically significant 
1.0 0.43 
adenocarcinoma 
= positive predictive value, NPV negative predictive value, SE = sensitivity, SP 
specificity. 
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6.3.5 o/cag!. 
cag! 
pylori isolates were analyzed with two different primer sets for the (HP547), cagE 
(HP544) cagM(HP537) of the region. The agreement between primer sets for 
cagA was 97%, cagE (100%) and cagM (98%). Isolates were considered positive one 
primer set gave a PCR amplification. The 26695 J99 were 
each combination Overall, (81%) 109 had all 
one hundred and nine of strains were cagA+ utilizing primers 
1 or cag2/4 (Figure 6.3). 
cagl marker genes 
location: 7,772-8,902 14,451-17,170--19,119-21,947 
Genes: cagM cagE 
Amplimers: _S86bp 1.33Sbp -349bp 
-1,130bp 2.719bp -449bp 
100 

90 

80 

70 

~ 60;,I! ~ 
!J) 
<D 50 
ro 
"0 
,!!l 40 
OJ 
>:;;;:; 

'iii 
 30 
0 
Il. 
20 

10 

0 

Figure 6.3 Schematic of with the PCR amplicons the three analyzed (top). 
positions are from No. U60176. Prevalence of genes 
different disease groups (bottom). *p < 0.009, +p < 0.05 vs. gastritis alone). 
The cagE was present in significantly more strains isolated 
ulceration (34 of 36 [94%]; p < 0.009) strains va,.",,, • ., with "'''''Tnl"' adenocarcinoma 
(24 26 [92%]; p < 0.04) than isolated from patients with gastritis alone (34 of 47 
with 
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III 
I 
[72%]). cagM was present in 85% from patients with alone, 
94% PUD 96% of gastric adenocarcinoma isolates (p = NS). strains 
26695 and had all the markers for cag!. results demonstrate that functionally 
important the cag! region were present in the majority of strains 
irrespective "u"",,,.:,,,,, status. However, which has previously been determined to play 
a critical CagA translocation and induction 212, was not PCR 
utilizing two H;"~·p...,t primer sets in a .",V'U".I'" from patients with no clinically 
significant 
6.3.6 peR analysis ofcagIl 
H. pylori "vu..",,, were analyzed with two primer sets for cagT which is 
present at 3 ' -end, and with one cag6-7 (HP520-521) at the 5' -end 
cagT was 87%. sixty-six 
(61 %) of 1 were both Thirty-five (97%) 
patients with ulceration were to 24 (92%) from 
patients with adenocarcinoma and 30 (64%) 47 isolates from with gastritis 
alone (p < 0.0002 vs. PUD, p < 0.007 vs. (Figure 6.4). Significantly more from 
peptic patients (29 of 36 [81 %]) adenocarcinoma patients ( [73%]) 
were compared to isolates from "",.,pn"o with gastritis alone (21 [45%], p < 
0.0009 vs. p < 0.02 vs. GCa). strains produced cagT 
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cagl/ marker genes 
Location: 4,289-5,193-------21,480-22,322 

Genes: cag6-7 cagT 

-590bp
----885bpAmplimers: 
--_842bp 
** ++100 
90 
* 
80 

70 

60 
~ ~ 
(/) 
(!) 50 
iii 
a 
.!!! 40 
(!) 
>
:;::; 
·iii 30 
0 
a... 
20 
10 
0 
cag6-7 cagT 
D Gastritis alone II Peptic ulceration II Gastric adenocarcinoma 
Figure 6.4 Schematic of cag!! with the PCR amplicons of the three genes analyzed (top) . 
Genes and positions are from GenBank Accession No. ACOOOI08. Prevalence of target genes 
in the different disease groups (bottom). *p < 0.0002, **p < 0.0009, +p < 0.007, ++p < 0.05 
(all vs. gastritis alone) . 
In order to exclude sequence heterogeneity at primer annealing sites in the 5'-region of the 
cagPAI as a reason for negative PCR results, forty isolates which were PCR-negative for 
cag6-7 were also examined for cag5-10 (HP519-524). This region encompasses the virD4 
homologue, a putative toxin, and should result in a PCR product of 3,370 bp (predicted from 
GenBank Accession No. ACOOO108). Twenty-six isolates (65%) of the 40 isolates had PCR 
amplicons ranging in size from 880-2,902 bp compared to the expected 3,370 bp in all ten 
cag6-T isolates tested. We next tested whether an additional cag!! marker gene, cag13 
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negative for both using to cagIJ 
(cag5-cag1). amplicons of280-3,105 bp (compared to a v.v'...... '" 
ACOOO108) were generated in ten of 14 isolates. These 
isolates had lost the majority Analysis of the 
bp Vl"".lL\",,'~U 
II 
I 
I 73 
was present in these twenty-six isolates. (HP527), which is between 0 
five (96%) of these isolates were cag13+ (as were all ten cag6-T isolates 
PCR using primers to cag!! region (cag5-cag1) was performed on one 
isolate negative "HULAIU result a PCR product of 18,402 bp 
GenBank Accession No. ACOOOI08). A product of 8,396 bp was results 
suggest that which were all PCR-negative (using two 
sets) for cagT, a (Figure 6.5). 
cagll gene markers 
Location: 
Genes: 
Amplimers: __________ 881·2,902 bp _402 bp 
--------""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""- 280-8,396 bp 
Figure 6.S Variability in forty isolates which are Genes 
and positions are GenBank Accession No. ACOOOI08. isolates had 
variable length (881-2,902 bp) for cag5-10 (3,370 predicted), and were 
PCR-positive for isolates (all cag13-negative) had PCR 
amplimers (280-8,396bp) (18,402 bp predicted). were cagIJ PCR-
negative. 
we fourteen isolates which 5 of cagIJ (PCR­
from 
remaining L~~-fiiel!~nl\ire isolates demonstrated that one had lost all the 
genes between cagM, one isolate, all the genes and and two 
isolated 
demonstrate that a complete, intact (cag6-cag1) is present 
in significantly more isolates from patients with peptic ulcer (81 %, p = 0.0001) than 
in patients with alone (38%). Analysis of of cagPAI products 
association with PUD (X2 = 0.0001 Seventy-three 
a.u"•• u.:> with gastric adenocarcinoma a complete, intact cagIJ (ppercent 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
74 
= 0.004 vs. gastritis alone) while downstream elements of the cagII region (cag10-cagI) 
were present in 100% of these isolates (p < 0.005 vs. gastritis alone). The distribution of 
cagPAI gene products was similarly, but not as strongly, associated with gastric 
adenocarcinoma (X2 = 10.14, P < 0.05). 
6.3.7 Relationship between gene markers and vacA status 
As previously demonstrated (cf. Chapter 5), vacA s 1 occurred significantly more often in 
isolates from patients with peptic ulceration (p < 0.00001) or gastric adenocarcinoma (p < 
0.0001), while vacA s2 invariably occurred in patients with gastritis alone. In addition, the 
vacA midregion (ml subtype) was present more often in patients with clinically significant 
disease (p < 0.01). Multiple regression analysis demonstrated a statistically significant 
relationship between vacA sl alleles and disease (p = 0.001 [PUD], p = 0.014 [GCa]). 
When analyzing the data by vacA status (Table 6.5), there was a significant difference 
in the distribution of alleles between the different cagPAI groups (X2 = 41.5, P < 0.00004). A 
strong association was noted between vacA sImI and strains containing the entire genetic 
information of cagPAI. Fifty-four (77%) of70 vacA sImI strains had all the genetic markers 
(cag6-cagA) compared to 10 of 19 (53%, p < 0.04) vacA slm2 and 2 of 17 (12%, p < 
0.00001) vacA s2m2 strains. Singificantly more strains with vacA slm2 (37%, p < 0.008) and 
vacA s2m2 strains (71%, p < 0.000001) had intervening regions of the cagPAI which were 
not detected by PCR compared to strains with vacA sImI. 
Table 6.5 Relationship between cagPAI gene markers and vacA alleles 
cag genes detected HP numbers sImI 
(n = 70) 
s1m2 
(n = 19) 
s2ml 
(n = 3) 
s2m2 
(n = 17) 
All tested 
genes detected 
HP520-HP547+ 52 (77%)*# 10 
(53%) 
2 (67%) 2 (12%) 
HP524-HP547+ 6 (9%) 1 (5%) 1 (33%) 0(0%) 
Some cag HP532-HP547+ 0(0%) 0(0%) 0(0%) 0(0%) 
genes detected HP544-HP54 7+ 1 (1%) 1 (5%) 0(0%) 2 (12%) 
Intervening 
sequences missing 
8 (11%)*& 7 (37%) 0(0%) 12 (71%) 
Only cagA detected HP547+ 1 (1%) 0(0%) 0(0%) 1 (6%) 
• #- • & . *p < 0.00001 vs. vacA s2m2, p < 0.04 vs. vacA s1m2, p < 0.008 vs. vacA slm2 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
75 
6.3.8 Prevalence ofcagQ-S/T amplification products 
The primer combinations of cag7/12 and cagTF/QR test both for the presence of the 
cagQ~S/T genes and also for joined cagl and cagIJ regions. The agreement between primer 
sets for cagQ~S/Twas 78%. This is lower than for cagl but reflects the fact that these primer 
combinations identify different5' -genes. PCR amplification using these primer sets resulted 
in the correct amplicon sizes in both 26695 and J99. Overall, seventy-one (65%) of 109 
strains were both cagQ~S and cagQ-r. Eight-six percent of isolates from patients with 
peptic ulcer disease were positive for the 532 bp product predicted for ail intact cagQ-S 
region, compared with only 20 (43%) isolates from patients with gastritis alone (p < 0.0001). 
Seventy-seven percent of strains (20 of 26) from patients with gastric adenocarcinoma were 
cagQ-S (p < 0.007 vs. gastritis). The 842 bp product predicted for an intact cagQ~T was 
present in eighty-nine percent of isolates from patients with peptic ulcer disease compared 
with only 24 (51 %) isolates from patients with gastritis alone (p < 0.0001). All strains from 
patients with gastric adenocarcinoma were cagQ-r (p < 0.00001 vs. gastritis). 
Twenty-eight isolates did not have an amplifiable cagQ~S/T gene product. One (3%) 
of the isolates was also cagT, cag13 and cag6-7PCR-positive. This suggests thatthis isolate 
(from a patient with PUD) had a complete but spatially separated pathogenicity island. These 
results suggest that in the majority (89%, 26 of 28) of isolates where cagQ-S/T were not 
detectable other genes in cagll would also not be present. There is also a strong association 
between specific vacA alleles and an absence of the cagQ-S/T amplicon. Significantly more 
vacA s2 isolates (13 of20 [65%]) were cagQ-S/TPCR-negative compared to 14 of83 (17%, 
p < 0.0001) vacA sl strains, suggesting that the vacA s2 allele may be a surrogate marker for 
the loss of this region. 
6.3.9 Prevalence ofthe insertion sequences, IS605 and IS606 
While 26695 had an intact IS605 sequence (tnpA+tnpB) detected by PCR and J99 only 
exhibited tnpA, only three South African isolates had an intact IS605 sequence. All three had 
all had the marker genes for the cagPAI and yielded gene products with cag7/12 and 
cagTF/QR primer sets suggesting that the complete insertion sequence was elsewhere in the 
genome. Analysis of the cagPAI deletion endpoints in the twenty-eight isolates which did not 
have an amplifiable cagQ-S/T gene product demonstrated that IS605 (tnpA) was present in 6 
(27%) of them suggesting that this insertion sequence may playa role in cagPAI disruption. 
Analysis of IS605, however, also demonstrated that tnpA was present in the majority of 
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isolates (95%), while tnpB was present in only 18 (24%) of isolates. This suggests that tnpA 
and tnpB occur most often as separate entities in the genome of South African samples. 
In contrast to IS605, IS606 was present in forty (54%) of the isolates (p < 0.000001 
vs. IS605). There were no differences in distribution of this insertion sequence in either the 
disease groups (43% gastritis alone, 56% peptic ulceration, and 68% GCa, p = NS) or in 
isolates with (31 [60%]) or without (9 [41 %]) a cagQ-S amplicon. These findings suggest 
that complete insertion sequences are not involved in alterations of the PAlin these South 
African isolates but that tnpA from IS605 might be involved in a quarter ofthe isolates. 
6.3.10 Predictive value ofvacAs1+ cagPAr strains 
Strains (vacAs1) with all the information encoding cagA and the cagPAlwere found in 29 of 
36 (81%; P < 0.00001 vs. gastritis alone) peptic ulcer disease strains and in 18 of26 (69%; p 
< 0.0007 vs. gastritis alone) gastric adenocarcinoma strains compared to 13 of 47 (28%) 
strains from patients without clinically significant disease (gastritis alone). The sensitivity of 
vacAsllcagPAI as a marker for gastric disease (either GCa or PUD) is >80% (Table 6.6), 
while the specificity for this as a disease marker is 72%. The predictive values ranges 
between 58-69%. 
Table 6.6 Predictive value ofvacAs1+cagPff strains for clinically significant disease 
Diagnosis PPV NPV SE SP 
PUD 0.69 0.83 0.81 0.72 
GCa 0.58 0.81 0.69 0.72 
PUD = peptic ulcer disease, GCa = gastric adenocarcinoma 

PPV = positive predictive value, NPV = negative predictive value, SE = sensitivity, SP = 

specifici ty. 

6.4 Discussion 
In the present study, the results indicate that usmg a subset of previously defined, 
functionally important marker genes, the cag PAl appears complete and contiguous (cag6­
cagA) in 65% of South African H. pylori isolates. One third of isolates had non-amplifiable 
gene regions in the island. Marker genes from the entire cagIJ region (cag6-cagT) were 
absent in -90% of these cases. The caveat of over-interpretation of PCR results is 
recognized, as this methodology can fail for a number of reasons including heterogeneity at 
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pnmer annealing sites. Such heterogeneity may be one reason to explain our findings 
although we took care to use two established, different primer sets per gene site (these primer 
combinations have previously been used to identify cag genes in European populations 
216,222) to confirm negative forms. It is more likely, however, that the target regions are 
deleted. This is suggested both by the pattern of changes and by the evidence that South 
African H. pylori cag + isolates share more sequence homology with European than Asian 
strains 167. 
All (100%) of tested strains, irrespective of the organization of the P AI, were cagA+. 
Data on the cagPAI from the rest of Africa are scarce, but CagA appears to be commonly 
expressed 296. Our data suggest dissociation between the presence ofcagA and of other genes 
in the cagPAI island and further that analysis of the PAI may be a prerequisite for the 
investigation of any relationship with gastroduodenal disease processes. The nucleotide 
sequence of the gene cagA contains internal duplications of a 102 base pair fragment, 
encoding a proline rich region in the 3'-region 7. Differences in this region have been 
suggested to generate proteins with different sizes and immunogenicities 7,202,218. 
Comparable differences in sequences were found in the majority of South African isolates in 
this study. This suggests that such genetic alterations may be a common phenomenon in H. 
pylori. We evaluated whether there was a pathological significance to the variability in 
fragment length of the 3'-region of cagA in a popUlation with a high prevalence of isolates 
( 
containing this gene. The length of this region was shorter in South African strains isolated 
from patients with gastritis alone compared to those with peptic ulceration. This is in contrast 
to a German study which found the obverse 193. III addition, significantly fewer gastric 
cancer isolates had gene fragments of this length « 600 bp). The cagA-3' fragment length 
(600-700 bp) was not differentially distributed. In contrast, significantly more isolates from 
patients with gastric cancer had the longest fragment lengths (> 700 bp) than those from 
either patients with gastritis alone or peptic ulceration. These results are similar to the 
preliminary results from a Japanese study which demonstrated that a structural subtype of 
cagA (strain C) encoding a protein with a higher molecular weight and detectable by its 
larger size, was associated with gastric carcinoma and atrophy 218. These data thus support 
the view that cagA variants may provide additional markers to distinguish disease-associated 
strains ofH. pylori. 
While the majority of isolates (~80%) from patients with peptic ulceration had all the 
marker genes for a complete cagPAI, less than half(~40%) of the isolates from patients with 
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gastritis alone had this pathogenic fingerprint. In contrast, significantly more isolates from 
patients with gastritis alone (23%) had regions of cagII (cag6-cag1) which were not detected 
compared to only three (8%) peptic ulcer disease isolates. This region includes the putative 
virulence factor, cagJO (HP524) or virD4 168,176,214. Analysis of the distribution of the 
virulence associated vacA alleles demonstrated that subtype sllm1 was strongly associated 
with a complete island, whilst subtype s2/m2 was associated with deletions in cagII. These 
findings suggest the potential importance of genes in the cagII region for the pathogenesis of 
peptic ulcer disease and are supported by the observation of a significantly negative 
relationship between the virulence associated vacA s1 allele and deletions in cagII. 
The association between genes in the cagPAI other than cagA and gastric 
adenocarcinoma has not previously been reported. Our results demonstrate significant 
differences between isolates from patients with gastritis alone and those with this disease. 
Specifically, an intact, frequently contiguous P AI was found more often in patients with 
cancer than in patients without clinically significant disease. The finding of a conserved 
pathogenicity element (cagPAI) shared by isolates from patients with gastric adenocarcinoma 
y/ 
and peptic ulcer disease is of interest given the inverse relationship between these two 
diseases. Such a generalized association suggests that an intact P AI, while implying 
"virulence", may not be a specific marker for either of these diseases which is entirely 
compatible with the current understanding of the multi-factorial nature of the pathogenesis of 
these diseases. An alternate explanation may be sought in the demonstration that alterations 
in the 3'-gene sequence of cagA differentially identifies isolates from patients with gastric 
cancer 218,297,298. It is possible that while an intact PAI (type IV secretion system) is . 
necessary to deliver CagA into epithelial cells, it is the structural product of this gene which 
determines the degree of amino acid phosphorylation and which intracellular pathway 
(secretory or proliferative) a cell undergoes 215. 
The grouping of clinical isolates into two broad families, type I and type II has been 
evaluated in this study. The data suggest that type I strains are strongly associated with 
gastroduodenal disease in these South African popUlations. The finding that all strains were 
cagA indicates that the vacA status may be an adequate surrogate marker for type I strains in 
the study population. Revising this classification to include strains which encoded all the 
information for the cag P AI did not diminish the ability to discriminate disease associated 
strains, but indeed increased both the positive predictive value as well as the specificity of 
this method as a diagnostic test. 
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The insertion sequence, /S605, was present in 25% of cagPAI deletion endpoints 
which supports the postulate that this DNA element may generate rearrangements and 
deletions in a small proportion of South African strains so as to result in sub-populations of 
organisms with differences in virulence 176,214. Other potential mechanisms which may result 
in cag gene deletions include the observation that elimination of one part of the cagPAI may 
readily result in the loss of virulence of other parts of the genome, the possibility that 
organisms with such deletions are more readily cultured or that the non-random distribution 
of sequences may promote such losses. Irrespective of the mode of genetic deletion, it may 
be advisable to classify strains that carry the cagA gene and have internal deletions in the 
cagPAI as functionally cag- rather than cag+. 
6.5 Conclusion 
The presence of the gene cagA in all isolates, irrespective of associated pathology, suggests 
limited use of this as a measure of virulence. However, variability noted in the fragment 
length of the 3'-region of the gene correlates with disease (particularly gastric cancer) in this 
popUlation and may prove to be a useful virulence marker. It may also provide a tool to 
differentiate between peptic ulcer disease and gastric cancer. 
The presence of a contiguous cag PAlin sixty percent of patients suggests that this is 
conserved in most South Africans as it is in European and Asian populations 216,221,222. The 
importance of genes in this island (particularly in cag/I) to the pathogenesis of 
gastroduodenal disease in South Africa is, however, suggested by the prevalence of deletions 
in the 5'-region in patients with gastritis alone. In addition, the strong relationship between 
the virulent vacA type sllml and the entire PAl, would seem to support the importance of 
both these elements to disease pathogenesis, although it appears that the relationship with 
clinically significant disease may be stronger for vacA alleles than for an intact cagPAI. 
These studies suggest that a number of the associations established between H. pylori 
virulence factors and disease in other parts of the world apply to the South African setting. 
Analyses of these associations suggests that the relationship between specific genes (cagA, 
cagE) in the cagPAI and disease appear to be similar world-wide. There are, however, some 
interesting differences. The prevalence ofcagA is extremely high. The widespread prevalence 
of this gene may have important ramifications and requires further study. 
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Chapter 7. 
Relationship between iceA genotypes, vacA alleles 
and clinically significant disease 
7.1 Introduction 
The structure and function of the ieeA genes are described in Chapter 4.4.3. Recently, a 
polymorphism of the ieeA gene which may be clinically relevant has been reported 185. In 
some populations (USA. Netherlands) ieeA1 strains appear to be much more prevalent among 
patients with ulcers 185,223. and ieeA1 may be a marker for peptic ulcer disease. independent 
of the genes eagA and vaeA 185. It appears that a combination analysis of ieeA allele and vaeA 
allele may be more useful for identifying strains associated with patients with peptic ulcer 
disease than analysis of each allele alone 185. In another study. utilizing patients mainly from 
the Orient (South East Asia), no association was present 201. The authors of the latter study 
suggest that the distribution of ieeA1 may reflect population clustering rather than virulence 
perse. 
In contrast to ieeA1. ieeA2 has no homology to known proteins and its structure 
reveals patterns of repeated protein cassettes 225. More recently, the genetic organization and 
sequence heterogeneity of ieeA2 has been studied 224, revealing 5 distinct ieeA2 subtypes. 
While ieeA2 strains are more prevalent among patients with gastritis alone and non-ulcer 
dyspepsia 185, a statistically significant relationship bern:een ieeA2 subtypes and disease has 
not yet been defmed. 
South African H. pylori isolates are characterized by an almost universal presence of 
eagA, but have differences in the 3'-region of eagA and the vaeA gene which correlate 
significantly with clinically significant disease (c.f. Chapters 5 and 6). Our hypothesis was 
that H. pylori isolates from South African patients may also exhibit variability in their ieeA 
alleles and that this variability may be related both to the expression of clinically significant 
disease and to vaeA allelic status. 
7.2 Materials & Methods 
7.2.1 H. pylori strains and DNA 
A total of 109 H. pylori isolates (vaeA and eagA determined [Chapters 5 and 6]) were 
examined. Reference strains 26695 (ieeA1) isolated from a patient in the UK with gastritis 41 
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and J99 (iceA2) isolated from a US patient with duodenal ulcer disease 42 were used as iceAl 
and iceA2 positive and negative controls, respectively, in this study. 
7.2.2 Amplification ofice A by peR 
PCR reactions were performed as described (cf. Chapter 5.2.3) but a final MgCh 
concentration of 3.5mM was used for iceAl. For amplification of the iceAl allele, forward 
primer IceA1F (5'-CGTTGGGTAAGCGTTACAGAATTT) and reverse primer IceA1R (5'­
TCATTGTATATCCTATCATTACAAG) yielded a fragment of 558 bp (Figure 7.1). For 
iceA2, pnmers IceA2F (5'-GTTGTCGTTGTTTTAATGAA) and IceA2R (5'­
GTCTTAAACCCCACGATTAAA) yielded a fragment of 120 bp. PCR was performed in a 
Sprint PCR (Hybaid, South Africa) under the following conditions: 4-minute preincubation at 
94°C, followed by 30 cycles of 1 min. at 94°C, 1 min. at 62°C (iceAl) or 53°C (iceA2) and 1 
min. at 72°C. Final extension was performed for 10 min. at 72°C. 
Additional genotype-specific PCR assays that used primers for iceAl [IceA1F5 (5'­
GTGTTTTTAACCAAAGTATC) and IceA1R4 (5'-CTATAGCCASTYTCTTTGCA)] and 
primers flanking the iceA2 internal cassette were performed to confirm the presence of mixed 
iceAl+/iceA2+ isolates and to identify the size of the iceA2 allele 185. Primers IceA2F6 (5'­
GTTGGGTAT ATCACAA TTTAT) and IceA2R5 (5'-TTRCCCTATTTTCTAGTAGGT) 
yielded a fragment of 229, 334 or 439 bp according to the existence of repeated sequences of 
105 nucleotides. PCR was performed under the following conditions: 4-minute preincubation 
at 94°C, followed by 30 cycles of 1 min. at 94°C, 1 min. at 53°C (both iceA1 and iceA2) and 
1 min. at 72°C. Final extension was performed for 10 min. at 72°C. iceA amplimers were 
examined by electrophoresis on 1 % agarose gels according to standard procedures 297. 
CysE (HP1210) iceA 1 (HP1209) hpylM (HP1208) 
~ 
IF 
'558bp ~ 
IR 
..... 246bp .... 
F5 R4 
CysE (J HP1133) iceA2 (JHP1132) hpylM (,IHP1131.) 
I I I I 
..... 229-439 bp ..... 
F6 R5 
,,120bp" 
2F 2R 
Figure 7.1 Primers, sites and amplicon sizes for iceAl (HP1209) and iceA2 (JHPl132). 
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7;2.3 Sequencing ofice A 1 and iceA2 

iceA1 and iceA2 were amplified using primer sets IceAF5/R4 and IceA2F6/R5. PCR products 

were gel extracted (QIAEX II gel extraction kit, Qiagen, Cape Town, South Africa) and 

sequenced on an ABI PRISM 377 automated sequencer (ABI, Foster City, California, USA) 

using the ABI PRISM ™ BigDye ™ terminator cycle sequencing reagent kit with AmpliTaq 

® DNA polymerase FS (PE Biosystems, Johannesburg, South Africa) as described 

previously 290. PCR and direct sequencing were performed at least twice to determine DNA 

sequences for each strain. 

7.2.4 Computer analysis 

DNA and protein sequences were analyzed using the National Center for Biotechnology 

Information (NCB I) server (USA) and META Predict Protein (which includes the SignalP, 

JPRED, TopPred and DAS servers [Columbia University, USA]) 291,293,294,299. SignalP 

predicts the presence and location of signal peptide cleavage sites, JPRED predicts secondary 

structures, TopPred is useful for the prediction of the location and orientation of 

transmembrane sequences through the use of hydrophobicity patterns and by applying the 

"positive-inside" rule while DAS predicts the location of transmembrane using 

hydrophobicity patterns. Internet-based searches were performed at NCBI, TIGR (Maryland, 

USA) and Astra-Zeneca (Boston, USA). 

7.2.5 Statistics 

Data (n 109) were examined using the chi-squared test or Fisher's exact test as appropriate. 

Probability levels of< 0.05 were considered statistically significant. 

7.3 Results 
7.3.1 iceA1 sequence analysis 
In a preliminary study, in order to establish the composition of iceA gene products in South 
African H. pylori isolates, iceA1 (246 bp) and iceA2 (229-334 bp) were sequenced. 
Four isolates with the iceA1 genotype (two from patients with gastritis alone and two 
from patients with peptic ulceration) were sequenced and compared to the predicted iceA1 
gene (HP1209) in strain 26695 (Figure 7.2). Alignment of these sequences revealed the 
presence of a putative conserved initiation codon at position ATG919 (GenBank Accession 
No. U43917), as previously reported 224 and no in-frame insertions or deletions were evident. 
All isolates shared substantial DNA (93-95%) homology with HP1209 over the 246 bp 
sequenced. 
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Figure 7.2 Alignment of ice A 1 nucleotide sequences showing the putative start codon. 
HP1209: TGTGTTTTTAACCAAAGTATCTGTGAAGACATTAAAAACCACTATAAGCAACAATGTTGT 
Hp27: C 
1715: C C C 
215: C T'F GC C 
464: C T 
HP1209: GC~TGTGGTGTGCGTGGCAACTCTGAAAACACTCAAATAGAGGTGGATCATAAAGAC 
Hp27: C C T C A 
1715: C G 
215: C 
464 : T 
START 
HP1209: GGCCGCAAGGATGATTCAAGAGTTTCTGATTTAAGCACACAAGCTTTTGATGATTTCCAG 
Hp27: A G GA T 
1715: C GA T A 
215: T GA T A 
464: T AA C AT GA T 
HP1209: GCTTTATGTAAGCT'FGTAATGATAAGAAACGCCAGA'TTTGTAAAAAATGCAAAGAGACTGGC 
Hp27: c C G A 
1715: C G A 
215: C C G A 
464 : C G A 
All isolates therefore generated predicted proteins of 63 amino acids (from the consensus 
start), within the putative ORFs (Figure 7.3). The protein homology between HP1209 and the 
four South African isolates over this distance was 93-96%. 
Figure 7.3 Putative proteins from the iceAl peR fragments 
HP1209: MCGVRGNSENTQIEVDHKDGRKDDSRVSDLSTQAFDDFQALCKACNDKKRQICKKCKETGYR
tI· . 
Hp27: MC~NSENTQIEVDHKDGRKDDSRVSDLS~QAFDDFQALCKACNDKKRQIC~CKETGYR 
1715: MC~GNSENTQIEVDHKDGRKDD~VSDLSTQAFDIDFQALCKACNDKKRQIC~~CKETGYR 
215: MC~GNSENTQIEVDHKDGRKDDI!}VSDLSTQAFDDFQALCKACNDKKRQICKKCKETGYR 
464 : MCGVRGNSENTQIEVDHKDGR~~VSDL~TQAFDDFQALCKACNDKKRQIC~CKETGYR 
I'
T
C
 
/-  
DD~VSDLSTQAFDDFQALC
EVDHKDGRK D~VSDLSTQAFD FQALCKACNDKKRQI
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7.3.2 iceA2 sequence analysis 
Seven isolates with the iceA2 genotype (two from patients with gastritis alone, two from 
patients with peptic ulceration and three from patients with gastric adenocarcinoma) were 
sequenced and compared to the predicted gene (JHPl132) present in the same locus in strain 
J99 (Figure 7.4). 
Figure 7.4 Pile-up of iceA2 genotypes. Peptide domains and sizes are indicated. 
JHP1l32 : 
Hp27: 
1715: 
215: 
464: 
Ca102: 
Ca1104: 
Ca1506: 
JHP1132 : 
Hp27: 
1715: 
215: 
464 : 
Ca102: 
Ca1104: 
Ca1506: 
JHP1132 : 
Hp27:. 
1715 : 
215: 
464: 
Cal02: 
Ca1104: 
Ca1506: 
MAVVIKVVNGKIQE YENGNYKRTYDSN IVAADTDGHIVAAVKTA 
MAVVIKVVNGKIQE YENGNYKRTYGSN****************** 
MAVVVKVVNGKIQE FENGSHKRTYGSN****************** 
MAVVIKVVNGKIQE YENGNYKRTYGSN****************** 
MAVVIKVVNGKIQE YENGIYKRTYGSN IVAADTDGHIVAAV*TA 
MAVVIKVVNGKIQE YENGNYKRTYGSN IVAADT*GHIVAAV*TA 
MAVVIKVVNGKIQE YENGIHKRTYGSN IVAADTDGHIVAAV*TA 
IMAVVIKVVNGKIQ~ IIVAADTDGHIVAA v*:!jA 
14 13 16 
************************************* 
*********************AVNVQVSGGVVAVTTS 
*********************AINVQVSGGVVAVTTS 
*********************AVNVQVSGGVVAVTTS 
KGKVEE FENGSYKRTYGSN AINVQISGGVMAVTTS 
KGKVEE FENGSYKRTYGSN VINVQISGGVMAVTTS 
KGKVEE FENGSYKRTYGSN VINVQISGGVMAVTTS 
KGKVEE 
KGKVEE 
KGKMEE 
KGKVEE 
KGKVEE 
KGKVEE 
KGKVEE 
IKGKVEEI iV1N*QISGGVMAVTTSI IKGKVEEI 
6 13 15 6 
************* ************************YKNGIHKRTY 
************* ************************YKNGSYKRTY 
[yKNGSYKRTTKRAj I@NVQISGGVMAVTTSI IKGKVEEICKNNGIHKGTY 
************* ************************YKNGIHKRTY 
************* ************************YKNGIHKRTY 
************* ************************CKNGIHKRTY 
************* ************************CKNGIHKRTY 
************* ********************** 
13 16. 6 10 
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The iceA2 gene from strain J99, JHPI132, conforms to the structure of repeats (14-13-162B-6­
10) demonstrated by van Doom 225 224, generates a protein of 59 amino acids and is an 
example of the iceA2B subtype 224. None of the South African isolates sequenced in this 
series had either a 2A (14-13-6-10) or a 2B motif. Two isolates (Hp27 & 215), however, had 
the sequence 14-13-162c-6-1O and could be classified as iceA2C sUbtypes. Four isolates had 
the sequence 14-13-162B-6-13-162c-6-1O and are examples of the ice A2D subtype. These 
subtypes typically generate proteins of 94 amino acids but one isolate (Cal02) had an in­
frame 3 nucleotide deletion in 162B which resulted in a putative protein of 93 amino acids. 
Sequence analysis of a fifth isolate (1715) demonstrated a novel variant of the iceA2D 
subtype which was typified by the sequence 14-13-162c-6-13-162c-6-1O (sequence identity 
(71 %) and positive residues (80%) with iceA2D). 
Analysis of the protein signal sequences, secondary structures and topology for the 
South African iceA2 variants is provided in Table 7.1. 
Table 7.1 Protein characteristics of iceA-variants 
JHP1132 HP27 Ca1506 1715 
Variant 2B 2C 2D 2D' 
Amino acids (n) 59 59 94 95 
#Cysteine (%) 0 0 0 1 
#proline (% 0 0 0 0 
Topolo2Y: N-terminus "in" "in" "in" "in" 
Topolo2Y: C-terminus ? ? ? ? 
TopPred *PTM (n) 
+Position 
(Score) 
None None One 
58-78 
(0.758) 
One 
23-41 
(0.615) 
DAS PTM(n) 
Position: 
None One 
32-41 
Two 
37-40 
66-75 
Two 
31-41 
70-76 
#Helix (%) 11.7 0.0 0.0 0.0 
#Sheet (%) 41.7 62.7 72.3 54.2 
#Other (%) 46.7 37.3 27.7 45.8 
#Class Mixed All-beta All-beta All-beta 
..
"m" = onentatlOn mSIde cell membrane, ? = not determmed 
*PTM = putative transmembrane segment, +Position = amino acid position, # from JPRED 
DAS = Dense Alignment Sequence ' 
Of note are the observations that these proteins do not have a typical prokaryote signal 
sequence (from the SignalP server), and the N-terminus appears to be embedded within the 
cell membrane. The TopPred topology program demonstrated that variants 2B and 2C had no 
predicted transmembrane regions whilst 2D and the novel 2D variant (2D') had a single 
putative transmembrane region with scores of 0.758 and 0.615 respectively (Figure 7.5) 293. 
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The Dense Alignment Surface (DAS) method confinned that variant 2B had no 
transmembrane region but suggested a possible transmembrane region in 2C and confinned 
two putative transmembrane regions in 2D and the 2D' variant 294. Variant 2B can be 
classified as a mixed class protein, but 2C, 2D and 2D' are all all-beta proteins. 
TopPred DAS 
oIHP1132 
2B 
.. 
SAHP27 
.. .. •• 
2C 
.a 
o.w.,.",..~. 
~ ..
... 
... 
a 
~ 
'" n 
o _ 
il 
o H. 
~ .. 
I
..i ~ 
.t ~ 
SA1501 
2D 
SA1715 
2D" 
• " R ~ woQ...i_,. 4 • ..,.".c. 
Figure 7.5 Results of topology profiles obtained using the TopPred program (left) and DAS 
(right) are shown as well as the isolates and the four iceA2 variants (on the far right). Arrows 
indicate putative transmembrane regions. 
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7.3.3 Clinical relevance ofice A genotypes 
After validating the PCR-protocol and examining the structure of iceAl and iceA2, PCR was 
performed in 109 defined clinical isolates and products were analyzed in terms of the 
distribution of genotypes. iceAl was detected in 74 (68%) of 109 isolates, and iceA2 was 
found in 85 (80%). Fifty-four (50%) isolates were positive for both iceAl and iceA2 using 
previously described primers IceA1AFI1AR and IceA2FI2R 12,223. One isolate (1 %) did not 
yield any PCR product for either of the iceA genotypes. 
Twenty-one of the 54 iceAl+ liceA2+ isolates were re-examined with different iceA 
primer sets (F51R4 and F61R5) 185 224 to determine whether this mixed genotype was a 
consistent finding. All twenty-one isolates (100%) were positive for both genotypes, 
suggesting that these primer sets are concordant. These isolates each had a single vacA allele, 
a single cagA-3'-amplicon and were derived initially from single colony isolates. This 
suggests the presence of multiple iceA genotypes in these strains. PCR products from four 
isolates (HP27, 1715, 215, 464) were sequenced (cf. Chapter 7.3.1 & 7.3.2) confirming the 
presence ofboth alleles in these isolates. 
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Analysis of the iceA genes in all demonstrated a significantly higher 
l.:>Ula",,;"J from patients with adenocarcinoma 1 1%])prevalence 
of 47 [57%], p 0.0376) (Figure 
7.6A). Although prevalence of iceAl was in isolates from peptic 
than patients without significant 
ulcer disease (26 [72%]), this was not different to (p 
0.123). Conversely, a significantly lower of iceA2 alleles was the gastric 
adenocarcinoma (16 of 26 [62%], p = 0.0029) than patients with (43 of 
[91 %]). patients with peptic disease had intermediate of iceA2 
(29 of P 0.13 vs. gastritis alone, p 0.086 vs. GCa). 
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Figure Distribution of all isolates. *p < alone, **p < 
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Among the fifty-four isolates with a single iceA allelic type, the association between 
the distribution of the iceA genes (iceAl and gastric adenocarcinoma and iceA2 and gastritis 
alone) was more striking (p < 0.01) (Figure 7.6B). No such relationship was evident for 
peptic ulcer disease (p = 0.2). 
80 ** 
70 * 
60
-~ 
'--' 50 
(/) 
Q) 
ro 40 o 
.~ 
~ 30 
~ 
(/) 
&. 20 
10 
0--'---'--­
iceA1 iceA2 
iceA alleles 
D Gastritis alone III Peptic ulceration • Gastric adenocarcinoma 
Figure 7.6B Distribution of iceA genotypes in 54 H. pylori isolates with single iceA 
genotypes. *p < 0.01 vs. gastritis alone, **p < 0.001 vs. GCa. 
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7.3.4 Distribution oficeA2 alleles 
As previously reported 185 224, most isolates with iceA2 alleles (66 of 88 [75%]) could be 
divided into two types according to the presence of repeated sequences of 105 nuc1eotides 
and whether PCR products were ~229 bp (iceA2BIC) or ~334 bp (iceA2D) long. Twenty-two 
[26%] isolates had either both products or a combination of iceA2BIC and/or iceA2D or 
iceA2E (449 bp) products. These isolates each had single vacA alleles, and were derived from 
single colony isolates. This suggests the presence of mUltiple iceA2 gene copies rather than 
DNA contamination. 
The iceA2BIC subtype (229 bp) was predominant in gastritis cases (29 of 43 [67%], p 
< 0.02 vs. PUD) and was also found in GCa cases (11 of 16 [62%], p < 0.03 vs . PUD) (Figure 
7.7). The iceA2D subtype (334 bp) was predominant in PUD cases (19 of29 [66%], p < 0.02 
vs. gastritis). The iceA2E subtype was more prevalent in GCa cases (7 of 16 [44%], p < 0.04) 
vs. gastritis). Among the sixty-six isolates with a single iceA2 SUbtype, the association 
between the distribution of the iceA2 subtypes (iceA2BIC and gastritis alone and iceA2D and 
PUD) remained statistically significant (p < 0.003). 
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iceA2BC iceA2D iceA2E 
iceA alleles 
D Gastritis alone • Peptic ulceration • Gastric adenocarcinoma 
Figure 7.7 Distribution of iceA2 subtypes and relation to disease. *p < 0.01 vs. PUD and 
GCa, **p < 0.03 vs. gastritis alone and GCa, +p < 0.04 vs . gastritis alone. 
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7.3.5 Combination and cagA genotypes 
All strains were cagA+ a single 3'-amplicon. By method of van Doom et 
s region (sl and s2), and 
the iceA type (iceA 1 , iceA2D and in patients with 
multiple genotypes Significant associations genotypes and clinical 
outcome were noted p < 0.000001). isolates (69%, p < 
0.005 vs. gastritis and gastric adenocarcinoma (81 %, p < 0.0005 vs. 
gastritis) were vacA s1 In addition, significantly more isolates were 
slliceA2D (53%, p < 0.0007 vs. gastritis alone, p = 0.07 vs. GCa). In contrast, isolates 
patients with were identified by either s21iceAI (21 %, p < 0.00001 vs. 
PUD, P < 0.0001 vs. or vacA s21iceA2 (22%, p < 0.00001 vs. PUD, P < 0.00003 vs. 
GC). 
100 
90 
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80 
70 
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50 
40 
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20 + 
10 + 
0 
iceA 1 iceA2BC iceA2D iceA2E iceA 1 iceA2BC iceA2D iceA2E 
va cAs 1 vacAs2 
vac iceA combination 
+ 
1Figure Combination analysis of Gun"""" and disease outcome 
alone, +p < 0.05 vs. or* p < 0.01 vs. gastritis alone, **p < 0.005 vs. 
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In addition, a similar analysis was undertaken in patients with a single iceA genotype, with 
similar results (Table 7.2). Significant associations between genotypes and clinical outcome 
were noted (X2 = 30.41, p < 0.0008). Significantly more PUD isolates (47%, p < 0.01 vs. 
gastritis) and GCa isolates (67%, p < 0.0004 vs. gastritis) were vacA slliceAl. In contrast, 
significantly more (p < 0.009) isolates from patients with gastritis alone were vacA 
s2liceA2BC. 
Table 7.2 Distribution ofvacAlice A alleles in single genotype isolates (n = 54). 
Allele Gastritis PUD GCa 
(n = 17)(n= 22) (n = 15) 
2 (19%) 8 (47%)* vacAs lliceA 1 10 (67%t 
5 (23%) 3 (18%) 4 (26%) vacAslliceA2BC 
6 ("CO/,\3 (14%) 1 (7%) vacAslliceA2D 
1 (5%) 0(0%)vacAs21iceAl 0". 
8 (36%) vacAs21iceA2BC 0(0%)**o(u 'UJ 
3 (14%) 0(0%) 0(0%)vacAs21iceA2D 
PUD :;::: peptic ulcer disease, GCa = gastric adenocarcinoma 

*p < 0.02 vs. gastritis, +p < 0.0008 vs. gastritis, **p < 0.006 vs. gastritis. 

7.3.6 Predictive value ofvacAsl+cagA+cagPAFiceAl+ strains 
Strains (vacAsl) with all the information encoding cagA, the cag P AI and iceAl were found 
in 21 of 36 (58%; p < 0.0003 vs. gastritis alone) peptic ulcer disease strains and in 14 of 26 
(54%; P < 0.003 vs. gastritis alone) gastric adenocarcinoma strains compared to 9 of 47 
(19%) strains from patients without clinically significant disease (gastritis alone). The 
-
sensitivity of iceAl as a marker for gastric disease (either GCa or PUD) based on the data 
generated in this study is -50% (Table 7.3), while the specificity of iceAl is >80%. The 
predictive values for iceAl range between 61-70%. 
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Table 7.3 Predictive value of vacAsl +cagA+cagPATiceAl + strains for clinically significant 
disease 
Dia 
'" 
. PPV NPV SE SP 
PUD 0.70 0.72 0.58 0.81 
GCa 0.61 0.76 0.54 0.81 
PUD = peptic ulcer disease, GCa = gastric adenocarcinoma 

PPV positive predictive value, NPV = negative predictive value, SE = sensitivity, SP = 

specificity. 

7.4 Discussion 
These findings support the hypothesis that strain differences in iceA genotypes may 
(partially) explain the differences in disease expression associated with H. pylori infection. 
South African H pylori isolates were distinguished by a higher prevalence of iceA2 
than iceAl alleles, as well as the large number of strains with both iceA genotypes. Fifty 
percent of organisms, irrespective of pathology, had both iceAl and iceA2 genotypes. The 
reason for such a high prevalence of strains with both genotypes in South African patients 
appears to be a consistent finding since repeated P R with different primers for iceAl and 
iceA2 185 on 21 of the 51 isolates consistently demonstrated both genotypes (iceAl+/iceA2+), 
and this was confirmed by sequencing. Nevertheless, it is possible that mUltiple strains might 
have been present in the culture from which the DNA was obtained. Mixed strains are 
commonly found and estimates range from 26% in a world-wide study 224, to 15% in the 
Netherlands 185,4% in the USA 201,22% in Colombia 201, and 17% in Japan 201. However, 
single colony derivatives obtained by repeatable culturing of these "mixed;; genotype strains 
produced putatively clonal strains which consistently produced a single iceA product 224. 
Analysis ofboth "mixed" as well as single iceA genotypes demonstrated that although 
iceAl was more prevalent in PUD patients than in gastritis alone patients, this was not 
statistically significant. Previous studies in the USA 223 and the Netherlands 185, but not in 
South East Asia 201 have demonstrated a strong association between this allele and peptic 
ulcer disease. It is possible that the high prevalence (53%) of mixed iceA genotypes in 
patients with PUD may obscure any potential relationship between the allele and the disease. 
There was, however, a strong relationship between the combination of vacA signal sequence 
subtype, iceA alleles and peptic ulcer disease. Significantly more PUD isolates were vacA 
slliceAl compared to 40% of isolates from patients with gastritis alone. 
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The function of iceA2 is unknown. In this study, amplicon SIze appeared to 
discriminate between peptic ulcer disease and gastritis alone. iceA2BC (229 bp) occurred in 
~62% of isolates from South African patients with no clinically significant disease, while 
iceA2D (334 bp) was more prevalent (53%) in isolates from patients with PUD. Combination 
vacAliceA analysis demonstrated that the vacAslliceA2D was more prevalent in patients with 
PUD (53%) than in patients with gastritis alone (23%). There seems to be a significant 
relationship between the cassette structure of iceA2 and expression in vivo, where iceA2ABC 
variants are associated with higher mucosal transcript levels of this gene than iceA2D variants 
300. This suggests that down-regulation of iceA2 expression, in addition to induction of iceA, 
may also contribute to disease outcome. It is possible therefore that South African strains 
from patients with clinically significant disease may not readily express iceA2 since the 
majority of these isolates encode the iceA2D variant. Alternatively, alterations in the number 
of repeat cassettes results in potential changes in protein secondary structure. For example, 
variants 2A and 2B may exist as a single globular entity outside the cell, while variants 2C 
and 2D are predicted to display one and two surface exposed regions respectively. These 
changes may translate into differential binding and/or function of the protein. This has not 
been directly proven, but may result in "altered" pathogenicity of the organism. 
There is a paucity of investigations of iceA alleles in isolates from patients with 
gastric adenocarcinoma. In the one small study to date, gastric cancer isolates from Japan and 
Korea were distinguished by the prevalence of iceAl (67%), while 75% of isolates from the 
USA were iceA2 201. The numbers in this study were relatively small which limited statistical 
analysis. In a second Japanese gastric cancer study, iceAl was associated with enhanced 
gastric inflammation but not adenocarcinoma per se 301. South African H. pylori cancer 
isolates, similar to South East Asia strains, were distinguished by the presence of iceAl and 
the absence of iceA2. In contrast, however, the prevalence of these alleles in cancer patients 
was significantly different to that found in patients without clinically significant disease in 
this study. In addition, gastric cancer isolates, unlike those from South African patients with 
PUD or gastritis were not distinguished by any specific iceA2 allele. This data was 
strengthened when analyzed in combination with the vacA status of the strains. Significantly 
more gastric cancer isolates were distinguished by vacA slliceAl compared to patients 
without disease. The putative role for IceAl in gastric cancer is not defined. Experimental 
studies have demonstrated that long-term colonization in both mouse and monkey models of 
experimental H. pylori infection require a wild-type iceAl strain 224,302. It is possible that the 
higher percentage of iceAl+ strains in South African gastric cancer patients may simply 
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reflect the fact they these patients have been infected for a longer time period. Alternatively, 
analysis ofdifference in iceAl gene transcription and therefore protein production may reveal 
a functional role for this protein in this condition 303. 
The predictive value for type I strains has been noted (Chapter 6.3.4) and revising this 
classification to include strains which encoded all the information for the cagPAI served to 
increase both the positive predictive value as well as the specificity of this method as a 
predictor of clinically significant disease. Including whether the strains were iceAl or not 
further improved the positive value but weakened both the sensitivity and negative predictive 
value of any characterization. These alterations may be because of the relatively low (not 
significant) numbers of iceAl+ isolates in patients with PUD. This is reflected in the 
decreased n~bers of patients positive for all four markers « 60%) compared to type I alone 
(100%) or type I + cagPAI (> 70%). 
7.5 Conclusion 
The sequences and prevalence of iceAl and iceA2 in South African H. pylori isolates has 
been investigated. A novel iceA2D subtype has been identified. The potential association 
between iceAl and gastric adenocarcinoma, iceA2D and peptic ulcer disease and iceA2C and 
gastritis alone has been demonstrated in our study populations. No isolate from patients with 
clinically significant disease exhibited either the vacA s21iceAl or the vacA s21iceA2 allele. 
Overall, this data support the hypothesis that there is a difference between organisms 
associated with disease and those not. An absolute separation cannot be made which suggests 
that other factors must play a role in disease pathogenesis. Analysis of iceA allelic types, 
however, is useful in South Africa and certain combinations of virulence factors may provide 
excellent negative markers for disease. 
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Chapter 8. 
Analysis of genomic heterogeneity in 

Helicobacter pylori - relationship to gastroduodenal disease 

8.1 Introduction 
As discussed in detail (cf. Chapter 4), Helicobacter pylori is genetically one of the most 
diverse bacterial species so far reported 163. It appears also subject to the highest known rate 
of intraspecific recombination 165. The panmictic structure of the bacterial genome has been 
demonstrated 166, as has the possibility that it is clonal only over short time periods after 
natural transmission 165, Genomic comparison has, however, demonstrated that the overall 
genomic organization, gene order and predicted proteins of two unrelated H. pylori isolates 
may be quite similar 42, Variability extends to the last codon of the triplet (encoding bacterial 
amino acids); 20% ofdifferences are found in this position 42. Such information suggests that 
there might be a balance between pantnictism and clonality within the organism. More 
recently, analysis of twenty H. pylori strains from diverse geographic regions indicate the 
finding of two weakly clonal groupings superimposed on a pattern of free recombination 167. 
Several genome-based typing studies suggest that disease-specific strains of H. pylori 
may cluster together, Yoshimura et aL utilizing DNA-DNA hybridization have shown that 
strains from duodenal ulcer patients are more homologous to each other than to strains from 
patients with gastritis alone 169, Repetitive extragenic palindromic (REP) sequences, which 
have been successfully used to differentiate bacterial strains associated with disease 
outbreaks 304-306, have been identified in H. pylori 170,307. Cluster analysis of REP-PCR 
fingerprints from USA strains has demonstrated duodenal ulcer isolates to be more similar to 
one another than to isolates from patients with gastritis alone 170, The ability of REP-PCR to 
identifY virulence associated genes, however, appears to be limited 307, Random-amplified 
polymorphic DNA (RAPD)-PCR has also been previously used to successfully differentiate 
clinical isolates 163,172 but have not been used in popUlation based studies. 
Analysis of specific genes demonstrates that the cag pathogenicity gene cluster and 
polymorphic types within vacA and iceA are associated with peptic ulceration and gastric 
cancer in South African populations while strains with the vacA s2 allele are usually found in 
patients with gastritis alone (cf. Chapters 5 & 6), The Cape-colored population is a mixed 
population descended mainly from East Africans, South East Asians (Indonesia), Indians 
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from Western India, native South Africans (mainly Khoisan) and Western Europeans 308, has 
the highest incidence of gastric adenocarcinoma in South Africa 156, has a high prevalence of 
H. pylori infection 4,5, and the organism is invariantly cagA+ 297. Sequence analysis of the 
vacA and cagA gene in H. pylori isolates from this population has suggested that these strains 
may be more clonal than German and Asian strains 165,167. The question arises whether there 
is any correlation between virulence genotypes and strain classification in this population, 
and we therefore attempted to analyze isolate differences utilizing whole genome-based 
strategies. 
8.2 Materials and Methods 
8.2.1 H. pylori strains 
A total of seventy-six clinical H. pylori isolates (20 gastritis alone, 34 peptic ulcer disease 
and 22 gastric adenocarcinoma isolates) were examined. H. pylori strain 26695 isolated from 
a patient in the UK with gastritis 41, and strain J99, isolated from a USA patient with 
duodenal ulcer disease 42 were used as positive controls. 
8.2.2 peR amplification typing oiH. pylori isolates 
For REP-PCR, the I8-mer degenerate primer pair REPIR-DT 304 and REP2-Dt 305 were 
used. Following initial denaturation of 95 0 C for 3 min, each reaction consisted of 35 cycles 
of denaturation at 95 0 C for 30 s., annealing and extension for 1 min. and final extension at 
72 0 C for 10 min. The annealing temperature was set at 45 0 C. In additional experiments with 
26695 and J99, PCR reactions were performed with a single primer to test the specificity of 
the product. 
For RAPD-PCR, the specific H. pylori informative decanucleotide primer, 1254 
(70%G+C) was used in a low-stringency PCR amplification 172. Briefly, 4 cycles of 94°C for 
5 min, 36 0 C for 5 min and 72 0 C for 5 min were followed by 30 cycles of 94 0 C for 1 min, 
then 36 0 C for 1. min, and 72 0 C for 1 min, with a final extension of 10 min at 72 0 C. 
Twenty microliters of each PCR mixture was electrophoresed through a 1 % agarose 
gel with a standard of 100 bp or a Ikb DNA ladder (Roche Diagnostics, Johannesburg, South 
Africa). Variability in the intensity or shape of bands was not considered to represent 
differences. The signal sequence and the mid-region of the gene vacA, the cagA and cagPAI 
status and the iceA status of isolates was known (cf. Chapter 5,6, and 7). 
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8.2.3. Computer assisted analysis 
Potential REP and RAPD-PCR sites in strain 26695 and J99 were identified using the NCBI 
blast server, and the expected number of band sizes identified for each. A cut-off of 10,000 
bp for band sizes was chosen, based on PCR results. 
The REP and RAPD-PCR fingerprints of the H. pylori strains were analyzed with 
GelCompar software Windows version 4.1 (Applied Math, Kortrijk, Belgium) 309. Both REP 
and RAPD-PCR patterns were normalized using the 0.1 Kb pair molecular size standard. 
Comparison of the fingerprints was performed by Ward's method 310. Strains were 
considered related when they shared banding patterns with a similarity coefficient> 99% 309. 
For cluster analysis, the virulence data were summarized into two-way tables. Each 
table had 78 rows and columns for vacA genotypes (sl or s2, ml or m2), cagA 3'-fragment 
length (short [< 600 bp], medium [600-600 bp] or long [> 700 bpD, cagPAI (intact or partial), 
iceA status (iceAl+, iceAl+2+ or iceA2+), REP fingerprint (REPI or REP2), RAPD 
fingerprint (RAPDl or RAPD2) and disease classification (gastritis alone, PUD or GCa). The 
presence or absence of each character was binarily coded, present = 1, absent = O. All 
analyses were performed with STATISTICA © software (Gaithersburg, Maryland, USA). 
8.2.4 Statistics 
Data were analyzed using the Wilcoxon rank sum test for independent samples, chi-squared 
test or Fisher's exact test as appropriate. Probability levels of < 0.05 were considered 
statistically significant. 
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8.3 Results 
8.3.1 Potential REP sites in 26695 and J99 
Initially, the expected number of REP-peR products was identified in the two completely 
sequenced strains. NeBI BLAST analysis revealed a total of 480 possible bands (26695) and 
742 bands (J99) respectively. Utilizing 10,000 bp as an upper limit (based on the peR 
conditions), four and 8 peR amplicons were predicted for 26695 and J99 respectively. REP­
peR was then performed on DNA isolated from each strain (Table 8.1). Repeated REP-peR 
(n =3) showed that fingerprints were stable. 
Table 8.1 Expected and obtained REP-peR products 
26695 J99 
Expected Expected 0 
6,672 9,771 
5,604 8,061 
3,370 6,862 
2,720 2,154 4,196 1,157 
1,424 3,815 1,044 
1,044 3,365 894 
806 2,130 806 
690 2,070 480 
0 
71 
A large number of small amplicons « 2000 bp) as well as the low frequency of predicted 
amplicons (20% for 26695 and 13% for J99) was demonstrated. The specificity of the REP 
products was then investigated by performing peR with each primer separately. This 
generated nine bands for REP 1 R-Dt and 5 bands for REP2-Dt in 26695. Nine (64%) of the 14 
bands were also found when both primers were used in a single reaction. In 199, nine bands 
for REP1R-Dt and 6 bands for REP2-Dt were identified. Three (20%) of the 15 bands were 
also found when both primers were used in a single reaction. Graphical analysis of the 
putative REP primer sites in both genomes demonstrated that both REP1R-Dt and REP2-Dt 
were not restricted to any specific region of the genome in either isolate. This data suggest 
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the possibility that the REP-PCR is largely non-specific and may instead be an arbitrarily 
primed protocol. 
8.3.2 REP-PCRjingerprinting in clinical isolates 
REP-PCR generated bands ranging in size from 0.1 to 6 kb pairs in all 76 isolates. Each 
isolate was distinguished by 1-9 distinct bands, with an average of 4 different bands per 
isolate. No amplification band was common to all strains. Repeated REP-PCR (n = 3) showed 
that fingerprints were stable. Of the 76 isolates, 58 different DNA fingerprints were seen; 2 
pairs of isolates from the same patients and 6 pairs of isolates from different patients had 
DNA fingerprints with a similarity co-efficient> 99%. 
Cluster analysis revealed that there was a large degree of genetic heterogeneity of the 
H pylori strains in this study (Figure 8.1). Examination of the dendrogram demonstrated that 
REP-PCR divided isolates into two distinct and unrelated (similarity coefficient = 0%) 
clusters. Cluster 1 (REPl) consisted exclusively of 23 peptic ulcer isolates, 8 gastric 
adenocarcinoma isolates, and J99 which had been isolated from a patient with duodenal ulcer 
disease. No isolates from patients with gastritis alone were evident in this cluster. The second 
cluster (REP2) included 20 isolates from patients with gastritis alone, 13 gastric cancer 
isolates, 11 peptic ulcer isolates, and 26695, isolated from a patient without clinically 
significant disease. Statistical analysis demonstrated a significant difference in the 
distribution of isolates between these two clUsters (X2 24.68, P = 0.000005). Significantly 
more isolates associated with clinically significant disease were present in REPI (100%) than 
in REP2 (55%, p 0.000002). 
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Figure 8.1 Dendrogram of H. pylori REP-PCR DNA fingerprints. Similarity coefficients are 
included in the top bar. G = gastritis alone, P peptic ulcer disease, C= gastric 
adenocarcinoma. J99 and 26695 are indicated by asterisks. Two separate clusters are 
indicated. 
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8.3.3 Potential RAPD sites in 26695 and J99 

The expected number of RAPD-PCR products were next identified in the two type strains. 

NCBI BLAST analysis revealed a total of 208 possible bands (26695) and 429 bands (J99) 

respectively. Two and 5 RAPD-PCR amplicons were predicted for 26695 and J99 

respectively. RAPD-PCR Was then performed on DNA isolated from each strain (Table 8.2). 

Repeated RAPD-PCR (n = 3) showed that fingerprints were stable. 

Table 8.2 Expected and obtained REP-PCR products 
26695 J99 
Expected Obtained 
4,098 4,866 
581 2,652 
1,098 
Obtai 
5,725 2,250 
926 4,087 2,080 
727 2,250 1,843 
485 1,632 
254 1,134 
1,004 
698 
192 
These results which include a large number of small amplicons « 2000 bp) as well as the low 
frequency ofpredicted amplicons (0% for 26695 and 10% for J99) confirms that RAPD-PCR 
is, as described, an arbitrarily primed protocol. Graphical analysis of the putative RAPD 
primer sites in both genomes demonstrated that these sites were normally distributed. 
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8.3.4 RAPD-PCRfingerprinting 
RAPD-PCR resulted in 1~7 distinct bands, with an average of 4 different bands per isolate. 
Repeated RAPD-PCR (n = 3) showed that fingerprints were stable. The band sizes ranged in 
size from 0.1 to 4.6 kb pairs, and there was no amplification band common to all strains. In 
RAPD-PCR of the 76 isolates, 60 different DNA fingerprints were seen; 5 pairs of isolates 
from the same patients and 3 pairs of isolates from different patients had DNA fingerprints 
with similarity co-efficients > 99%. 
Cluster analysis revealed that there was a large degree of genetic heterogeneity of the 
H. pylori strains in this study (Figure 8.2). Examination of the dendrogram demonstrated 2 
readily distinguishable clusters of H. pylori strains at a similarity coefficient of 64.2 ± 4.3%. 
Cluster 1 (RAPD1) included 5 isolates from patients with gastritis alone, 12 gastric cancer 
isolates and 17 peptic ulcer isolates. The second cluster (RAPD2) consisted of 17 peptic ulcer 
isolates, 10 gastric adenocarcinoma isolates and 15 isolates from patients with gastritis alone. 
Both type strains were also present in this cluster. Analysis suggested that the isolates 
associated with specific disease subtypes may not be differently distributed between the two 
clusters (X2 = 4.39, P = 0.111). However, more isolates associated with clinically significant 
disease (both peptic ulcer disease and gastric adenocarcinoma) were present in RAPD1 (85%) 
then in RAPD2 (64%) (p == 0.034). 
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Figure 8.2 Dendrogram of H. pylori RAPD-PCR DNA fingerprints. Similarity coefficients 
are included in the top bar. G = gastritis alone, P = peptic ulcer disease, C= gastric 
adenocarcinoma. J99 and 26695 are indicated by asterisks. The two clusters are indicated. 
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8.3.5 Relationship between REP-DNA fingerprinting and virulence status 
The dendrogram based on REP-DNA contains 2 clusters which segregate with pathology. As 
expected, analysis of vacA signal sequences demonstrated that vacA type sl occurred more 
frequently in REP 1 (100%), then in cluster 2 (77%, p < 0.003). There were also differences in 
segregation ofvacA mid-regions between the 2 groups (88% vs. 61 %, p = 0.01). No specific 
segregation of cagA-3'-fragment length or cagPAI status (intact or partial) was evident. iceA 
genotypes were, however, differentially segregated (X2 = 7.43, P < 0.03). Specifically, 
iceA1I2+ occUrred more often in REP2 (62% vs. 33%, p < 0.02) while iceA2 occurred more 
often in REP 1 (42% vs. 18%, p < 0.02). 
Within REP 1 , there were no differences in the distribution of either vacA sl or vacA 
ml between the different disease groups Twenty-eight (88%) of these isolates had the vacA 
sImI combination, while the two (9%) isolates from patients with peptic ulcer disease and 
two (22%) of gastric adenocarcinoma isolates had the vacA s1m2 combination. No 
differences in iceA genotypes were noted. 
Within REP2, significantly more peptic ulcer disease isolates (100%, p < 0.004) and 
gastric adenocarcinoma isolates (100%, p < 0.002) were vacA sl, compared to gastritis alone 
isolates (50%). There were no differences, however, in the segregation of vacA mid-region 
alleles. No differences in iceA genotypes were noted. 
8.3.6 Relationship between RAPD-DNAfingerprinting and virulence status 
The dendrogram based on RAPD-PCR analysis contains 2 clusters which potentially 
correlate with pathology. Analysis of signal sequences demonstrated that vacA sl type 
occurred more frequently in RAPDl (100%), then in RAPD2 (77%, p < 0.002), while vacA 
s2 alleles were found exclusively in the second cluster. There were no differences in 
segregation of vacA mid-regions between the 2 clusters (74% vs. 70%, p < 0.5). No specific 
segregation of cagA-3'-fragment lengths was evident. The cagPAI status was, however, 
differentially segregated (p < 0.002). Specifically, an intact pathogenicity island was present 
more often in RAPDl (85%) than in RAPD2 (52%). While iceA genotypes did not appear to 
be differentially segregated between the two clusters (X2 = 5.4, p = 0.066), iceA2 genotypes 
were present significantly more often (p < 0.02) in RAPD2 (63%) than in RAPDl (15%). 
Within RAPDl, all five isolates from patients with gastritis alone were vacA slml. 
There were therefore no differences in the distribution of vacA alleles between the different 
disease groups in this cluster (vacA sl = 100% all isolates, vacA ml = 71% peptic ulcer 
disease, 67% gastric adenocarcinoma, 100% gastritis alone). Neither cagPAI status nor iceA 
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genotypes (X2 = 5.86, p = 0.053) segregated between the disease groups, but ieeA2 was more 
prevalent in peptic ulcer disease isolates (30%, p 0.05) than gastric adenocarcinoma isolates 
(0%). 
Within RAPD2, significantly more peptic ulcer disease isolates were vaeA sl (100%, 
p < 0.00005) and vaeA ml (94%, p < 0.0005) than gastritis alone isolates (sl=33%, ml = 
33%). This was similar for gastric adenocarcinoma isolates (vaeA sl = 100%, p < 0.001, vaeA 
ml 80%, p < 0.03). No specific segregation of ieeA genotypes was evident. The eagPAI 
status was, however, differentially segregated between disease groups in RAPD2 (X2 = 12.13, 
P < 0.003). Specifically, an intact pathogenicity island was present more often in peptic ulcer 
disease isolates (78%, p < 0.001) and gastric adenocarcinoma isolates (60%, P < 0.05) than 
gastritis alone isolates (23%). 
8.3.7 Cluster analysis a/virulent and fingerprint data 
Hierarchical analysis was performed using Unweighted pair-group average (UPGMA) and 
Euclidean distances for the variables. This resulted in two distinct clusters (Figure 8.3) which 
were clearly delineated. Cluster I was defined by the presence of gastritis alone and gastric 
adenocarcinoma isolates, vaeA s2 and m2, a partial eagPAI, medium and long eagA-3' 
fragment lengths, the ieeA alleles and the RAPD llREP2 fingerprints. Further analysis of 
cluster I, however, suggested the presence of 2 sub-clusters (Ia and Ib). Cluster la 
demonstrated that gastritis, vaeA s2, a partial eagPAI and the iceA2 genotype were related, 
while cluster 1 b was characterized by gastric adenocarcinoma isolates, the medium and long 
eagA-3'fragments and ieeAl. The RAPDI and REP2 fingerprints occurred outside these 
clusters. 
Cluster 2 included PUD, REPI, the virulence associated vacA sl and ml alleles, an 
intact cagPAI, RAPD2 and a short cagA 3'-fragment length. This suggests that PUD was 
associated with specific virulence genes as well as specific genomic fingerprints. Clustering 
using the k-Means test confirmed the presence of two clusters. Using the latter analysis, 
cluster 2 contained, in addition, the ieeAl+12+ variable. 
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Figure 8.3 Cluster diagram based on hierarchical analysis using genomic analysis (REP and 
RAPD fingerprints), and virulence data (vaeA, eagA and eagPAI, and ieeA genotypes). The 
two major clusters are evident, as are the sub-clusters in I. 
8.4 Discussion 
The DNA fingerprints of 76 eagA+ H. pylori isolates from Cape-colored individuals with a 
panoply of gastroduodenal diseases were analyzed by two complementary genomic DNA 
based polymerase chain reaction techniques, REP-PCR and RAPD-PCR. This study indicates 
that REP-PCR is probably an arbitrarily-primed protocol rather than a site-directed genome 
analysis. Nevertheless, because of differences in primers and annealing temperatures, these 
techniques will generate different fingerprints. Both the REP and the RAPD-PCR fingerprints 
were stable and reproducible for each isolate. It appears, however, that REP-PCR may be 
more useful than RAPD-PCR for generating DNA fingerprints that can classify pathogenic 
South African strains. 
REP-PCR typing has generated stable, reproducible DNA fingerprints which have 
been successfully used to discriminate H. pylori strains associated with peptic ulcer disease in 
a USA study 170. The results from the present study suggest that REP fingerprints (although 
probably generated as arbitrarily primed products) may be useful for defining disease­
associated strains. In particular, REP-PCR clearly discriminated a pathogenic cluster which 
accounted for 69% of peptic ulcer disease isolates and 41 % of gastric adenocarcinoma 
isolates in our study group. This cluster was also distinguished by the almost universal 
presence of the vaeA sImI allelic type, as well as the inclusion of the type strain (J99, vaeA 
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s1bm1) isolated from a patient with duodenal ulcer disease .. The vaeA s2 allele (low or non­
cytotoxic activity, not associated with peptic ulceration in the USA 11) was completely absent 
from this cluster. The second REP cluster was composed chiefly of gastritis alone isolates 
(61 %). In addition, vaeA s2 alleles were found exclusively in this cluster, while the vaeA m2 
allele, which has been less strongly correlated with epithelial injury (epithelial degeneration, 
mucus depletion and microscopic erosions) than mid-region m1 6 tended to segregate into this 
cluster (81 %). Interestingly, a fair percentage of gastric adenocarcinoma isolates (59%) was 
also found in cluster 2. These results suggest that carcinogenic potential, unlike that for peptic 
ulcer disease, may not be associated with any particular REP cluster. Interestingly, ieeA 
genotypes appeared to segregate with REP fingerprints. Specific subtypes of ieeA2 did not, 
however, separate between the two clusters. Both ieeA2C and ieeA2D were equally present in 
REP1 while a mixed genotype (ieeA1I2+) was principally found in REP2. The latter was 
often characterized by the iceA2D subtype (60%) which identifies isolates from patients with 
PUD (cf. Chapter 7). 
RAPD-PCR uses an oligonucleotide of arbitrarily chosen sequence to prime DNA 
synthesis from pairs of sites to which it is matched or partially matched. It results in strain 
specific arrays of DNA products and has been successfully used to analyze DNA diversity 
among clinical isolates of H. pylori 172,180. The RAPD results from this study using a high 
(70%) GC content primer show two main clusters, one containing mainly isolates from 
patients with peptic ulcer and gastric adenocarcinoma (RAPD 1) and the other isolates mainly 
irrespective of pathology (RAPD2). In contrast to REP fingerprinting which distinguished 
peptic ulcer isolates into a separate cluster, RAPD-PCR may not be associated with peptic 
ulcer disease potential, isolates from peptic ulcer disease patients being present in similar 
numbers in both RAPD 1 and RAPD2. Similarly to REP fingerprinting, there was a 
correlation between RAPD-PCR and vaeA polymorphism. Strains with the vaeA s2 allele 
were exclusively present in isolates from RAPD2, while RAPD 1 contained only strains with 
vaeA s 1 alleles. As noted for REP analysis, the ieeA2 genotype segregated with RAPD 
fingerprints. Interestingly, an intact eagPAI also appeared to segregate with the fingerprint 
(RAPD1). 
Sixty-four percent of strains identified in the virulence-associated REP1 were also 
present in the heterogeneous RAPD2 (but made up only 48% of isolates identified in this 
cluster), suggesting that the RAPD and REP techniques may be only partially 
complementary. It would appear that REP-PCR and RAPD-PCR differently differentiate 
groups of organisms. The former identifies isolates associated with clinically significant 
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disease, and that cany virulence associated genes, vaeA sImI and ieeA2. The resultant is a 
clearly defined virulence group. The latter technique, however, appears to segregate isolates 
based on virulence genes but not consistently by pathology. In addition, this is obscured by 
the complex nature of RAPD2 where the association between virulence genes (vaeA sImI 
and an intact eagPAI) and PUD is diluted by the presence of non-virulent genes and a high 
prevalence of isolates from patients with gastritis alone. It is possible that this may merely 
reflect a statistical anomaly. It should also be pointed out that these results are only indicative 
of a particular time in the natural history of infection and it is feasible that with time patients 
with gastritis alone whose isolates are identified in RAPD2 may develop clinically significant 
disease. 
Alternatively, such anomalies may be as a result of the methodology used (Ward's 
method using the. GelCompar program). Binary coding and hierarchical analysis using 
UPGMA and k-Means clustering with the STATSITICA program demonstrated a clear 
clustering of PUD, virulence associated H. pylori alleles (vaeA sImI and an intact eagPAI) 
and the REP1lRAPD2 fingerprint. This was clearly delineated from a second cluster 
containing the remainder of the variables, and did not generate the anomalies noted with the 
GelCompar program. This alternative methodology may potentially provide a more robust 
method of analyzing the relationship between the genome and virulence. Interestingly, this 
result differs to that of Salaun et al. whose similar analysis of the genome and virulence 
factors demonstrated a panmictic structure of H. pylori 166. It is feasible that the relationships 
noted in the present study reflect the possibility that H. pylori in the Cape-colored popUlation 
may be more clonal than European strains 165. 
8.5 Conclusion 
Analysis of genome relatedness demonstrated that computer-assisted analysis of clustering of 
REP-PCR fingerprints was strongly associated with disease and with vaeA signal sequence 
type in South African isolates from Cape Town, while RAPD-PCR fingerprints were less 
strongly associated with these parameters. Isolates from peptic ulcer patients and patients 
without ulcers tended to cluster differently, but strains from patients with gastric 
adenocarcinoma appeared to show no specific genomic clustering. This is novel, particularly 
because only one other study has shown H. pylori genome-relatedness and gastric disease 
clustering. Additional studies using a number of molecular genetic techniques in other South 
African popUlation groups as well as in geographically isolated groups require to be 
conducted to explore the results from this South African population. 
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Chapter 9 
Identification and analysis of the 

effect of H pylori LPS Oil naive EeL cells 

9.1 Introduction 
In the preceding four experimental chapters, potential virulence factors in H. pylori isolates 
from the Western Cape were analyzed and their relationship to pathology defined. These 
results suggest strongly that clinically significant gastroduodenal diseases in South Africa are 
partially due to the virulence of the infecting organism. 
Infection with the organism (irrespective of virulence), however, results in a number 
of endocrine and physiological alterations in the gastric mucosa (reviewed more fully in 
Chapter 3). These effects may be modulated by LPS. Essentially, H. pylori can elevate 
plasma gastrin levels 311-313 and increase acid output in patients compared with uninfected 
persons 72,73. In addition, whilst serum gastrin levels are similar in H. pylori infected healthy 
volunteers and patients with duodenal ulcer disease, acid secretion is disproportionately 
increased in patients with the disease 314. The effects of H. pylori on acid secretion appear to 
depend both on the stage ofbacterial infection, and have been reported as diminished, normal 
or increased 72,73,315. 
Although the relationship of H. pylori infection and gastrin and somatostatin (SST) 
cell function has been studied extensively 72,315, little is known of the effects of this infection 
on the fundic enteJochromaffin-like (ECL) cell. This neuroendocrine cell, which is critical in 
the regulation of parietal cell secretion, is both the major source of histamine in the mucosa 
316 and a prime target for the secretory and trophic effects of gastrin 317. Although the 
immediate effect of gastrin is to initiate synthesis and secretion of histamine, its long-teim 
action is to promote ECL cell hyperplasia and possibly even neoplastic transformation, 
particularly in rodents 318. The effects of H. pylori on ECL cell proliferation or histamine 
secretion have not been reported. 
One may postulate that H. pylori might affect acid secretion by altering the histamine 
secretory response of the ECL cell. To investigate this question and to explore the possible 
relationship between H. pylori infection and ECL cell hyperplasia, the effects of H. pylori 
LPS on either histamine secretion or DNA synthesis were examined in rat ECL cells. 
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9.2 Materials and Methods 
9.2.1 Experimental design 
An isolated, purified preparation of rat ECL cells maintained as a primary short-term cell 
culture was used in all experiments 319. The effect on ECL cell histamine secretion over I hr 
of both H pylori and E. coli LPS (10 fg/ml - 10 ug/ml) alone or with maximal or sub­
maximal concentrations of gastrin (10-8 M or 10-10 M) was initially examined. To investigate 
whether H pylori LPS-mediated histamine secretion occurred via activation of the 
gastrinlCCK2receptor the effect of adding the specific receptor antagonist, L365,260 (10-12 _ 
10-6 M) was evaluated. Thereafter, the effect of the ubiquitous gastrointestinal inhibitor 
somatostatin (10-16 - 10-6 M), on LPS-stimulated histamine secretion was determined. Cells 
were initially pre-incubated with either L365,260 or somatostatin for 30 min, followed by 1 
hr incubation with H pylori LPS (100 ng/ml). The presence of the CD14 receptor was 
thereafter identified by reverse transcription-polymerase chain reaction (RT -PCR) from 
cDNA derived from ECL cells. Subsequently, the effect of H pylori and E. coli LPS (10 
fg/ml- 10 ug/ml) alone or in combination with a maximal dose of gastrin (10-8 M) on DNA 
synthesis by measurement of the 24 hr uptake of bromodeoxyuridine (BrdU) was 
investigated. 
9.2.2 Materials 
All materials were obtained commercially from Sigma Chemical Co. (St. Louis, Missouri, 
USA) except where otherwise indicated. Lipopolysaccharide (LPS), prepared from the 
cytotoxic (VacA+/CagA+) H pylori strain 84-183 by hot phenol-water extraction exactly as 
previously described 320, had a molecular weight of 5,000-10,000 Daltons. E. coli LPS, 
(Sigma Chemical Co.) was prepared from cells of serotype 026:B6 by phenol extraction and 
ion-exchange chromatography; the RNA and protein concentrations were < 1%. 
9.2.3 Buffers 
The composition of medium A (mM): NaH2P04 (0.5), Na2HP04 (1.0), NaHC03 (20), NaCI 
(70), KCI (5), glucose (11), Na2-ethylenediaminetetraacetic acid (EDTA) (1.0), HEPES 
buffer (50) at pH 7.8, and BSA (10 mg/ml). Medium B was similar to A except for CaCh 
(1.0) and MgCh (1.5) at pH 7.4 and there was no EDTA. Medium C contained HEPES buffer 
(15) (PH 7.4), NaCI (140), MgS04 (1.2), CaCh (1.0), D-glucose (11), BSA (1 mg/ml), 
dithiothreitol (0.5). Stock Nycodenz: MgCh (1.2), HEPES buffer (15), BSA (10 mg/ml), 
Nycodenz (Accurate Chemical and Scientific Corporation, Westbury, New York, USA). 
Stock Nycodenz was diluted 1: 1 and 1:2 with medium C. 6 ml of 1: 1 solution was overlaid by 
7 ml of 1:2 solution to form the step gradient for ECL cell purification. 
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9.2.4 Cell isolation 
Rat ECL cells were prepared by a modification of the method of Prinz, as previously 
described 319, For each experiment, 4 non-fasting female Sprague-Dawley rats (200 - 250g) 
were sacrificed by cervical dislocation subsequent to CO2 anesthesia. The stomachs were 
excised and everted to mucosal-side-out sacs. Following a thorough wash in phosphate 
buffered saline (PBS), pronase E solution (Boehringer Mannheim, Indianapolis, Indiana, 
USA) (1.6 mglml) was injected into the stomach sacs (3 ml). The stomachs were then 
incubated in oxygenated medium A for 30 min at 37°C, followed by a 10 min incubation in a 
calcium respiration medium (B) at the same temperature. The stomach sacs then were 
transferred back to medium A for a further 30 min incubation. The mucosal cells were 
harvested by gentle stirring for 10 min in medium B and collected by centrifugation (100 x g, 
5 min). 
9.2.5 Cell purification 
The crude mucosal cell fraction was subjected to counter-flow elutriation (JE-6 rotor, 
Beckman Instruments). Small cells with a diameter of 8-10 Jim were collected at 2,000 rpm 
and a flow rate of 20 mllmin. This fraction was subsequently layered on a step Nycodenz 
gradient and centrifuged at 1100 rpm for 8 min. The ECL cell-enriched fraction (90-95%) 
was collected by aspiration at the interface of density 1.040 g/ml. After washing in Medium 
C, the viability and number of this enriched fraction was evaluated by trypan blue exclusion. 
9.2.6 Short term culture 
The enriched ECL fraction was resuspended in growth medium (Dulbecco's Minimal 
Essential medium (DME):FI2, 2% Fetal Calf Serum (PCS), Insulin Transferrin Sodium 
Selenite 0.5 mglml, hydrocortisone 10 nM, gentamicin 0.1 mgl100 ml, pH 7.4) at a final 
concentration of lOscells/ml. Thereafter, 100 Jil ofcell suspension was applied per well in rat 
collagen-I coated 96-well plates (Collaborative Research, Bedford, Massachusetts, USA) for 
measurement of DNA synthesis. For measurement of histamine secretion, 200 Jil of cells 
were applied per well in a 48-well plate and incubated overnight. 
9.2.7 Histamine secretion 
Measurements ofbasal and gastrin (human gastrin-17, Ix! 0.8 M) stimulated histamine release 
were undertaken to confirm cell function and viability. In a previous study the ECso for 
gastrin was determined to be 10.10 M and the maximal response 10.8 M 319. In all experiments, 
growth medium was removed and replaced with 200 Jil of culture medium (DME~FI2, 2% 
FCS, pH 7.4) containing agents of interest. Control wells contained culture medium alone. At 
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the termination of the experiment, 180 J,tl ofmedium was removed and, after centrifugation at 
10,000 rpm, decanted and stored at -20°C for subsequent histamine measurement. Histamine 
analysis was performed by enzyme immuno-assay (AMAC, Immunotech, Westbrook, Maine, 
USA) and expressed as nmolesll 03 cells. Final results were expressed as mean percentage of 
control ± SEM. 
9.2.8 RT-PCR 
The FastTrack mRNA isolation kit (Invitrogen, San Diego, California, USA) was utilized to 
isolate mRNA from ECL cells. SuperScript preamplification system (Gibco BRL, 
Gaithersburg, Maryland, USA) was utilized to prepare first strand cDNA. Specific DNA 
amplification for CD14 was carried out with the following combinations of primers derived 
from the CDJ4 nucleotide sequence 268: sense: 5'-CTTGAACCTCCGCAACGTGTC and 
antisense: 5'-CCCAGTGAAAGACAGATTGA. PCR using 0.7 J,tg cDNA template was 
carried out with Taq DNA polymerase through 35 cycles of denaturation (1 min at 94 0 C), 
annealing (1 min at 45 0 C) and extension (1 min at 72 0 C) on a thermal cycler from MJ 
Research (Watertown, Massachusetts, USA). Products were electrophoretic ally separated and 
visualized using UV. 
9.2.9 DNA synthr:sis 
Cells were cultured overnight for analysis of DNA synthesis. Subsequently, the medium was 
aspirated and replaced with growth medium containing BrdU (pre-diluted labeling reagent 
(1 :200) - Amersham, Arlington Heights, Illinois, USA) and the indicated stimulant. After 
incubation for a further 24 hr, the medium was removed by inverting the plate, the cells fixed 
at 4°C in 90% ethanoV5% acetic acid/5% water, then washed in PBSlTween-20 (0.1 %). The 
wells were incubated with anti-BrdU antibody with nuclease (1 :400 - Amersham) for 1 hr at 
room temperature, and following 3 washes, incubated with rabbit anti-mouse IgG conjugated 
to horseradish peroxidase (1:800 • Amersham) for 30 min at room temperature. After further 
3 washes, wells were incubated with substrate (30 mg O-phenylenediamine dihydrochloride 
in citrate-phosphate buffer, pH 4.12), and optical density determined spectrophotometrically 
at 405 nm (Biotad Microplate reader model 450, Winooski, Vermont, USA). Results are 
expressed as OD unitS(405 nm) and final results are expressed as mean ratio to control ± SEM. 
9.2.10 Analysis ofcytotoxicity 
To assess non-specific damage to the ECL cells, the presence of lactic acid dehydrogenase 
(LDH) in culture supernatants was assessed. LDH was measured in overnight cultured 
samples stimulated for 1 hr with either H. pylori or E. coli LPS (both 10 uglml). Final results 
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are expressed as percentage of control levels (LDH release from unstimulated cells). In 
addition, freshly isolated ECL cells (5 x 104 cells) were incubated at 37°C for 0,5, 15,30,60, 
90, 120 min or 24 hr with either H. pylori or E. coli LPS (both 10-6 M) in PBS and cell 
viability was assessed by trypan blue exclusion. Final results, representing viability in PBS, 
are expressed as percentage of control levels. 
9.2.11 Statistical analysis 
Results are expressed as mean ± SE. "n" indicates the number of separate ECL cell 
preparations. Statistical analysis was perfonned using the two-tailed Student's t-test for paired 
values as appropriate and p-values < 0.05 were considered significant. 
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9.3 Results 
9.3.1 Effect ofE. coli LPS on Histamine secretion 
Initially the effect of E. coli LPS on basal and stimulated EeL cell histamine release was 
measured. Basal levels for the rat EeL cell preparation were 3.4 ± 0.13 nmolll 03 cells. 
Although gastrin (10-8 M) stimulated histamine release as expected (Figure 9.1), E. coli LPS 
alone did not significantly alter basal histamine release over the 1 hr experimental period 
(Figure 9.1). However, co-incubation of E. coli LPS (10 uglml) resulted in a significant 
inhibition of gastrin-stimulated histamine secretion. These results are consistent with early in 
vivo data 321, the mechanism is, however, unknown. 
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Figure 9.1 Effect ofE. coli LPS on EeL cell histamine secretion .• Gastrin 10-8 M, • LPS + 
gastrin (10-8 M), ... LPS alone. All points are expressed as means ± SEM. *p = 0.03 (n = 5). 
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9.3.2 Effect ofH. pylori LPS on Histamine secretion 

The effect of H. pylori LPS on basal and stimulated EeL cell histamine release was then 

measured. As in the previous experiments, incubation with gastrin significantly (p < 0.05) 

stimulated histamine levels, with stimulation higher at 10-8 M (1.36 fold) than at 10-10 M (1.24 

fold). H. pylori LPS stimulated basal histamine secretion maximally at 10 ng/ml (1.69 ± 0.25 

vs. basal, p = 0.05) (Figure 9.2-left panel), had no significant effect on maximal (10-8 M) 

gastrin-stimulated release, but significantly increased sub-maximal (10-10 M) gastrin­

stimulated release with a maximal concentration of 100 ng/ml (1.48 ± 0.08, p = 0.05 vs. 

gastrin alone) (Figure 9.2-right panel). 
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Figure 9.2 (left panel) Effect of H. pylori LPS on basal secretion .• Gastrin 10-8 M, • LPS 

alone. • p = 0.05 (n = 5). 

Figure 9.2 (right panel) Effect of H. pylori LPS on sub-maximal gastrin-stimulated release . 

• Gastrin 10-10 M, • LPS + gastrin (10-10 M). +p = 0.05 (n = 4). 
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9.3.3 Lack of effect of the GastrinlCCKB receptor antagonist, L365,260, on H. pylori LPS­
stimulated histamine secretion 
The major stimulatory mechanism for EeL cell histamine release is via activation of the 
gastrin receptor 22. To determine whether H. pylori LPS stimulated histamine release by 
interaction with this receptor, the potential inhibitory effect of the specific receptor 
antagonist, L365,260, on H. pylori LPS-stimulated secretion was evaluated. Basal levels were 
3.2 ± 0.18 nmolesll 03 cells and as expected, both gastrin (10-8 M) and H. pylori LPS (100 
ng/ml) stimulated histamine release (1.4 ± 0.1 and 1.6 ± 0.2 times basal respectively, p = 
0.01). L365, 260 (10-8 M) significantly inhibited gastrin-stimulated histamine release (1.05 ± 
0.04, p < 0.05) but at concentrations ranging from 10-12 - 10-6 M, had no effect on H. pylori 
LPS (100 ng/ml)-stimulated histamine secretion, making it unlikely that the stimulatory effect 
ofH. pylori is mediated by the gastrin receptor (Figure 9.3). 
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Figure 9.3 Effect of L365,260 (10-6 M) on gastrin or LPS-stimulated histamine release. G = 
gastrin (10-8 M), G+L = gastrin + L365,260 (10-6 M), LPS = H. pylori LPS (100 ng/ml), LPS 
+ L = LPS and L365,260 (10-6 M).•p < 0.05 (n = 3). 
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9.3.4 Inhibitory effect ofsomatostatin on H. pylori LPS-stimulated histamine secretion 
Because a major inhibitory mechanism for basal and stimulated ECLcell histamine release is 
via activation of the somatostatin receptor 22, the effect of somatostatin on H. pylori LPS­
stimulated histamine release was investigated. As in previous experiments, H. pylori LPS 
(100 ng/ml) significantly stimulated histamine release (p = 0.02). However, pre-treatment 
with somatostatin inhibited H. pylori-driven histamine secretion in a dose dependent manner 
with an estimated IC50 of approximately 5x10-13 M and maximum inhibitory concentration of 
10-10 M (p = 0.05 vs. LPS alone) (Figure 9.4). These results are similar in magnitude to the 
inhibitory effect of somatostatin on gastrin stimulated histamine secretion 319. Thus, the 
inhibitory effect of somatostatin appears to act on intracellular secretory pathways activated 
by both gastrin and H. pylori LPS . 
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Figure 9.4 Effect of somatostatin (SST) on H. pylori LPS-stimulated histamine release. LPS 
=H. pylori LPS (100 ng/ml), LPS + SST = LPS + somatostatin (10-10 M).•p < 0.05 (n = 4). 
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9.3.5 Lack ofcytotoxic effect on EeL cells by H. pylori or E. coli LPS 
The possibility that these LPS preparations altered histamine secretion via a cytotoxic effect 
was next evaluated. When assessed at high concentrations (10 uglml), neither H. pylori nor E. 
coli LPS had a significant effect on cell viability, measured either by trypan blue exclusion 
assessed over 24 hr (Figure 9.5-left panel) or by LDH release at 1 hr (Figure 9.5-right panel). 
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Figure 9.5 (left panel) Effect of LPS on ECL cell Trypan blue exclusion .• E. coli LPS, • 
H. pylori LPS. (n = 3). 

Figure 9.5 (right panel) Effect of LPS on LDH release. C = control (no LPS), Ec = E. coli 

LPS, Hp = H. pylori LPS. (n =3). 
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9.3.6 Identification ofCD14 message in ECL cells 
The presence of CD14 messenger RNA in ECL cells was next identified. RT-PCR revealed 
the presence of a band of 430 bp in rat spleen (positive control). A similar band was obtained 
from rat ECL cell eDNA, demonstrating the presence of message for the LPS receptor on the 
ECL cell (Figure 9.6). 
Figure 9.6 RT-PCR amplification of CD14. mRNA w s prepared from rat spleen (positive 
control) and rat ECL cells. A blank control (Con) was also performed to exclude non-specific 
amplification. After reverse transcription, eDNA was quantified and CD14 message 
amplified. The expected priming sequence (432 bp) was detected in both samples. The gel is 
representative of 3 separate experiments. 
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9.3.7 coli and pylori LPS on DNA synthesis 
The effect coli on basal and stimulated EeL cell DNA synthesis was initially 
evaluated. E. coli significantly increased basal synthesis only at 10 ug/ml (p < 0.01), but 
not substantially gastrin-stimulated DNA (Figure 9.7). 
In parallel studies, pylori (10 fg/ml 10 ug/ml) had no effect, but 
augmented (10-8 M) maximally at 100 ng/ml (2.5 ± 0.17 times 
basal, (p = 0.03) (Figure 9.7). concentration of LPS is the same 
release,both gastrin-stimulated DNA common 
modifications at an intracellular level for these responses. 
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9.4 Discussion 
The results of the present study demonstrate that LPS alters both basal and gastrin-stimulated 
histamine secretion and that this effect may be bacterial species-specific. Of interest is that 
the combination of LPS and submaximal doses of gastrin resulted in an increased but not 
completely additive release of histamine from ECL cells. It is probable that this combination 
alters histamine release via modifications at a second messenger level. 
The mechanism by which H. 'pylori LPS potentially mediates histamine secretion was 
thereafter investigated. Since co-incubation with L365,260 did not alter LPS-induced 
histamine secretion, it appears unlikely that H. pylori LPS alters histamine secretion via 
activation of the gastrin receptor. In addition, the stimulatory effect ofLPS both on basal and 
gastrin-stimulated histamine release, which is in contrast to the auto inhibitory effect of the H3 
receptor 322 suggests that it is unlikely that LPS interacts with this receptor in vitro. In 
previously reported investigations it has been shown that somatostatin inhibits ECL cell 
histamine secretion with an ICso of 10-13 M 319. In this study it was noted that somatostatin 
inhibited H. pylorfLPS induced histamine secretion in a dose dependent manner, suggesting 
that LPS-mediated histamine release is amenable to SST receptor induced modifications in 
second messenger pathways. The p'robability exists that H. pylori LPS could block the 
interaction between somatostatin and its receptor in vitro 323, and this study's observations 
could thus be explained by the presence of a contaminating population of D-cells in the ECL 
cell preparation. However, this appears to be unlikely since the percentage of such cells is 
low, typically less than 1%. In addition Significant levels of the peptide in the cell cultures 
were not detected. Since the subtype 2 SST receptor is predominant on ECL cells 324,325, it is 
likely that the inhibition of histamine induced secretion occurs via this receptor SUbtype. 
Given that neither E. coli nor H. pylori LPS significantly altered ECL cell viability over a 24 
hr period, it is probable that H. pylori LPS did not cause histamine release by physically 
damaging the cells. 
The presence of both an LPS receptor (CD14) and the related intracellular pathways 
have been described previously in a number of immunological cell types 269. Within the gut", 
this receptor has been identified only in the SW620 human colonic carcinoma cell line 326. 
The presence of this receptor has not yet been investigated in the gastric mucosa. This study 
was able to identify CD14 message in the fundic ECL cell, thus confirming the presence of 
an LPS receptor and suggesting a mechanism by which H. pylori can directly affect this cell 
in vivo. 
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The observation that H. pylori LPS, while having no substantial effect on basal DNA 
synthesis resulted in a substantial augmentation of the trophic response of gastrin, resembles 
the physiology of fundic ECL cells exposed to elevated gastrin levels in association with 
elevated pH and fundic colonization of H. pylori. ECL cells are exquisitely sensitive to the 
trophic action of gastrin and undergo hyperplasia in a variety of hypergastrinemic conditions 
22. Experimental long-term (> 16 week) administration of the gastric H2-receptor antagonist, 
loxtidine, prolonged acid inhibition, resulting in a secondary hypergastrinemia in rodents, 
Praomys natalensis (mastomys) 327. The resulting hyperplastic proliferation of the oxyntic 
ECL cells generates gastric carcinoid tumors within four months 318,328. In humans, ECL cell 
hyperplasia is generally reversible even after prolonged administration of proton pump 
inhibitors 22. A marked increase in peripheral blood histamine levels and an increased urinary 
histamine excretion are also associated with ECL cell proliferation and histamine itself may 
function as a mitogen 329,330. In experimental studies, the HI receptor subtype is expressed on 
the ECL cell and stimulates DNA synthesis 331. 
H. pylori is classified as a gastric carcinogen (cf. Chapter 3) but a direct effect in the 
pathogenesis of ECL cell proliferation is not known. Several observations, however, 
implicate the bacterium in this process. Micronodular pseudohyperplasia probably represents 
a passive process of endocrine cell clustering and is frequently observed in foci of gland 
atrophy that may occur in H. pylori-gastritis 124,126,332. The phenomenon of endocrine cell 
clustering appears to be restricted to patients with H. pylori colonization but has not been 
demonstrated to progress beyond micronodular hyperplasia, which only occasionally has 
been of the pre-dysplastic adenomatoid type 126,127,332. It may be noteworthy, however, that 
such cell clustering is more marked in fundal than in antral gastritis 102, and may reflect a 
direct mitogenic effect of the bacterium on endocrine cells. Long term usage of proton pump 
inhibitory (PPI) therapy may result both in a migration of the organism from the antrum to 
the fundus 333 as well as an accentuation of the gastritis and atrophy in patients 334 although 
this may be controversial. The combination of long term treatment with PPI's (5 years) and 
H. pylori infection has been demonstrated to be associated with an increase in ECL cell 
hyperplasia in one study 335. It has thus been proposed that the organism might be an 
important risk factor for ECL cell proliferation in certain clinical settings. The mechanisms 
by which this occurs is currently open to conjecture. However, the production of 
autoantibodies against Lewis x antigens observed in patients infected with the organism 
262,264 suggests that the Lewis x glycoconjugate (which is mimicked by LPS of Helicobacter 
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pylori) is able to enter the gastric mucosa. In addition, it is likely that LPS may enter via 
mucosal micro-lesions associated with the infection. It is thus feasible that local 
concentrations adequate to stimulate the ECL cell occur, especially given the propensity of 
the organism to autolyze during colonization 236. In addition, although this has not yet been 
documented, the possibility exists that LPS may be present in the plasma of infected 
individuals as are many endotoxins. This could provide an alternative mechanism for the 
stimulation of the ECL cell in vivo. 
9.5 Conclusion 
A model endocrine system examining the effects of LPS on a biologically relevant gastric 
cell has been demonstrated. This study has revealed both a proliferative and a secretory effect 
of a toxigenic H pylori LPS on the naIve rat ECL cell. The presence of CD14 suggests a 
mechanism by which this may occur. It seems plausible that similar effects may occur in 
vivo, where direct H pylori stimulation of ECL cells may result in altered acid secretion and 
gastric mucosal proliferation. In addition, it is possible that a similar effect on other cells of 
the oxyntic mucosa could be relevant to the carcinogenicity ofH pylori. 
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Chapter 10 
Analysis of the effects ofLPS on transformed EeL cells 
10.1 Introduction 
Infection by H. pylori may evolve into atrophic gastritis, with increased mucosal proliferation 
and the predisposition to neoplastic transformation (reviewed more fully in Chapter 3) 336,337. 
Although atrophy and destruction of mucosal glands, balanced by a "compensatory" gastric 
proliferative response has been hypothesized to result in mucosal transformation 107, the 
mechanisms by which this may occur are currently open to conjecture. 
Several studies have documented that polyamine homeostasis, a tightly regulated, 
Ubiquitous eukaryotic cellular phenomenon responsible for mediating growth responses to 
most agents stimulating cell growth including gastrin and growth factors 338, is important in 
the development of gastrointestinal neoplasia. The activity of the rate-limiting enzyme, 
ornithine decarboxylase (ODC) is elevated in gastric cancer 339,340. ODC activity is also 
increased in patients infected with H. pylori and eradication of the organism has been 
demonstrated to result in a decreased ODC activity, and by inference, the potential for a 
decreased risk of gastric cancer 341-343. 
A role for H. pylori LPS in mediating both histamine release and DNA synthesis in 
naive rat ECL cells in vitro has been identified (cf. Chapter 9), while a role for polyamines in 
the regulation of gastrin-mediated ECL cell DNA synthesis has been demonstrated 344. One 
may postulate that H. pylori directly affects proliferation in tumor ECL cells via LPS 
activation of DNA synthesis and activation of polyamine biosynthesis (ODC activity). 
Furthermore, based on the observation that CD14 is a putative receptor for LPS, the 
possibility that such a phenomenon could be mediated via interaction with the CD14 receptor 
was therefore examined. 
10.2 Materials and Methods 
10.2.1 Materials 
All materials, including E. coli LPS (serotype 026:B6), were obtained commercially from 
Sigma Chemical Co. (St. Louis, Missouri, USA) except where otherwise indicated. The 
cytotoxic (VacA+/CagA+) H. pylori LPS (strain 84-183) was a kind gift from M.J. Blaser and 
G.1. Perez-Perez (Division of Infectious Diseases, Vanderbilt University, Tennessee, USA). 
Loxtidine, an irreversible Hz receptor blocker, was akind gift of Glaxo UK, (Ware, England) 
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and the irreversible inhibitor of ODC activity, difluoromethyl-ornithine (DFMO), was a kind 
gift from Dr. E. Bohme, Mamon Merrell Dow Research Institute, (Cincinnati, Ohio, USA). 
Human gastrin-17 and rat TGFa was obtained from Research Plus Inc. (Bayonne, New 
Jersey, USA), BCA protein assay reagent from Pierce (Rockford, Illinois, USA), 14C_. 
ornithine from New England Nuclear (Boston, Massachusetts, USA) (43.8 mCi/mmol), 5­
bromo-2-deoxyuridine (BrdU) proliferation kit from Amersham Corp (Arlington Heights, 
Illinois, USA), collagen-I coated 96 well plates from Becton Dickinson (Bedford, 
Massachusetts, USA), Nycodenz from Accurate Chemical and Scientific Corp (Westbury, 
New York, USA), and Pronase E from Boehringer Mannheim (Indianapolis, Indiana, USA). 
The mouse monoclonal antibody, M-M42, against CDI4, was obtained from Novocastra 
Laboratories Ltd., Newcastle upon Tyne, UK. 
10.2.2 Animals 
All animals for these studies were bred from the mastomys colony (ModYale) maintained at 
the West Haven Department of Veterans Affairs Medical Center, West Haven, Connecticut, 
USA. The animals were maintained in accordance with the National Institutes of Health 
Guide for the Care an~ Use ofLaboratory Animals. Animals with equal sex distribution were 
assigned to receive loxtidine (1 mglkg/day) delivered in drinking water (2 gil iter) for 16 
weeks. All animals had free access to rodent chow (purina, S1. Louis, Missouri, USA). 
Hypergastrinemia was confirmed by gastrin RIA 345. 
10.2.3 Isolation ofECL cells 
Mastomys tumor ECL cells were prepared as previously described 345. From each loxtidine­
treated mastomys, macroscopic carcinoids, mainly free of other gastric mucosal cells, were 
isolated and minced by hand, and individual cells released by alternate pronase (3 mglml) and 
collagenase (3 mglml) digestion. Cells were either immediately snap frozen and stored at -70 
o C for mRNA extraction, used within an hr. in ODC assays or cultured in culture medium 
(DMEM:FI2 and 2% BSA, pH 7.4) at a final concentration of 105 cells/ml, 100 J.lllwell for 
DNA studies. 
10.2.4 Experimental design 
An isolated, purified preparation of mastomys tumor ECL cells was used in all experiments 
345. 
10.2.4.1 Polyamine biosynthesis in tumor ECL cells: To evaluate an effect on DNA synthesis, 
cells were incubated with either TGFa, putrescine, spermidine or spermine alone (10-12 - 10-6 
M), or with a combination of each polyamine (10.12 - 10-6 M) and a maximal concentration of 
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TGFa (10-9 M) for 24 hr. To examine whether the effect of polyamines and TGFa was 
mediated via ODC, the effect of DFMO on TGFa (10-9 M) stimulated DNA synthesis was 
next evaluated. Thereafter the effect of TGFa (10-13 - 10-9 M) on the activity of this enzyme 
was examined using a modified radiometric technique 346. In addition, in order to examine 
whether gastrin had an effect on tumor cells the ability of this agent (10-11 - 10-7 M) to alter 
ODC activity was thereafter evaluated. 
10.2.4.2 LPS effects on tumor ECL cells: To evaluate an effect on DNA synthesis, cells were 
incubated with either a maximal concentration of TGFa (10-9 M) (positive control) or with H. 
pylori LPS alone (10 fglml - 1 uglml) for 24 hr LPS from E. coli (1 ug/ml) was used as a 
non-gastric control. To examine whether the proliferative effect of H. pylori LPS was 
mediated via polyamine biosynthesis and ODC, we next evaluated the effect of ~he 
irreversible inhibitor of ODC, DFMO (10-11 - 10-8 M), on LPS (10 nglml) stimulated DNA 
synthesis. To further examine whether the effect of H. pylori LPS was via activation of this 
pathway, we evaluated the effect of this agent alone (1 nglml - 1 uglml) on the activity of 
ODC. TGFa (10-9 M) and E. coli LPS (1 uglml) were used as controls. The presence of the 
CD14 receptor was identified by RT-PCR from cDNA derived from the tumor cells. In order 
to confirm whether the CD 14 receptor played a role in mediating LPS stimulated ECL cell 
DNA synthesis, we assessed the effect of pre-incubation for 5 min with the specific 
monoclonal antibody against CD14, M-M42 , (1:250 - 1:50) on H. pylori LPS (10 nglml) 
stimulated BrdU uptake. 
10.2.5 Cell proliferation assay by BrdU incorporation 
After 24 hr in culture (96-well collagen-I coated plate, 104 cells/well) at 37 0 C (5% C02), 
medium was aspirated and replaced with culture medium containing BrdU (pre-diluted 
labeling reagent (1:200) - Amersham) and the indicated agent (TGFa or LPS) as previously 
described 345. After incubation for an additional 24 hr, the medium was removed and the cells 
fixed at 4°C in 90% ethano1l5% acetic acidl5% water, then washed in 0.1% Tween-20 in 
phosphate buffered saline (PBS, pH 7.4). The wells were incubated with anti-BrdU antibody 
with nuclease (1 :400 - Amersham) for 1 hr at room temperature, and following 3 washes, 
incubated with rabbit anti-mouse IgG conjugated to horseradish peroxidase (1 :800 -
Amersham) for 30 min at 20°C. After a further 3 washes, wells were incubated with substrate 
(30 mg O-phenylenediamine dihydrochloride in citrate-phosphate buffer, pH 4.1), and optical 
density determined at 405 nm by spectrophotometry (Biorad Microplate reader model 450, 
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Winooski, Vennont, USA). Results are expressed as OD unitS(405 nm) and final results are 
expressed as ratio ofmean ± SEM to control. 
10.2.6 Evaluation ofODC activity 
Freshly isolated cells (105/100 J,.tl culture medium) were incubated with either TGFa (10-9 M) 
or H pylori LPS (1 ng/ml- 1 ug/ml) for 1 hr at 37°C. E. coli LPS was used as a non-gastric 
control and unstimulated cells provided values for basal ODC activity. ODC activity was then 
assayed as previously described 344. Briefly, after stimulation, cells were homogenized in ice 
cold Tris-HCI buffer (15 roM Tris-HCI, 0.1 roM EDTA, 2.25 roM dithiothreitol (DTT), pH 
7.5), centrifuged and an aliquot of the cytosolic extract removed and later assayed for protein 
content using the bicinchoninic acid (BCA) method. A second aliquot of the cytosolic extract 
was immediately incubated in the reaction buffer containing radio1abeled 14C-omithine (200 
nCi), for 1 hr at 37°C, the reaction tenninated by addition of HCI (37%) and the liberated 
product extracted in Betablend over 30 min at 37°C, and counted. Final results (dpmfJ,.tg 
proteinll hr) were expressed as ratio to control. 
10.2.7 RT-PCRforCD14 
The FastTrack mRNA isolation kit (Invitrogen, San Diego, CA) was utilized to isolate 
mRNA from ECL cells. SuperScript preamplification system (Gibco BRL, Gaithersburg, 
Maryland, USA) was utilized to prepare first strand cDNA. Specific DNA amplification for 
CD14 was carried out with the following combinations of primers derived from the CD14 
nucleotide sequence 268: sense: 5'-CTTGAACCTCCGCAACGTGTC and antisense: 5'­
CCCAGTGAAAGACAGATTGA. PCR using 0.7 J,.tg cDNA template was carried out with 
Taq DNA polymerase through 35 cycles of denaturation (1 min at 94°C), annealing (1 min at 
45 ° C) and extension (1 min at 72 ° C) on a thennal cycler from MJ Research (Watertown, 
Massachusetts, USA). Products were electrophoretically separated and visualized using UV. 
10.2.8 Evaluation ofthe effect ofM-M42 on DNA synthesis 
M-M42 at a final concentration of 1 :250 to 1 :50 was added 5 min prior to adding H pylori 
LPS (1 ng/ml) to cells which were then incubated overnight. Alterations in BrdU 
accumulation were measured as described above. 
10.2.9 Evaluation ofLPS cytotoxicity 
To assess non-specific damage to the ECL cells, cell viability was assessed by Trypan blue 
exclusion as previously described 347. Briefly, cells were incubated with either H pylori or E. 
coli LPS (both 10 ug/ml) in PBS for 0, I, 2 and 24 hr. Alterations in viability were compared 
to control levels (0 hr) and final results were expressed as percentage ofcontrols. 
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10.2.10 Statistical evaluation 
Results are expressed as mean ± SE. "nn indicates the number of ECL cell preparations. 
Statistical analysis was performed using the two-tailed Student's t-test for paired values as 
appropriate and p-values < 0.05 were considered significant. 
10.3 Results 
10.3.1 Polyamine biosynthesis in tumor EeL cells 
aJ Effect ofpolyamines on DNA synthesis 
The effect of putrescine, spermidine and spermine on basal and stimulated tumor ECL cell 
DNA synthesis was initially measured. All of the polyamines significantly increased (-30%) 
basal DNA synthesis over the 24 hr experimental period (Figure 10.1-left panel). The 
estimated ECso values were 3 x 10,12 M for putrescine and 2 x 10,10 M for spermidine and 
spermine, respectively. In addition, all of the polyamines significantly augmented (-40%) the 
stimulatory effect of TOFu (10'9 M) (Figure 10.I-right panel). The estimated ECso values 
were 2 x 10,11 M for putrescine, 2 x 10-10 M for spermidine and 3 x 10-10 M for spermine, 
respectively. 
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Figure 10.1 (left panel) Effect of polyamines on unstimulated ECL cell tumor DNA 

synthesis.• TOFu (10.9M), • putrescine, • spermidine, • spermine. (n = 6). 

Figure 10.1 (right panel) Effect of polyamines on TOFu-stimulated ECL cell tumor DNA 

synthesis.• TOFu (10.9M),. putrescine + TOFu (10.9M),. spermidine + TOFu (10-9M), 

• spermine + TOFu (10.9M). (n 5). 
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b) Effect ofDFMO on DNA synthesis 
The effect of DFMO, on basal and stimulated tumor ECL cell DNA synthesis was next 
measured. As in previous experiments, incubation with TGFu (10-9 M) significantly (1.58 ± 
0.02, p < 0.01) stimulated DNA synthesis (Figure 10.2). DFMO alone did not have a 
substantial inhibitory effect on basal DNA synthesis (Figure 10.2) but pre-treatment of the 
cells for 30 min with this agent dose dependently inhibited TGFu (10-9 M) stimulated DNA 
synthesis with an ICso of approximately 3 x 10-12 M and a maximal inhibition of -90% at 10-9 
M (1.07 ± 0.15, P < 0.05 vs. TGFu). 
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Figure 10.2 Effects of DFMO on DNA synthesis .• TGFu (10-9 M), • DFMO alone, ... 
DFMO + TGFu (10-9 M). *p < 0.05 vs. TGFu alone (n =5), 
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c) TGFa stimulation ofDNA synthesis and ODe activity 
The effect of TGFa. on DNA synthesis and ODC activity in ECL tumor cells was then 
measured. TGFa. stimulated DNA synthesis over 24 hr with an estimated ECso of 5 x 10-11 M 
and a maximal concentration of 10-10 M (1.92 ± 0.14, P < 0.01) (Figure 10.3). 
TGFa. stimulated ODC activity with an estimated ECso of 3 x 10-12 M and a maximal 
concentration of 10-11 M (1.5 ± 0.08, p < 0.01). Pre-treatment of the cells for 30 min with 
DFMO (10-8 M) reversed the stimulatory effect ofTGFa. (10-11 M) on ODC activity (1.17 ± 
0.07, p < 0.05 vs. TGFa. alone). Gastrin had no effect on tumor ECL cell ODC activity. This 
is consistent with our previous observation that the effect of gastrin on tumor cell DNA 
synthesis is negligible 345. 
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Figure 10.3 Effects ofTGFa. on BrdU uptake (_) and ODC activity (e) (n = 4). 
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10.3.2 Effect ofH. pylori LPS on DNA synthesis 
The effect of LPS on basal DNA synthesis in mastomys tumor cells was then measured. 
TGFa (10-9 M) stimulated DNA synthesis as expected (1.6 ± 0.08, p < 0.05 vs. control) 
(Figure 10.4). LPS from E. coli (1 ug/ml) had no significant effect on BrdU uptake over the 
24 hr experimental period (1.28 ± 0.14, P = NS vs. control). In contrast, LPS from H. pylori 
significantly stimulated DNA synthesis in mastomys tumor cells with an estimated ECso of 
50 fglml, and a maximal effect of 2.2 fold. 
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Figure 10.4 Effect of LPS on DNA synthesis. 0 TGFa 10-9 M, 0 E. coli LPS (1 uglml), • 
H. pylori LPS.•p < 0.01 vs. control (n = 4). 
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10.3.3 Effect ofDFMO on H pylori LPS stimulated DNA synthesis 
The effect of DFMO on H pylori LPS stimulated DNA synthesis was next evaluated. 
Incubation with LPS (10 ng/ml) significantly (2.08 ± 0.2, P < 0.01 vs. control) stimulated 
DNA synthesis (Figure 10.5). Whilst DFMO alone (10,l! - 10'8 M) had no significant 
inhibitory effect on basal DNA synthesis, pre-treatment of the cells for 30 min with this agent 
dose dependently inhibited LPS (10 ng/ml) stimulated DNA synthesis with an approximate 
ICso of2 x 10,11 M and a maximal inhibition of -75% at 10,10 M (1.25 ± 0.18, P < 0.05 vs. 
LPS alone). 
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Figure 10.5 Effect of DFMO on DNA synthesis. D TGFa (10'9 M), 0 H. pylori LPS (10 
nglml),. DFMO + H pylori LPS (10 nglml) .•p < 0.05 (n 3). 
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10.3.4 H. pylori LPS stimulation o/ODe activity 
The effect of LPS on ODC activity in freshly isolated cells was thereafter examined. TGFa. 
(10-9 M) significantly stimulated ODC activity (measured by 14C02 release from 14C_ 
ornithine) (1.47 ± 0.04, P < 0.01 vs. control) (Figure 10.6). While LPS from E. coli (10 
uglml) had no effect, H. pylori LPS significantly augmented ODe activity with an estimated 
half-maximal concentration of 1 ng/ml and a maximal effect of 1.4 fold (p = 0.05 vs. control). 
The specificity of this response was determined when pre-incubation of the cells with DFMO 
(10.9 M) for 30 min reversed the stimulatory effect of H. pylori LPS (10 nglml) (1.02 ± 0.06 
vs. 1.3 ± 0.03, p = 0.05 vs. LPS alone). 
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Figure 10.6 Stimulation of ODC activity by H. pylori LPS. 0 TGFa. 10-9 M, • E. coli LPS 
(10 ug/ml), ... H. pylori LPS. +p = 0.05 (n =4). 
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10.3.5 Identification ofthe CD14 receptor 
The identification of the presence of CD14 messenger RNA in tumor ECL cells was next 
attempted. RT-PCR revealed the presence of a band of 430 base pairs in mastomys spleen 
(positive control). A similar band was obtained from mastomys tumor ECL cell cDNA, 
demonstrating the presence of the message for the LPS receptor on the ECL cell (Figure 
10.7). 
--I 
0 I-f= 
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Figure 10.7 Identification of CD14 in mastomys A: Following reverse transcription, a band 
of 430 base pairs was identified by PCR from naIve ECL cells, spleen (positive control), and 
from tumor cells. A blank control was also performed to exclude non-specific amplification. 
MR =Molecular weight marker. B: The amount of cDNA from each sample was standardized 
by PCR amplification of the housekeeping gene, glyceraldehyde 3'-phosphate dehydrogenase 
(GAPDH). The lanes are the same as in A. The gel is representative of 3 separate 
experiments. 
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10.3.6 Effect ofM-M42 on LPS mediated DNA synthesis 

Thereafter, the possibility that CD 14 receptor mediated the stimulatory effects of H. pylori 

LPS in the tumor ECL cell was investigated. As in previous experiments, incubation with H. 

pylori LPS (10 ng/ml) resulted in a significant stimulation ofDNA synthesis (2.08 ± 0.14, P < 

0.01) (Figure 10.8). Pre-incubation with the monoclonal antibody against CDI4, M-M42, for 

5 min resulted in a dose dependent reversal ofH. pylori LPS stimulated DNA synthesis with 

a maximal effect at a final concentration of 1:50 (1.18 ± 0.1, P < 0.01 vs. LPS alone). Pre­

incubation ofcells with M-M42 alone had no effect on basal DNA synthesis. 

2.2 
HpLPS 
10 ng/ml
2 
......... 

e 
......
s::: 
o01.8 
.s 
o 
:.;:::; 
,!g,1.6 
~ 
.s 
0. 
::l 1.4 

:::> 

"E [tJ 
1.2 
1~--~-----r------~----~------~,---
1:250 1:100 1:50 
M-M42, dilution 
Figure 10.8 Inhibitory effect ofM-M42 on H. pylori LPS mediated DNA synthesis. 0 TGFa 
10-9 M, 0 H. pylori LPS (10 ng/ml), • M-M42 + H. pylori LPS (10 ng/ml). +p < 0.05, .p < 
0.01 (n 3). 
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10.3.7 Cytotoxicity ofLPS 
When assessed at high concentrations, neither H. pylori nor E. coli LPS (10 ug/ml) had any 
significant effect on tumor ECL cell viability measured by uptake of Trypan blue over the 24 
hr period (Figure 10.9). 
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Figure 10.9 Effect of E. coli LPS (e) and H. pylori LPS (_) on ECL cell Trypan blue 
exclusion. (n =3). 
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10.4 Discussion 
The gastric endocrine ECL cell plays a critical role in the regulation of gastric exocrine 
function. Of particular pathological significance is the self-replicative nature of ECL cells 
under long term hypergastrinemia in mastomys and rats 345. Gastrin as a physiological 
hormone promotes cell proliferation, and sustained hypergastrinemia may culminate in ECL 
cell hyperplasia and neoplasia 318,345. The loss of gastrin "control" is associated with the 
involvement of alternative growth regulatory mechanisms such as a TGFa. autocrine pathway 
345. Although gastrin and TGFa. activate different post receptor second messenger systems, it 
is not known whether they share a common downstream intracellular denominator that is 
involved in activation of the DNA synthesis process. 
Polyamines are especially evident in rapidly proliferating cells and tissues such as 
developing embryos and tumors, which have higher putrescine and spermidine concentrations 
than non-growing tissues 338. These positively charged amines alter DNA conformation and 
catalyze nucleosome condensation - effects considered to be of importance in establishing the 
conditions necessary for DNA synthesis 348,349. In addition, increases in ODC activity and 
polyamine synthesis are evident in cells in the G 1 phase of cell division cycle 338, further 
supporting the critical role for ODC activity in cell proliferation. Alterations in polyamine 
homeostasis (by the addition of DFMO which inhibits ODC activity) have previously been 
demonstrated to result in growth inhibition of a pancreatic neuroendocrine cell line (BON) 
350. Since addition of polyamines to neuroendocrine tumor ECL cells resulted in stimulation 
ofbasal DNA synthesis (approximately 30%) it seems probable that polyamines have a direct 
mitogenic effect on tumor ECL cells. Of particular interest was the observation that the 
mitogenic effect of TGFa. was significantly augmented by all tested polyamines. This is 
consistent with previous observations that growth factors increase both polyamine uptake, as 
well as intracellular polyamine concentrations, and DNA synthesis 351-353. Pre-incubation 
with DFMO completely inhibited TGFa.-stimulated DNA synthesis. This suggests that the 
TGFa. mediated pathway is largely driven via ODC activity and polyamine biosynthesis and 
may be a reflection that tumor cells in general are more dependent on polyamine biosynthesis 
than their normal counterparts. This observation is consistent with reports that in quiescent 
fibroblasts, fibroblast growth factor and platelet-derived growth factor all stimulate ODC 
activity through at least one pathway involving protein kinase C 354. It was unexpected that 
DFMO had no effect over 24 hr on basal DNA synthesis. This may reflect the fact that ECL 
cells are well differentiated, and are not rapidly proliferating. 
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In addition, TGFa stimulated tumor ECL cell ODC activity with an ECso of 10-13 M, a 
value consistent with that of the effect on tumor cell DNA synthesis (10-11 M). This supports 
the conclusion that the proliferative effect of TGFa is mediated almost exclusively by this 
pathway in ECL tumor cells. This proposal is further strengthened by the observation that 
DFMO completely inhibits TGFa stimulated DNA synthesis. 
In this study, a specific proliferative effect for H. pylori LPS on tumor ECL cell DNA 
synthesis was demonstrated. This effect was potent (ECso -0.1 nglml), 2.2 fold over basal. 
The efficacy and potency of this effect is similar to that of the principal regulator of tumor 
ECL cell proliferation, TGFa (5 x 10-11 M and 1.9 fold, respectively) 344. While H. pylori 
LPS had no effect on basal naive (rat) ECL cell DNA synthesis, it could augment gastrin­
stimulated DNA synthesis (cf. Chapter 9). The potent effect of LPS on "unstimulated" tUmor 
cell DNA synthesis could either be a result of a direct mitogenic effect, or could reflect the 
relatively increased number of mitogenic cells potentially present in a preparation of tumor 
cells. 
It has previously been demonstrated that polyamine homeostasis is an important 
mechanism by which tumor cell proliferation is mediated 344. Thus, the addition of the 
irreversible ODC enzyme inhibitor, DFMO, potently and dose dependently inhibited LPS 
stimulated DNA synthesis. The potency (2 x 1O-l! M) and efficacy (-75% inhibition) was 
similar to that reported for inhibition of TGFa mediated DNA synthesis (3 x 10-12 M, and 
-90%) 344. Analysis ofODC activity demonstrated a significant stimulation by H. pylori LPS 
(ECso 1 nglml, 1.4 fold vs. control). These values are somewhat similar to that ofTGFa (10­
11 M, 1.5 fold vs. control), and suggest that LPS mediates tumor cell proliferation almost 
exclusively via activation of the biosynthetic pathway, and confirms the relevance of this 
pathway to tumor ECL cell DNA synthesis. 
CD14 is a myeloid differentiation antigen, and its expression has been correlated with 
various forms of malignant myeloid leukemias 355. Within the gut, this receptor has been 
identified only in the SW620 human colonic carcinoma cell line 326 and in the naIve ECL cell 
(cf. Chapter 9). The additional identification of CD14 message in the transformed ECL cell 
and its protein (albeit indirectly), supports the presence of an LPS receptor on this 
neuroendocrine cell and provides an explanation for the mechanism by which H. pylori can 
directly affect ECL cells in vivo. 
Studies analyzing the relationship between CDI4, LPS and proliferation have 
concentrated on cell lines derived from the immune system. In these experiments, addition of 
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LPS to the monocytic Mono Mac 6 cell line resulted in an up regulation ofCD14 expression 
(mRNA and protein) and retarded proliferation 356,357, In contrast, addition of H pylori LPS 
to a neuroendocrine cell system resulted in proliferation, via activation of the CD14 receptor. 
This apparent contradiction suggests that CD14 may have different functions in different cell 
systems. Similar findings have been noted for the inhibitory neuropeptide somatostatin, 
which, through its normal mechanism of decreasing intracellular cAMP, inhibits intestinal 
epithelial proliferation in cultured cells 358, and induces proliferation in human meningioma 
and pancreatic carcinoid cells 359,360. Unraveling the CD14 mediated intracellular pathway in 
the ECL cell may answer this question. 
10.5 Conclusion 
The relationship of H pylori to gastric neoplasia is clinically relevant and the ECL cell 
related interactions may be involved in this association. Products of H pylori may either 
directly stimulate ECL cell proliferation or accentuate histamine secretion which itself may 
be mitogenic. In addition, the associated increased gastrin levels are linked to both ECL cell 
and fundic mucosal cell proliferation. Since the ECL cell itself produces growth factors such 
as TGFa. 345, it is possible that an H pylori "activated" mucosa may be exposed to multiple 
mechanisms predisposing to neoplasia. A direct mitogenic effect of H. pylori LPS on 
carcinoid ECL cells in vitro has also been demonstrated, as well as the probability that LPS 
can initiate this polyamine mediated effect by binding to the CD14 receptor. It is possible that 
H pylori may influence mucosal function in vivo via its effects (CD14 activation) not only on 
exocrine cells but on cells of the neuroendocrine cell system of both the fundus and the 
antrum. 
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Chapter 11. 
Analysis of the effects of LPS on 
transformed gastrointestinal cells 
11.1 Introduction 
A role for H. pylori LPS obtained from a toxigenic (84-183) isolate in modulating DNA 
synthesis in both the narve and transformed neuroendocrine ECL cell has been demonstrated 
(cf. Chapters 9 & 10). This effect is potent (10 ng/ml), is mediated by CD14 and appears to 
be specific to H. pylori. 
A number of studies have evaluated the effects ofH. pylori or its products on the cell 
cycle (reviewed more fully in Chapter 3). An analysis of these studies suggest that H. pylori 
products (sonicates and water extracts) are less effective than E. coli at stimulating 3H_ 
thymidine uptake in the IEC-6 small intestinal epithelial cell line 18,19. Co-culture studies 
with the gastric AGS cell line demonstrate that the H. pylori organism differentially alters the 
cell cycle compared to non-gastric E. coli or C. jejuni 17,20,21. The mechanisms by which 
either a heterogeneous mixture of bacterial products or the organism itself affects the cell 
cycle is unknown. In addition, little information exists specifically relating the effects of H. 
pylori LPS to either DNA synthesis or to cell cycle parameters. 
We therefore decided to evaluate a toxigenic H. pylori LPS (84-183) with known 
effects on ECL cells on both these parameters in the AGS cell line. In addition, a potential 
role for CD 14, as well as the LPS-activated intracellular pathways were investigated. 
11.2 Materials and Methods 
11.2.1 Materials 
All materials, including the toxigenic E. coli LPS (serotype 05:55B) were obtained from 
Sigma Chemical Co. (Cape Town, South Africa). The well-characterized cytotoxic 
(VacA+/CagA+) H. pylori LPS (strain 84-183) were kind gifts from M.J. Blaser and G.!. 
Perez-Perez (Division of Infectious Diseases, Vanderbilt University, Tennessee, USA). LPS 
from C. jejuni subspeciesjejuni, biotype 1, serotype 18 (obtained from a 3 month old Cape 
Town girl with profuse diarrhea) was extracted using a micro-adaptation of the phenol/water 
extraction procedure of Westphal and Jann 361 as described for small numbers ofbacteria 362. 
The yield was approximately 1 % LPS per wet weight ofcells. Protein contamination was less 
than 1% (ranging from 0.1 - 8 ug/ml) and DNA contamination less than 0.3% (ranging from 
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0.01 2.7 ug/ml). 3H-thymidine was obtained from ABC Amersham (Cape Town, South 
Africa) (37 MBq; 1mCi/ml). The mouse monoclonal antibody, M-M42 against CD14, was 
obtained from Novocastra Laboratories Ltd., Newcastle-upon-Tyne, UK. The AGS human 
gastric epithelial cell line (ATCC CRL 1739) was obtained from ATCC, Rockville, 
Maryland, USA). RPMI-1640 was obtained from Gibco Brl, Cape Town, South Africa, while 
a tissue-culture antibiotic solution was obtained from Roche Diagnostics, Johannesburg, 
South Africa. 
11.2.2 Experimental design 
Experiments were performed with AGS human gastric epithelial cells (ATCC CRL 1739), 
and LPS from the H. pylori reference strain 84-183 and as negative controls, LPS from E. 
coli and C.jejuni. AGS cells were cultured in RPMI-1640 supplemented with 10% FBS and 
10ug/ml antibiotic solutions in 180 ml tissue culture flasks at 37 °C in 5% C02. Cells were 
fed fresh medium with senuil every 3 days and split when sub-confluent. For all DNA 
synthesis and flow cytometry experiments, cells were synchronized by serum-deprivation for 
24 hr as described 20. 
11.2.2.1 To evaluate an effect of LPS on DNA synthesis, serum-deprived AGS cells were 
incubated with either a maximal concentration of spermine (10-5 M) (positive control) or with 
the LPS (84-183, E. coli or C. jejuni) preparations (lOfg/ml - O.lmg/ml) for 4 hr. Pre­
incubation with polymyxin sulfate (lmg/ml) for 10 min was used to evaluate the specificity 
of the LPS effect 363. To examine whether the CD 14 reCeptor modulated LPS, we assessed 
the effect of pre-incubation for 10 min with the. specific monoclonal antibody against CD 14, 
M-M42 (1:100-1:1,000) on H. pylori LPS (84-183) (O.lmg/ml) stimulated thymidine uptake. 
Different cell-permeable inhibitors of intracellular second messenger systems were then used 
to elucidate the signal transduction pathway mediated by LPS stimulation. All inhibitors were 
co-incubated with a maximal concentration (O.lmg/ml) of LPS (84-183). Rp-8-Br-cAMP, a 
cAMP antagonist (reported Ki ~ 10-5 M) was used in concentrations of 10-6 M to 10-4 M with 
the adenylate cyclase activator forskolin (10-5 M) as a positive controL Wortmannin, a 
microbial metabolite found in a variety of fungal species, inlllbits phosphatidylinositol-3­
kinase (IP3 kinase; reported Ki - 3 x 10-9 M). It was co-incubated with LPS in concentrations 
ranging from 10-8 to 10-5 M. 
1/2.2.2 For analysis of cell cycle events, serum-deprived AGS cells were incubated with a 
maximal concentration of spermine (10-5 M) (positive control) or with a maximal 
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concentration (O.lmg/ml) of the different LPS preparations for 4 hr and analyzed flow 
cytometrically. 
11.2.3 Cell proliferation assay by 3H-thymidine incorporation 
Exponentially growing cells were harvested and cultured overnight (for 24 hr) in the absence 
of serum. Thereafter, serum-starved cells were plated in triplicate at 104 cells per well in 96­
well flat-bottom microculture plates in 200ul of medium containing serum, luCi of 3H_ 
thymidine and LPS/products of interest. Plates were incubated for a further 4 hr, cells 
harvested, using the Titertek cell harvester and radioactive incorporation measured in a 
Packard Tri-carb 1500 (Bioteknik, Cape Town, South Africa) liquid scintillation counter. 
11.2.4 Flow cytometric analysis 
For cell cycle parameter analysis, serum-deprived cells (104 cells/experiment) were incubated 
in 200ul of medium containing serum and LPS (100uglml) for 4 hr. Thereafter, cells were 
incubated with 20 uglml propidium iodide, and DNA content was measured using a 
FACSCaliber (Becton Dickinson, Johannesburg, South Africa) as described 20,364. Data were 
plotted using the Cell Quest software (Becton Dickinson); 15,000 events were analyzed for 
each sample. 
11.2.5 Statistical analysis 
Results are expressed as mean ± SE. "n" indicates the number of cell studies. Statistical 
analysis was performed using the two-tailed Student's t-test for paired values as appropriate 
and p-values < 0.05 were considered significant. 
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11.3 Results 
11.3.1 Effect ofLPS on DNA synthesis 
The effect ofLPS on DNA synthesis in AGS cells was initially measured. Spennine (10-5 M) 
stimulated DNA synthesis as expected (3.13 ±O.74, p < 0.01 vs. control) (Figure 11.1). LPS 
from 84-183 stimulated DNA synthesis maximally at 1ug/ml (4.43 ± 1.23, P < 0.05 vs. 
control), with an approximate EC50 of 20ng/mL E. coli and C. jejuni LPS had no significant 
effect over the concentration range. 
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Figure 11.1 Effect ofH. pylori LPS on DNA synthesis. D spennine (100ug/ml or 10-5 M), 0 
E. coli LPS, • C. jejuni LPS, • H. pylori LPS. All points are expressed as means ± SEM. *p 
< 0.05 vs. both E. coli and C. jejuni LPS (n = 6). 
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11.3.2 Effect ofM-M42 on LPS stimulated DNA synthesis 
Thereafter, the possibility that CDl4 mediated the stimulatory effects of H. pylori LPS in the 
AGS cell was investigated. As in previous experiments, incubation with H. pylori LPS (0.1 
mg/ml) resulted in a significant stimulation of DNA synthesis (5.08 ± 1.43, P < 0.01) (Figure 
11.2). Pre-incubation with the monoclonal antibody against CDI4, M-M42, for 10 min 
resulted in a dose dependent reversal of H. pylori LPS stimulated DNA synthesis with a 
maximal effect at a final concentration of 1:100 (1.23 ± 0.16, P < 0.01 vs. LPS alone). Pre­
incubation ofcells with M-M42 alone had no effect on basal DNA synthesis. 
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Figure 11.2 Inhibitory effect of M-M42 on H. pylori LPS mediated DNA synthesis. 0 
forskolin 10.5 M, 0 H. pylori LPS (0.1 mg/ml), • M-M42 +H. pylori LPS (0.1 mg/ml). *p = 
0.034, **p = 0.008 (n =6). 
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11.3.3 Effect ofPolymyxin B on LPS stimulated DNA synthesis 
The effect of polymyxin B, which specifically binds to lipid A, on LPS mediated DNA 
synthesis was evaluated. As in previous experiments, incubation with H. pylori LPS (0.1 
mg/ml) resulted in a significant stimulation of DNA synthesis (5.1 ± 1.4, P < 0.01) (Figure 
11.3). Pre-incubation with polymyxin B (1 mg/ml) for 10 min resulted in a complete reversal 
of H. pylori LPS stimulated DNA synthesis (0.95 ± 0.2, P < 0.01 vs. LPS alone). Pre­
incubation of cells with polymyxin alone had no significant effect on basal DNA synthesis. 
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Figure 11.3 Inhibitory effect of polymyxin Bon H. pylori LPS mediated DNA synthesis. Hp 
LPS = H. pylori LPS (0.1 mg/ml), LPS+P-B = H. pylori LPS (0.1 mg/ml) + polymyxin B (1 
mg/ml). *p < 0.01 (n = 5). 
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11.3.4a ofintracellular pathways mediating IPJ 
The effect the 1P3 kinase Wortmann in, on mediated DNA was 
next in previous experiments, incubation with H. pylori LPS (0.1 mg/ml) 
resulted stimulation DNA synthesis (5 ± 1 p < 0.01) (Figure 11.4). Pre-
incubation Wortmannin a H. pylori stimulated 
DNA with a maximal at 10.7 M (2.04 ± p < 0.01 vs. Pre-
incubation cells with Wortmannin alone had no effect on basal DNA synthesis. 
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11.4 Inhibitory of Wortmannin on pylori LPS DNA synthesis.IvUIQ,tlo.,U 
forskolin (1 M), LPS = (0.1 mg/ml). Cross-hatched bars 
+H. (0.1 mg/ml). < +p = 0.06, vs. (n = 6). 
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11.3.4b Analysis ofintracellular pathways mediating LPS cAMP 
The effect cAMP analog, Rp-8-Br-cAMP, on mediated DNA was 
thereafter As in previous incubation with H. pylori LPS (0.1 mglml) 
resulted in a stimulation synthesis ± 1.1, P < 0.01) Pre-
incubation with Rp-8-Br-cAMP 10 resulted in a dependent pylori 
LPS stimulated synthesis with a maximal effect at 10-4 M (1.31 ± 0.26, P < 0.01 vs. 
LPS alone). Pre-incubation of with Rp-8-Br-cAMP alone had no effect on basal DNA 
synthesis. 
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Figure 11.5 Inhibitory of Rp-8-Br-cAMP on H. pylori mediated DNA 
forskolin (1 M), LPS = LPS (0.1 mg/ml), striped bars Rp-8-Br­
+ H. pylori (0.1 mglml). *p < 0.01, +p < 0.02, both vs. (n = 6). 
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11.3.5 Effect ofLPS on cell cycle parameters 
The effect of LPS (0.1 mg/ml) on the AGS cell cycle was next measured. LPS from C jejuni 
significantly elevated the sub-G1 fraction (apoptosis) (1.31 ± 0.24, P < 0.05 vs. unstimulated) 
(Figure 11.6). No agent had any significant effect on GOG1, but all agents stimulated the 
S+G2M fraction (p < 0.05 vs. unstimulated). Analysis of the data as a ratio of the growth 
fraction (S+G2M) to sub-G1 fraction (Gf/At) revealed that this ratio was only significantly 
higher for 84-183 (2.15 ± 0.26, P < 0.01 vs. spennine and C jejuni). 
** 
Apoptosis GOG1 S+G2M GflAf 
Cell cycle parameters 
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Figure 11.6 Analysis of the effects of LPS on cell cycle parameters. Spennine (10-5 M) was 
utilized as a positive control. All bars are expressed as means ± SEM. +p = 0.06 vs. 84-183, .p 
= 0.07 vs. spennine, "p < 0.01 vs. spennine and Cjejuni (n = 4). 
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11.3.6 Relationship between DNA and cell cycle parameters 
DNA and both the fraction and growth 
fraction ratio was next evaluated 11.1). Linear reQ:reS~ilon analysis 
significant elatIOllshlPS between DNA 1Hllv;:"';:' measured by tritiated thymidine YIJ<'t.W:\.v 
S+G2M flow-cytometrically as well as the calculated GflAf ratio. suggests 
that measurements LPS-stimulated DNA synthesis 4 hr correlate alteration 
the cell at this time point. 
Table 11.1 Relationship between different cell measurements 
Parameter p-value R R2 
DNA synthesis 0.0244 0.577 ~33 
vs. 
S+GzM 
DNA synthesis 
vs. 
0.0065 0.668 0.446 
11.4 Discussion 
that toxigenic pylori LPSThis data stimulates both as 
well as altering cell cycle parameters in the AGS line. 

Analysis of DNA synthesis demonstrated that the maximal "",-,-,,,,,,,-,.,,,,, concentration 

to stimulate this was 100-fold in AGS cells (1 compared to 
a nCllOrnCllOfl which was reflected the half-maximal 
Such aconcentrations vs. 20 nglml in effective 
suggests DNA stimulatory in AGS mediated by a 
mechanism other than binding and However, pre-incubation with the 
CD14 antibody, M-M42, reversed the stimulatory effect of pylori LPS in AGS 
Chapter 10)). In pharmacological inhibition of bothit does in 
"'lU,,-",," (the Ca2+ ...""enu,,, mediates 
....."TO'.., effects in the line (CD 14 ""'''''''1'\" are thought to modulated by 
tyrosine kinase activity or redistribution of intracellular G-proteins combination 
antibody inhibitor and the intracellular pathway studies, strongly 
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the LPS effect on the AGS cell is most likely mediated via CD14. It is possible that the 
differences between this cell line and the ECL cell may reflect differences in receptor number 
and/or specificity. 
The intracellular mechanism by which LPS alters the cell cycle is unknown. CD14 
has been demonstrated to co-precipitate with tyrosine kinase activity 365, and activation of the 
receptor results in rapid phosphorylation of p38 366. It is possible that activation of a tyrosine 
kinase pathway, as noted for TGFa in ECL cells 345, may playa role in proliferation, but the 
inhibitory effects of Rp-8-Br-cAMP and Wortmannin suggest a different pathway. CD14 may 
also be coupled to G-proteins 367 and it would appear likely that activation of stimulatory G­
subunits modulates the proliferative response in AGS cells. This would not be dissimilar to 
the effects of gastrin, which is known to affect ECL cell proliferation via IP3 and 
raslMAPKlc-fos and c-jun activation 368. In AGS cells, use of the cAMP analog appeared to 
be more inhibitory than IP3 and, while suggesting this may be the dominant pathway driving 
DNA synthesis (almost complete inhibition [95%] versus ~80% with Wortmannin), this 
could simply reflect the different uptake of these agents in this cell system. It is known for 
example that the latter agent (IP3 inhibitor/Ca2 + pathway) possesses a low potency in intact 
cell systems 369. Interestingly, differentiation rather than proliferation is associated with the 
protein kinase C (PKC) pathway in the Mono Mac 6 cell line 356. 
Polymyxin B, by binding to lipid A, is a well known inhibitor of the activation 
properties of Enterobacteriaceae LPS 363. Preincubation with this agent markedly inhibited 
the ability of H. pylori LPS to induce DNA synthesis. This suggests that the basis for 
activation of the AGS cell line by H. pylori LPS may be lipid A mediated, in spite of the 
marked differences in lipid A structure compared with the Enterobacteriaceae 258. The ability 
to activate DNA synthesis may therefore be a function of conserved core structures. The 
differences in DNA synthesis noted for the different bacterial LPS species studied suggests, 
however, that H. pylori LPS may be unique in its ability to promote this parameter. 
Analysis ofcell cycle events at 4 hr with a maximal concentration of LPS (0.1 mg/ml) 
demonstrated no statistically significant effect on the sub-G\ (apoptotic) fraction, except for 
LPS from the toxigenic C. jejuni isolate. Previous studies have demonstrated that C. jejuni 
does not alter gastric epithelial cell viability or apoptosis in vitro 17,370. These variances in 
results may reflect differences in both the study designs and methodologies used. Other 
studies, with co-cultures of H. pylori and AGS cells could demonstrate no significant 
alterations in apoptosis after 6 hr 20. A second study demonstrated that the most marked 
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1 
alterations in viability and were only after 72 21. Injection, in vivo, of 
0.5-2 mg/ml the pathogenic H. pylori isolate 11637) Sprague-Dawley 
rats "nr,ntr"""" 271. This must have 
sIllce has previously demonstrated to a mitogenic 
18 hrmouse cultures 371, It would appear that the time frame present study (4 hr 
incubation with may be too short to evaluate any significant apoptotic although 
this unlikely given apoptotic III a study 20. 
All preparations in S+G2M fraction, but 
not the GoG\ effect of at the G1 has been mooted 
This, along with a decrease the was only seen after 48 hr bacterial co­
incubation. present study suggests that may have a on DNA 
rather than resulting in a block. Alterations in balance of proliferation to apoptosis 
(proliferation > 1.0, apoptosis < 1.0) have been to occur during gastrin 
U'"".lUt'''''U gastric alterations in vivo Analysis ratio in the study 
demonstrated that this was most significant for H. pylori and after 4 hr 
em~cts on cells were most likely to be proliferative. Such an observation was supported 
by strong relationship between this and DNA (r = 0.67, p 0.008), It is 
possible that DNA (measured by thymidine uptake) may be a surrogate for 
cell cycle (proliferation). 
Conclusion 
A model examining effects on a relevant 
adenocarcinoma has been demonstrated. This study has shown toxigenic 
significantly and positively both DNA and cell cycle parameters in the 
gastric epithelial AGS vitro. These as in the appear to mediated 
by CD14 the respective intracellular alterations. 
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Chapter 
Analysis of the effects of LPS from clinical 
isolates on transformed gastrointestinal cells 
12.1 Introduction 
Toxigenic pylori LPS positively alters synthesis and cell cycle in gastric 
AGS line in vitro (cf. Chapter 11). studies have shown that strains 
enhance and attenuate apoptosis compared with cagA- A 
second study from the same group that a AGS viability, 
to the G2M and apoptosis, associated with co-incubation 
were mediated in part by expression of vacA and genes in cagPAI 
(particularly cagE) 21. other studies have produced views. The ability of H. 
pylori to alter apoptosis 17,20,374 or 17,20 did not ........,,''''''' to be to strain 
variation when analyzed by cagA status toxin production. Nevertheless, pylori 
colonization increases mucosal apoptosis 105,106,375 but epithelial cell proliferation 
rates in gastric tissue people harboring the organism have been either reduced or 
VarIOUS 
to variation ofLHUWV<LVU 
",...""Tn,'&>cell growth or death remains a valid and attractive hypothesis. It was decided to 
examine the effects of from South African clinical isolates with ...."'A.U ....'y virulence 
on both DNA synthesis and the cycle in the established AGS cell 
12.2 Materials and Methods 
1 Materials 
All materials, E. coli (serotype 05:55B) we obtained Chemical 
(Cape Town, Africa). well-characterized cytotoxic (VacA+/CagA+) H. pylori 
(strain 84-1 were kind from M.J. G.!. (Division 
Infectious Diseases, Vanderbilt University, USA). LPS C. jejuni 
Chapter 11) was as a controL 3H-thymidine was obtained from 
(37 MBq; 1mCi/ml). mouse monoclonal 
antibody, CD14, was obtained Novocastra Laboratories 
Newcastle-upon-Tyne, UK. The human gastric epithelial cell CRL 1 
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was obtained from ATCC, Maryland, USA). RPMI-1640 was obtained from 
Town, South while a tissue-culture solution was obtained 
","U''"'U''"' Diagnostics, JOllarmesDllrg Africa. 
pylori strains 
H. pylori strains were from a larger population had 
previously described as part an ongoing study designed to the relationship 
virulence factors and clinically significant disease in populations from South 
Chapters 5,6,7,8). Because we sought to evaluate the potential importance of virulence-
genes (i.e. cagA, 3' length of cagA, 5' cagPAI, vacA, iceA) in 
........ ,.•vu 
of cell cycle we selected strains parameters (Table 
1 1). 
12.1 Characteristics of clinical H. pylori 
012 gastritis 
slbm2 
slbml <600 complete 
slbml >700 caglJp 110 PUD 
slbml <600 complete 110 PUD 
= partial cagPAI 
the 5'-region of eag!I) 
*442 the structure of the lipopolysaccharide side chains are known 378 
Strain vacA cagA-3' cagPAI iceA Pathology 
240 
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J2.2.3 Preparation 
pylori which conformed to standard phenotypic and biochemical criteria were harvested, 
U1<>",.. ,>r! once with normal centrifuged at 1O,000g for 10 min and stored at -20 DC. 
After the was extracted a microadaptation of the phenol/water 
procedure Westphal and Jann 361 as described for small numbers of 362. The 
was approximately 1 % LPS wet weight of In total, protein contamination was less 
from 0.1 12.5 ug/ml) DNA contamination less 0.25% 
0.01- ug/ml). 
Experimental design 
Experiments were performed with AGS human epithelial cells (ATCC 1739), 
and from the African pylori strains, with 84-183 as a positive and as 
E. coli jejuni (cf. 11). cells were 

RPMI-1640 supplemented with 10% FBS and lOug/ml antibiotic solution in 180 ml 

were medium 3 days and 
split all DNA synthesis and flow cytometry were 
synchronized by serum-deprivation for 
4. J Exponentially growing n·.. r""p~'T"£1 and cultured overnight (for hr) in 
UV",,'''"'U>,''' of serum. Thereafter, serum-starved were plated in triplicate at 1 cells per 
well in flat-bottom microculture in 200ul ofmedium serum, 1 
and LPS (0.1 mg/ml). Plates were incubated for a further 4 
the Titertek harvester radioactive incorporation 
...'"'''' ....... u Tri-carb 
1500 (Bioteknik, Cape South Africa) liquid scintillation counter. 
12.2.4.2 cell cycle serum-deprived (104 were 
incubated in 200ul of medium containing serum and LPS (O.lmg/ml) for 4 hr. Thereafter, 
were with 20 ug/ml propidium and DNA content was usmg 
a F ACSCaliber (Becton Dickinson, South Africa) as described Data 
were plotted using the Quest software Dickinson); 15,000 events were analyzed 
sample. 
Statistical analysis 
Results are expressed as mean ± SE. indicates 
analysis was performed two-tailed Student's t-test paired as appropriate 
p-values < were significant. 
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parameters and the cagPAJ 
(0.1 mg/ml) from twelve different H. pylori isolates on 
AGS cells was measured. LPS with an intact 
.7 ± 0.87) more than from (1.18 ± 
was also significantly higher than from 
(p< 1 1). Deletions in the In 
fraction and the GO/G1 fraction 
InCI'eaS!~(i (p = 0.036) the S+G2M fraction (1.42 ± 0.08) 
0.05). growth fraction tended to be higher in (p 0.07). 
± 
cagPAI Partial 
and cell cycle parameters. LPS Figure 12.1 Effect of 
C. jejuni were used as n ... "t.-.", controls, while 183 was a gastric control. 
complete cagPAI, partial deletions the 5'-region (cagJ/). GflAf = the 
of the growth fraction to fraction ... p < 0.03 vs. partial, +p < 0.05 vs. coli (1.3 
± 0.3), and C. jejuni (1.18 ± 0.2) (n 4). 
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12.3.2 DNA synthesis, cell cycle parameters and cagA-3' length 
LPS from isolates with the largest cagA3 '-fragment length (> 700 bp) significantly stimulated 
DNA synthesis (6.15 ± 2.3, P = 0.0005) compared to LPS from isolates with a small « 600 
bp) cagA3 '-fragment length (1.26 ±0.16) (Figure 12.2). LPS from isolates with an 
intermediate fragment length (600-700 bp) had a similar effect (3.6 ± 0.9, p < 0.003 vs. < 600 
bp). cagA3 '-fragment length had no statistically significant effect on cell cycle parameters. 
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DNA Apoptosis GOG1 S+G2M Gf/Af 
cagA<600 D cagA 600-700 cagA>700 
Figure 12.2 Effect of LPS on DNA synthesis and cell cycle parameters. LPS from E. coli and 
C jejuni were used as non-gastric controls, while 84-183 was a gastric control. cagA <600 = 
isolates with shortest fragment length, 600-700 = isolates with an intermediate fragment 
length, cagA>700 = isolates with the longest fragment length. • p < 0.003 vs. cagA<600 and < 
0.03 vs. E. coli (1.3 ± 0.3), and Cjejuni (1.18 ± 0.2) (n = 4). 
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J2.3.3 vacA alleles, DNA synthesis and cell cycle parameters 
LPS from isolates with the vacA slb/m1 type stimulated DNA synthesis (2.56 ± 0.6) 
significantly more than from Cjejuni (1.18 ± 0.2, P = 0.037) (Figure 12.3). The vacA slbm2 
tended to be higher than C jejuni (p = 0.08) while s2m2 the smallest effect. Because the latter 
was only one isolate it was excluded from formal statistical analysis. Analysis of cell cycle 
parameters demonstrated that LPS from isolates with vacA sl bm1 had a significantly lower 
effect on the sub-G t fraction (0.99 ± 0.03) than LPS from C jejuni (1.31 ± 0.24, P = 0.04) 
and isolates with vacA s1lbm2 (1.27 ± 0.19, P = 0.048). No other alterations in the cell cycle 
were noted. 
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Figure 12.3 Effect ofLPS on DNA synthesis and cell cycle parameters. LPS from E. coli and 
C jejuni were used as non-gastric controls, while 84-183 was a gastric control. *p < 0.05 vs. 
Cjejuni, up < 0.05 vs. vacA slb/ml, (n = 4). 
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J2.3.4 iceA alleles, DNA synthesis and cell cycle parameters 
LPS from isolates with iceAJ, or iceA1I2 tended to increase DNA synthesis compared to C. 
jejuni (1.18 ± 0.2, both p < 0.06) but not against E. coli (1.3 ± 0.3) (Figure 12.4). No 
differences in stimulation of DNA synthesis were, however, noted within the iceA groups. 
None of the iceA genotypes had any effect on the sub-G t , GoGI-fraction or S+G2M fractions. 
No differences in the growth fraction were noted. The null iceA genotype was only present in 
one isolate was excluded from formal statistical analysis 
5 
4.5 
4 
3.5 
0 
I­
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0 3 
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> 
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Cell cycle parameters 

DNA Apoptosis GOG 1 S+G2M Gf/Af 
iceAlIO D iceA1/2 D iceAO/2 iceAO/O 
Figure 12.4 Effect of LPS on DNA synthesis and cell cycle parameters. LPS from E. coli and 
C. jejuni were used as non-gastric controls, while 84-183 was a gastric control (n = 4). 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
160 
Clinical presentation, DNA synthesis and parameters 
patients with (4.61 ± 1.6) significantly 
synthesis more than from alone (1.21 ± 0.27, P < 0.04), peptic 
"'..",,"""'" (1.49 ± 0.13, P = 0.05), p = 0.04) and jejuni (1.18 ± p< 
0.02) (Figure 12.5). Analysis of parameters demonstrated that 
with gastric adenocarcinoma had a ''''''''''''''1''' to a lower apoptotic fraction (0.99 ± 0.04, P 
0.07 vs. gastritis) and significantly growth ratio (1.36 ± 0.08) compared to 
(1.13 ±0.09, p < 0.05). In addition, adenocarcinoma isolates had a higher 
0.01, P = 0.04 vs. E. coli 0.94 ± 0.03). Gastritis isolates also tended to have a lower S+GzM 
fraction (1.19 ± 0.07) to PUD isolates (1.43 ± 0.11, P < 0.06) but was not 
formally significant. 
(l.0± 
7.5 
7 
6.5 * Cell cycle 6 
Figure 
5 
4.5 
4 
3.5 
3 
Gastritis II GCa 
on DNA synthesis and cell LPS from coli 
C. jejuni were as non-gastric controls, while was a gastric control. PUD = peptic 
adenocarcinoma.•p < 0.05 vs. coli, C. jejuni, Gastritis, PUD, 
< 0.05 vs. gastritis (n 4). 
ulcer U''''''''''''''', 
••p< vs. 
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12.4 Discussion 
The present analyzes the p1"U'I'r", of LPS from twelve clinically defined South 
H. pylori in an established and validated system. data suggest strongly that 
from ."v......"''' are alterations both DNA 
synthesis as well as the cell cycle. alternative cell cycle 
be due to contamination of LPS with virulence proteins requires some attention, this 
appears unlikely given the stringent methodology to (phenol and 
boiling) would denature proteins, as well as the estimated nanomolar concentrations of 
any The cell cycle noted are most likely due to LPS 
molecule 
derived from strains with an intact PAl, to a PAl with In 
the 5'-region of the island, was significantly associated with increases in DNA synthesis, the 
S+G2M and the growth fraction. results are similar to one other 
study examined, by flow the relationship genes the and 
the AGS cell 21, study demonstrated that strains with a mutation 
(in significantly attenuated progression at 6 and decreased apoptosis with 
enhanced cell viability at 24 hr. It is possible that within the cagPAI are ""'''''Vv''".~,,.. 
with function of the either in terms construction of or pvr\..-..rr of 
this wall constituent 214. All isolates were the present study, so it was not 
to analyze a between the or absence of the and the effects 
of It was, however, to investigate the relationship between 1"P,.,·"I"',,,"'" in the 
length cagA and LPS. An in the size (> 600 bp) of the cagA3' which has 
previously associated adenocarcinoma in Japanese ."vu...."'''' 218 and in South 
isolates (cf. Chapter 6), was linked with an increase in DNA in AGS cells 
but not to any significant alterations in the cycle. While three previous studies have 
is that an ."'14....."'... cagA3' -fragment (which alters 
immunogenicity of result in with differing Lewis determinants. 
In this isolates with was associated with an 
in DNA synthesis. This is consistent 6hr et at 21, 
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demonstrated that vacA sIb was more "''',,)V'''.'''tl..U with an increase in 
subtype s 1 a or s2. Analysis of in apoptosis indicate that the subtype 
appeared to be more apoptotic in the present 
differences in the mid-region may with LPS-mediated ancmt()SlS is not, 
however, confirmed by the co-incubation studies, which demonstrated a relationship 
with the vacA signal sequence rather than mid-region 21. Interestingly, em~cts of 
iceA alleles (the iceAl is associated with peptic ulcer disease 1 and gastric 
adenocarcinoma (cf. Chapter 7) is associated with gastritis 185) on LPS 
demonstrated that there was no with any statistically alterations in 
either DNA or in the present study. 
The chemical structure (strain 442) is known 378. chain 
of LPS in this strain is moieties, and it appears to P466, whose 
LPS carries the "a.lj'''''I-a.'''''V .... a.I""U 2 sialyl LeX blood 442 is 
isolated from a patient disease and is characterized by s1bm1 allele 
wi th an intact cagPAI 3' < 600 bp) as well as being iceA isolate is 
also associated with pepsinogen secretion 260,380. stimulation of 
DNA synthesis and of LPS from strain 442 are to those of the other 
LPS isolated from patients with PUD. This suggests that the marked stimulation of DNA 
synthesis in patients with gastric cancer 12.5) may not be 
due to the structures. It is possible that either of the latter 
isolates moieties or else that differences in the 
lipid A structure effects. The finding polymyxin B reverses the 
DNA stimulatory from H. pylori 84-183 11.3) suggests that lipid A, 
rather than may be activity. This is 
supported by a separate study that different 
activities appeared to directly correlate with the molecular of lipid A from 
negative 381 
12.5 Conclusion 
In suggest that specific fingerprints are associated with 
and that LPS may be a marker for the effects of these 
12.6). In addition, this also appear to be clinically 
relevant. aQtmocar~'U~H ..~ isolates have an DNA synthesis, lower 
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higher S+G2M and an increased isolates did not have an increased 
DNA synthesis but certainly an which was not consistently reflected by 
the calculation of the growth fraction. In contrast, gastritis isolates have lower DNA 
synthesis, increased apoptosis, and as well as in the growth fraction. 
These different effects of LPS related to differences in lipid A structures. 
H. pylori LPS 
cagPAI (intact) > cagPAI (partial) 
(>600) > cagA «600) 
t/(;t1b* 
<H:> 
I 
(+) 
H. pylori LPS ~ 

vacA s 1bm2 > s 1 bm 1 (+) H. pylori LPS 
cagPAI (inlact) > cagPAI (partial) 
Figure 12.6 Summation of from South African H. pylori isolates with 
different virulence from isolates with the vacA s 1 bm2 allele stimulated 
entry into the apoptotic (sub-G\) more than the vacA slbml allele. LPS from 
with an intact cagPAI length> 600 bp stimulated DNA ",,,",Ttl,:>,,,,, 
more than isolates with cagPAI or cagA < 600 bp. *vacA s1b was 
associated with an into the G2M phase was increased by 
from an to a partial cagPAI. 
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13. 
Concluding summary & 
directions for future research 
and of Helieobaeter pylori to 
pathobiology have been conducted primarily the developed world. South a high 
level of pylori infection, but little is known about the prevalence of clinically 
.... ""en ...", of This isolates derived mainly 
from in the Cape, set out to profile clinical 
and to measure virulence IJV,.vH"lal in vitro. 
products) which virulence 
,",<.U."''''''''''','''' virulence in South 
whether a "virulent 
existed organisms. 
low CVLOWXIC vaeA sIb was widespread (as in Portugal and and the 
more cytotoxic vaeA a almost absent. non-cytotoxic vaeA allele was 
found in 1-'"""-''''''' with It is OJV.''''''''' that the high ofthe 
sIb low-cytotoxic allele may disease AV't"...""",,,, in the Cape.UV..... Ul<"'v 
ulcer disease and gastric cancer isolates had the same vaeA sIb as well as a 
similarly high distribution of the vaeA allele. It is apparent therefore that vaeA alleles do 
not two different 
The gene, was identified m 100% of (as countries) but 
m product (an identified South "-VALV"V 
with expressed 
both m secondary structure (an increased number of surface 
exposed regions) as well as in number phosphorylation sites. 
~~,,,.,__ .~ that in protein structure may be m 
it is possible that CagA from South African gastric cancer patients is potentially more 
Transduction of the effects is mediated only via tyrosine 
phosphorylation. It is possible that from cancer may affect 
proliferative signaling pathways because of 
potential tyrosine CagA peptic ulcer ~.uv~>v isolates tended to be 
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is differently Analysis of specific genetic IJH'-'''IJ.llV' 
that the functionally cagE product, which is important 
phosphorylation in a number of 
alone. Genes also tended to or 
a of strains from fJ~'A'VH'''' without clinically significant UA""V~'V. work 
_,.".,____ a supportive role for these in pathogenesis. Indeed, an 
IS a for CagA translocation phosphorylation. It is possible that the 
m noted in patients with the organisms " 
from patients with both ulcer disease and gastric 
yet the diseases have etiologies. The major difference n","u",.'''n 
was in the length of ,--,a'~1L. It is attractive to hypothesize that while CagA 
may amipclrte:Q into epithelial cells cases, its coupling with secondary 
differ depending on potentially contribute to 
noted. 
and structural variants tended to 
groups. Specifically iceAl appeared to be a for gastric adenocarcinoma. 
which is coupled to transcription of a downstream methylase enzyme, an 
enzyme based system for the organism, could 
for more successful colonization. It is possible that isolates 
cancer patients are more likely to be because these patients tend to be older, and 
by mH~CH::Q for a longer period time. Sequencing 
could produce proteins secondary structure. alter the 
product. iceA2C variant, expressed, 
was most often in patients significant the 2D 
variant, which has postulated regions and is not readily transcribed, was a 
patients with peptic Half of the isolates were both 
1 and iceA2 positive. An important question would be to gauge would have 
the dominant effect. One may speculate that the peptic ulcer disease ."vu;..,.-", may be more 
because 2D is not readily transcribed (at vitro). In 
contrast alone l';)V"<t,.<J more iceA2-like, has been 
shown to transcribed, is some evidence for mutations in iceAl gene 
its transcription and 
summation, a "virulent (vacA iceAl) 
80-100% of isolates with clinically It is 
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isolates both from patients with peptic ulcer disease and with gastric 
~'~U'f~U~~LU~L"~ tended to share a large proportion "virulence" genes, with only a few 
of the cagA distribution of the iceA genotypes). 
The to the differences Not all patients 
with pylori organisms, a clinically significant 
It is possible that by timing; only 
in the gastric milieu at the time investigation are 
part of this study can only unequivocally that at a 
natural history of infection, certain are more likely to be 
factors (bacterial or host) must play a role in disease etiology. 
some strains are non-virulent is difficult to prove but is 
of the is some evidence for a 
African clone pylori. Interestingly, this study is "European" in 
..."',;;....,"' .." that the cagPAI in the may be derived from a 
ethnic source that then swept through the bacterial population. The widespread 
this locus (100% of strains) "'Fo,=''''''''' that it may have engendered a ""~"Ti'T'" 
to the organism. This study a clonal grouping associated with 
might possibly reflect a progenitor source for a peptic ulcer Ul;:',I,;;a;:,I;;;-\_a,U;:'UI,~ 
Cape-colored population. contributions of virulence 
, "European" and sources are not known and still require to 
our study population. 
The !JUtH""·'" that lipopolysaccharides the virulence potential of pylori 
was tested in the second of LPS 
secretion of a mitogen (histamine), as well as the proliferation of 
transformed neuroendocrine ECL cell in vitro. addition, the gastric adenocarcinoma 
cell was stimulated both to enter the cell cycle as well as to synthesize DNA. 
were differentially modulated by South isolates with differences 
intact cagPAI) and to some extent with disease type 
by which this aPt)eared to be via activation of CD14 
intracellular production of the IP3 pathway. were conducted in vitro it is 
the results are to Other effectors 
1'-''-',11<+1..,,111 
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receptors/intracellular pathways) may also be involved. The effects of LPS have not been 
properly investigated in in vivo models and it remains a possibility that the in vitro results are 
not transferable to the intact host. 
The data presented in these studies, however, are supportive of a role for H. pylori virulence 
factors in the etiology of clinically significant gastroduodenal diseases in the Western Cape 
and provides a mechanistic basis for how this potentially may occur (Figure 13.1). 
"Non-virulent" 	 "Virulent" 
vacA s2m2 
cagA 3'-short 	 cagA 3'-longcagA 3'-short 
& 	 && 
intact cagPAI 	 intact cagPAI partial cagPAI 
iceA1iceA2C 
,
,
,
, 
~ 
non-cytotoxic low cytotoxicity low cytotoxicity 
low antigenicity low antigen icity higher antigenicity 
CagA not translocated CagA translocated CagA translocated 
no tyr phosphorylation ¢tyr phosphorylation ~ tyr phosphorylation 
apoptotic LPS non-mitogenlc LPS mitogenic LPS , 	 ,~ ~ 
GASTRITIS ULCER DISEASE CARCINOMA 
Figure 13.1 Relationship between virulence genes, potential in vivo effects and disease 
presentation - a hypothesis based on the study data. Other factors, e.g. host genetic 
polymorphisms may playa modulatory role. 
Despite the widespread prevalence of virulence-associated genes and their specific DNA 
stimulatory effects in vitro, a significant number of infected patients do not develop clinically 
significant disease. Conversely, some patients with disease have alterations in some, but not 
all of the virulence genes. A number of important areas of research that may clarify these 
anomalies require to be undertaken in the future. 
1) 	 The mechanisms by which South African H. pylori strains affect epithelial cellular 
function need to be investigated. This would involve in vitro co-colonization studies, and 
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would detennine whether isolates with differences in the cagPAI and in cagA or in the 
iceA genes differentially affect signal transduction pathways (specifically CagA tyrosine 
phosphorylation) in model cell systems. 
2) 	 The structure of LPS from differentially virulent organisms should be examined, in 
particular, whether the lipid A portion or the O-side chains of this complex chemical is 
the effector of DNA synthesis and cell proliferation/apoptosis. The mechanism by which 
this potentially may occur, either via activation of CD14 or intercalation into the cell 
membrane with subsequent modulation ofputative protein signaling, require elucidation. 
3) 	 Various host factors should be investigated in infected patients. These could include a 
study ofpolymorph isms in the IL-IP gene (which have been associated with alterations in 
gastric acid secretion and are risk factors for gastric adenocarcinoma). Alterations in the 
balance of the ThllTh2 immune response (which has been shown to modulate gastric 
colonization in a mouse model of Helicobacter infection) should also be examined. 
These, and other host phenomena, may potentially modulate the colonization and/or 
virulence of H pylori and may shed some additional light on the natural history of 
infection with the organism in different popUlations. 
 
]
 
 ll3
l I ltt
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
169 
Bibliography. 
1. Blaser M. Heterogeneity ofHelicobacter pylori. Eur J Gastroenterol Hepatol 1997;9 (Suppll):S3­
S7. 
2. Holcombe C. Helicobacter pylori: the African Enigma. Gut 1992;33:429-431. 
3. Kidd M, Marks I, Louw J. Helicobacter pylori in Africa: Observations on an "Enigma within an 
Enigma". J Gastoenterol HepatoI1999;14:851-858. 
4. Louw J, Jaskiewicz K, Girdwood A, et at. Helicobacter pylori prevalence in non ulcer dyspepsia ­
ethnic and socio-economic differences. S Afr Med J 1993;83:169-171. 
5. Jaskiewicz K, Louwrens H. Chronic atrophic gastritis in a population at risk for gastric carcinoma. 
Anticancer Research 1991;11:835-839. 
6. Atherton J. The clinical relevance ofstrain types ofHelicobacter pylori. Gut 1997;40:701-703. 
7. Covacci A, Censini S, Bugnoli M, et at. Molecular characterization of the 128-kDa 
immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. 
Proc Natl Acad Sci USA 1993;90:5791-5795. 
8. Atherton J, Cao P, Peek R, Tummuru M, Blaser M, Cover T. Mosaicism in vacuolating cytotoxin 
alleles ofHelicobacter pylori. J Bioi Chem 1995 ;270: 17771-17777. 
9. Ilver D, Arnqvist A, Ogren J, et al. Helicobacter pylori adhesin binding fucosylated histo-group 
antigens revealed by retagging. Science 1998;279:373-377. 
to. Wirth H-P, Yang M, Karita M, Blaser M. Expression of the human cell surface glycoconjugates 
Lewis x and Lewis y by Helicobacter pylori isolates is related to cagA status. Irifect Immun 
1996;64:4598-4605. 
11. Atherton J, Peek R, Tham K, Cover T, Blaser M. Clinical and pathological importance of 
heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterol 
1997;112:92-99. 
12. Peek R, Thompson S, Atherton J, Blaser M, Miller G. Expression of a novel ulcer-associated H 
pylori gene, iceA, following adherence to gastric epithelial cells. Gastroenterol 1996;110 (Suppl 
4):A225. 
13. Blaser M, Perez-Perez G, Kleanthous H, et aL Infection with Helicobacter pylori strains 
possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. 
Cancer Res 1995;18:2111-2115. 
14. Kuipers E, Perez-Perez G, Meuwissen S, Blaser M. Helicobacter pylori and atrophic gastritis: 
importance of cagA status. J Natl Cancer Inst 1995;87:1777-1780. 
15. Fan X, Kelleher D, Fan X, Xia H, Keeling P. Helicobacter pylori increases proliferation of gastric 
epithelial cells. Gut 1996;38: 19-22. 
 119 ; ll -
l -
  
L
 
m
10
l
p " ,'p
\.,Uflf,;t;;f  
'rn.~£\fir"n"p  
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
170 
16. Ricci V, Ciacci C. Effect of Helicobacter pylori on gastric epithelial cell migration and 
proliferation in vitro: role ofVacA and CagA. Infect Immun 1996;64:2829-2833. 
17. Wagner S, Beil W, Westermann J, et al. Regulation of gastric epithelial cell growth by 
Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterol1997;113: 1836-1847. 
18. Bark J, Enroth H, Engstrand L, Uribe A. Cancer-associated strains of Helicobacter pylori 
stimulate DNA synthesis in IEC-6 cells. Eur J Gastroenterol Hepatol 1998; 10:837 -841. 
19. Brannstrom J, Zachrisson K, Hulten K, Engsrand L, Uribe A. Helicobacter pylori stimulates DNA 
synthesis in a small intestinal cell line in vitro. Digestion 1998;59:33-39. 
20. Shirin H, Sordillo E, Oh S, et al. Helicobacter pylori inhibits the G 1 to S transition in AGS gastric 
epithelial cells. Cancer Res 1999;59:2277-2281. 
21. Peek R, Blaser M, Mays D, et al. Helicobacter pylori strain-specific genotypes and modulation of 
gastric epithelial cell cycle. Cancer Res 1999;59:6124-6131. 
22. Modlin I, Tang L. The Gastric Enterochromaffin-like Cell: An Enigmatic Cellular Lesion. 
GastroenteroI1996;111:783-810. 
23. Nilsson 0, Wangberg B, Johansson L, et al. Rapid induction of enterochromaffin-like cell tumors 
by histamine 2 receptor blockade. Am J PathoI1993;142:1173-1185. 
24. Bilchik A, Nilsson 0, Modlin I, Zucker K, Adrian T. Significance of gastric endocrine tumor and 
age-related gut peptide alterations in Mastomys. Regul Pept 1990;27: 195-207. 
25. Barranco S, Townsend C, Casartelli C, et al. Establishment and characterization of an in vitro 
model system for human adenocarcinoma of the stomach. Cancer Res 1983;43: 1703-1709. 
26. Kidd M, Modlin 1. A century of Helicobacter pylori. Paradigms lost - paradigms regained. 
Digestion 1998;59: 1-15. 
27. Bottcher G. Dorpater Med Z 1874;5:148. 
28. Jaworski W. Podrecznik Chorob zoladka: Wydawnictwa Dziel Lekarskich Polskich, 1889. 
29. Bizzozero G. Ueber die schlauchformigen Drusen des Magendarmkanals und die Beziehungen 
ihres Epithels zu dem Oberflachenepithel der Schleimhaut. Archfmikr Anat 1893;42:82. 
30. Lee A, Robertson B. New Helicobacter species. In: Hunt R, Tytgat G, eds. Helicobacter pylori 
Basic mechanisms to clinical cure. Lancaster, UK: Kluwer Academic Publishers, 1998: 3-12. 
31. Salomon H. Ueber das Spirillum des Saugtiermagens und sein Verhalten zu den Belegzellen. 
Zentralbl BakterioI1896;19:433-442. 
32. Krienitz W. Ueber das Auftreten von Spirochaeten vershiedener Form im Magen-inhalt bei 
Carcinoma ventriculi. Dtsch Med Wochenschr 1906;32:872. 
33. Edkins J. Spirella regaudi in the cat. Parasito/1923;15:296-307. 
34. Doenges J. Spirochaetes in Gastric glands ofMacacus rhesus and humans without definite history 
ofrelated disease. Proc Soc Exper BioI Med 1938;38:536-538. 
35. Freedberg A, Barron L. The presence of spirochetes in human gastric mucosa. Am J Digestive Dis 
1940;7:443-445. 
t
 
I199 ; :
,
,
I , ,
,
l
I
 
 i
ige t
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
171 
36. Warren J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 
1983;i: 1273. 
37. Marshall B. History of the discovery of C. pylori. In: Blaser M, ed. Campylobacter pylori in 
gastritis and peptic ulcer disease. New York: Igaku-Shoin, 1989: 7-23. 
38. Marshall B, Armstrong J, McGechie D, Glancy R. Attempt to fulfill Koch's postulates for pyloric 
campylobacter. Med J Australia 1985;142:436-439. 
39. Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting 
gastric pH. Am J Gastroenterol 1987;82: 192-199. 
40. The evaluation of carcinogenic risks to humans. Lyon: World Health Organization. International 
Agency for Research on Cancer, 1994. 
41. Tomb J-F, White 0, Kerlavage A, et al. The complete genome sequence of the gastric pathogen 
Helicobacter pylori. Nature 1997;388:539-547. 
42. AIm R, Ling L-S, Moir D, et al. Genomic-sequence comparison of two unrelated isolates of the 
human gastric pathogen Helicobacter pylori. Nature 1999;397: 176-180. 
43. Berg D, Hoffman P, Appelmelk B, Kusters G. The Helicobacter pylori genome sequence: genetic 
factors for long life in the gastric mucosa. Trends MicrobioI1997;5:468-474. 
44. Eisen A, Kaiser D, Myers R. Gastrogenomic delights: a moveable feast. The complete genome 
sequences of Escherichia coli and Helicobacter pylori provide insights into the biology of these 
species. Nature Med 1997;3: 1076-1078. 
45. Graham D. Helicobacter pylori: Its epidemiology and its role in duodenal ulcer disease. J 
Gastroenterol HepatoI1991;2:105-113. 
46. Eaton K, Dewhirst F, Radin M, et at. Helicobacter acinomyx sp. nov. isolated from cheetahs with 
gastritis. Int J Syst Bacteriol1993 ;43 :99-1 06. 
47. Bronsdon M, Goodwin C, Sly L, Chilvers T, Schoenknecht F. Helicobacter nemestrinae sp. nov., 
a spiral bacterium found in the stomach of a pigtailed macaque (Macaca nemestrina). Int J Syst 
BacterioI1991;41:148-153. 
48. Paster B, Lee A, Fox J, et al. Phylogeny of Helicobacterfelis sp. nov., Helicobacter mustelae, and 
related bacteria. Int J Syst BacterioI1991;41:3l-38. 
49. Solnick J, O'Rourke J, Lee A, Paster B, Dewhirst F, Tompkins L. An uncultured gastric spiral 
organism is a newly identified helicobacter in humans. J Inject Dis 1993;168:379-385. 
50. Jalava K, Kaartinen M, Utriainen M, Happonen I, Hanninen M. Helicobacter salomonis sp. nov., 
a canine gastric Helicobacter sp. related to Helicobacter felis and Helicobacter bizzozeronii. Int J Syst 
BacterioI1997;47:975-982. 
51. Hanninen M, Happonen I, Saari S, Ja1ava K. Culture and characteristics of Helicobacter 
bizzozeronii, a new canine gastric helicobacter sp. Int J Syst BacteriolI996;46: 160-166. 
52. Geyer C, Colbatzky F, Lechner J, Hermanns W. Occurrence of a spiral-shaped bacteria in gastric 
biopsies of dogs and cats. Vet Record 1993;133:18-19. 
.... """,tr,t,,, t 
... t<Un.U-UH'JU"
''']JUri",,: .~~., ......
.... """' ... 1
2 rl rrl n l~
i
tn rlOrrl ll tll
"'~"b"'V
l  ; : 1  
!  
l  
 
; :31
"'U\" ......... 1\.,,...
fo
!
l
I1  
....,..",11.11"'1 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
172 
53. Dewhirst F, Seymour C, Fraser G, Paster B, Fox J. Phylogeny of Helicobacter isolates from bird 
and swine feces and description of Helicobacter pamentis sp. nov. Int J Syst Bacteriol 1994;44:553­
560. 
54. Stanley J, Linton D, Bumens A, et at. Helicobacter pullorum sp. nov. - genotype and phenotype of 
a new species isolated from poultry and from human patients with gastroenteritis. Microbiol 
1994;140:3441-3449. 
55. Fox J, Li X, Van L,et aL Chronic proliferative hepatitis in AlJCR mice associated with persistent 
Helicobacter hepaticus infection - a model of Helicobacter-induced carcinogenesis. Infect Immun 
1996;64: 1548-1558. 
56. Fox J, Shen Z, Taylor N, Correa P, Araya J, Roa I. Hepatic Helicobacter sp. identified from 
Chileans with chronic cholecystitis: a risk factor for gall bladder cancer? Gut 1997;41 (Suppl 
1):AI23. 
57. Rudi J, Rudy A, Maiwald M, Stremmel W. Helicobacter sp. are not detectable in bile from 
German patients with biliary disease. GastroenteroI1999;116: 1 016-1017. 
58. Hill A. The environment and disease: association or causation? Proc Royal Soc Med 1965;58:295­
300. 
59. EI-Omar E, Penman I, Ardin J, Chittajulla R, Howie C, McColl K. Helicobacter pylori infection 
and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterol 
1995;109:681-691. 
60. Smith J, Pounder R, Nwokolo C, et aL Inappropriate hypergastrinemia in asymptomatic healthy 
subjects infected with Helicobacter pylori. Gut 1990;31:522-525. 
61. Kames W, Ohning G, Sytnik B, Kim S, Walsh J. Elevation of meal-stimulated gastrin release in 
subjects with Helicobacter pylori infection: reversal by low intragastric pH. Rev Infect Dis 1991;13 
(SuppI8):S665-S670. 
62. EI-Omar E, Penman I, Dorrian C, Ardill J, K. M. Eradicating Helicobacter pylori infection lowers 
gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993 ;34: 1060-1065. 
63. Nujumi A, Dorrian C, Chittajulla R, Neithercut W, McColl K. Effect ofinhibition of Helicobacter 
pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects. Gut 
1991;32:886-870. 
64. Chittajulla R, Dorrian C, Neithercut W, Dahill S, McColl K. Is Helicobacter pylori associated 
hypergastrinemia due to the bacterium's urease activity or the antral gastritis. Gut 1991;32:1286-1290. 
65. Lichtenberger L, Dial E, Romero J, Lechago J, Jarboe L, Wolfe M. Role of luminal ammonia in 
the development of gastropathy and hypergastrinemia in the rat. GastroenteroI1995;108:320-329. 
66. Weigert N, Schaffer K, Schusdziarra V, Classen M, Schepp W. Gastrin secretion from primary 
cultures of rabbit antral G-cells: stimulation by inflammatory cytokines. GastroenteroI1996;110:147­
154. 
.  ,  
-
l o
l.
 
1
-
ll j H
l.
} 8):
iti rt
n
nT11m",.""
 l1 l -
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
173 
67. Le A, Lambert J, Davenport P, et at. Antral mucosal gastrin and tumor necrosis factor alpha 
(TNFa) release in patients with nonulcer dyspepsia and H. pylori infection. Gastroenterol 
1993;104:AI047. 
68. Moss S, Legon S, Bishop A, Polack J, Calam J. Effect of Helicobacter pylori on gastric 
somatostatin in duodenal ulcer disease. Lancet 1992;340:930-932. 
69. Metz D, Weber H, Orbach M, Strader D, Lubensky I, Jensen R. Helicobacter pylori infection. A 
reversible cause of hypergastrinemia and hyperchlorhydria which may mimic Zollinger-Ellison 
syndrome. Dig Dis & Sci 1995;40:153-159. 
70. Lamers C, Ruland C, Joosten H, Verkoogen H, van Tongeren J, Rehfeld J. Hypergastrinemia of 
antral origin in duodenal ulcer. Dig Dis & Sci 1978;23:998-1002. 
71. Ramsey E, Carey K, Peterson W, et al. Epidemic gastritis with hypochlorhydria. Gastroenterol 
1979;76: 1449-1457. 
72. Calam J. Helicobacter pylori. Eur J Clin Invest 1994;24:501-510. 
73. Hunt R. Hp and pH - the relevance of gastric acid to the treatment of Helicobacter pylori 
infection. Scand J Gastroenterol1994;29 (SuppI7):128-133. 
74. SoIl A. Pathogenesis of peptic ulcer and implications for therapy. N Engl J Med 1990;322:909­
916. 
75. Cal am J. Helicobacter pylori, acid and gastrin. Eur J Gastroenterol HepatoI1995;7:310-317. 
76. Knipp U, Birkholz S, Wolfgang K, Wolfgang O. Partial characterization of a cell proliferation­
inhibiting protein produced by Helicobacter pylori. Infect Immun 1996;64:3491-3496. 
77. Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and 
duodenal ulcers: the gastrin link. Lancet 1989;1:1167-1168. 
78. Genta R. Helicobacter pylori infection in gastric pathology. In: Weinstein R, ed. Advances in 
pathology and laboratory medicine. St. Louis: Mosby, 1994: 443-465. 
79. Blaser M. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced 
inflammation. GastroenteroI1992;102:720-727. 
80. Dooley C, Cohen H, Fitzgibbons P, et at. Prevalence of Helicobacter pylori infection and 
histologic gastritis in asymptomatic persons. N Engl J Med 1989;321:1562-1566. 
81. Correa P. Chronic gastritis: A clinico-pathological classification. Am J Gastroenterol 
1988;83:504-509. 
82. Blaser M. Helicobacter pylori are indigenous to the human stomach: duodenal ulceration is due to 
changes in gastric microecology in the modem era. Gut 1998;43:721-727. 
83. Rauws E, Tytgat G. Epidemiology of Campylobacter pyloridis infection. In: den Ouden W, ed. 
Campylobacter pyloridis. Amsterdam, 1989: 13-21. 
84. Koch R. Untersuchungen uber die Aetiologie der Wundinfectionskrankheiten. Leipzig: FCW 
Vogel, 1878. 
.,." .. ,"',,,,, 
'om~erc;:n 1
"'''''''U''''~'1 E, .
lI -
l 10-
-
1992; :
l
.... "" •. ,,"'.," 
[
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
174 
85. Fonnan D, Newell D, Fullerton F, et al. Association between infection with Helicobacter pylori 
and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991 ;302: 1302-1305. 
86. Parsonnet J, Friedman G, Vandersteen D, et al. Helicobacter pylori infection and the risk of 
gastric carcinoma. N Engl J Med 1991;325: 1127-1131. 
87. Nomura A, Stemmennann G, Chyou P, Kato I, Perez-Perez G, Blaser M. Helicobacter pylori 
infection and gastric carcinoma in Japanese Americans in Hawaii. N Engl J Med 1991;325:1132­
1136. 
88. Wyatt J, Rathbone B, Sobala G, Shallcross T, Heatley R, Axon A. Gastric epithelium in the 
duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol 1990;43:981­
986. 
89. Marshall B, Warren 1. Unidentified curved bacilli in the stomach of patients with gastritis and 
peptic ulceration. Lancet 1984; 1: 1311-1315. 
90. Fiocca R, Villani L, Turpini F, Solcia E. High incidence of Campylobacter-like organisms in 
endoscopic biopsies from patients with gastritis, with or without peptic ulcer. Digestion 1987;38:234­
244. 
91. Rauws E, Langenberg W, Houthoff H, Zanen H, Tytgat G. Campylobacter pyloridis associated 
chronic active gastritis. Gastroentero/1988;94:33-40. 
92. McColl K, EI-Nujumi A, Chittajulla R, et al. A study of the pathogenesis of Helicobacter pylori 
negative chronic duodenal ulceration. Gut 1993;34:762-768. 
93. Sprung D, Apter M. What is the role of Helicobacter pylori in peptic ulcer and gastric cancer 
outside the big cities? J Clin Gastroenterol1998;26:60-63. 
94. Spiro H. About this Issue. J Clin Gastroentero/1998;26: 1-2. 
95. Carrick J, Lee A, Hazell S, Ralston M, Daskalopoulos G. Campylobacter pylori, duodenal ulcers 
and gastric metaplasia: Possible role of functional heterotopic tissue in ulcerogenesis. Gut 
1989;30: 790-797. 
96. Sipponen P, Varis K, Fraki 0, Korri UM, Seppala K, Siurala M. Cumulative 10-year risk of 
symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. Scand J 
GastroenterolI990;25:966-973. 
97. Marshall B, Goodwin C, Warren J, et al. Prospective double blind trial of duodenal ulcer relapse 
after eradication of Campylobacter pylori. Lancet 1988;2:1437-1442. 
98. Rauws E, Tytgat G. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. 
Lancet 1990;335: 1233-1235. 
99. Louw J, Lucke W, Jaskiewicz K, Lastovica A, Winter T, Marks 1. Helicobacter pylori eradication 
in the African setting, with special reference to reinfection and duodenal ulcer recurrence. Gut 
1995;36:544-547. 
100. Kuipers E. Review article: exploring the link between Helicobacter pylori and gastric cancer. 
Aliment Pharmacol Ther 1999;13 (Suppll):3-11. 
~ 
 
-
. 
-
"'u ... "' .......
..... ..,,, .... uv. 
-<l 4~OPIC
I
I
I
I1
to-
"'-'LLUll;,
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
175 
101. Siurala M, Lehtola J, Ihamaki T. Atrophic gastritis and its sequelae. Scand J Gastroenterol 
1974;9:441-446. 
102. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19 (Suppl 
1):S37-S43. 
103. Ihamaki T, Kekki M, Sipponen P, Siurala M. The sequelae and course of chronic gastritis during 
a30 to 40 year bioptic study. Scand J GastroenteroI1985;20:485-491. 
104. Moss S, Calam J, Argawal B, Wang S, Holt P. Induction of gastric epithelial apoptosis by 
Helicobacter pylori. Gut 1996;38:498-501. 
105. Mannick E, Bravo L, Zarama G, et al. Inducible nitric oxide synthase, nitrotyrosine, and 
apoptosis in Helicobacter pylori, effect of antibiotics and antioxidants. Cancer Res 1996;56:3238­
3243. 
106. Jones N, Shannon P, Cutz E, Yeger H, Sherman P. Increase in proliferation and apoptosis of 
gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 
1997;151:1695-1703. 
107. Shirin H, Moss S. Helicobacter pylori induced apoptosis. Gut 1998;43:592-595. 
108. Anti M, Armuzzi A, Gasbarrini A, Gasbarrini G. Importance of changes in epithelial cell 
turnover during Helicobacter pylori infection in gastric carcinogenesis. Gut 1998;43 (Suppl 1):S27­
32. 
109. Sung J, Lin S-R, Ching J, et al. Atrophy and intestinal metaplasia one year after cure ofH. pylori 
infection: A prospective, randomized study. GastroenteroI2000;119:7-14. 
110. Parsonnet J, Vandersteen D, Goates J, Sibley R, Pritikin J, Chang Y. Helicobacter pylori 
infection in intestinal- and diffuse-type gastric adenocarcinomas. J Nat! Cancer Inst 1991;83:640-643. 
111. Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma. Serum antibody 
prevalence in populations with contrasting cancer risks. Cancer 1990;66:2569-2574. 
112. Craanen M, Dekker W, Blok P, Ferwerda J, Tytgat G. Intestinal metaplasia and Helicobacter 
pylori: an endoscopic bioptic study of the gastric antrum. Gut 1992;33:16-20. 
113. Brenes F, Ruiz B, Correa P, et al. Helicobacter pylori causes hyperproliferation of the gastric 
epithelium. Pre- and post-eradication indices of proliferating cell nuclear antigen (PCNA). Am J 
Gastroenterol 1993;88: 1870-1875. 
114. Tsuji M, Kawano S, Tsuji S, et al. Cell kinetics of mucosal atrophy in rat stomach induced by 
long term administration of ammonia. GastroenteroI1993;104:796-801. 
115. Cahill R, Sant S, Beattie S, Hamilton H, O'Morain C. Helicobacter pylori and increased 
epithelial cell proliferation: a risk factor for cancer. Eur J Gastroenterol HepatoI1994;6: 1123-1127. 
116. Wyle F, Chang K. Do strains of Helicf!bacter pylori differ from one another? Eur J 
Gastroenterol Hepato11993;5 (Suppll):S9-S15. 
117. Goldstone A, Quirke P, Dixon M. Helicobacter pylori and gastric cancer. J Pathol 
1996;179: 129-137. 
I 

.   t t l 
 S S
S  
lOS ......... ' ..... L ....
,i  -
nn
-
 
m!l ll
Ill L
 lI
 
1994; :  
/
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
176 
118. Smoot D, Wynn Z, Elliot T, et al. Effects of Helicobacter pylori on proliferation of gastric 
epithelial cells in vitro. Am J GastroenteroI1999;94: 1508-1511. 
119. Hamper! H. Uber argyrophile Zellen. Virchows Arch 1951;321:482-507. 
120. Azzopardi J, Pollock D. Argentaffin and argyrophil cells in gastric carcinoma. J Pathol Bacteriol 
1963;86:443-451. 
121. Waldum H, Haugen 0, Isaksen C, Mecsei R, Sandvik A. Enterochromaffin-like tumour cells in 
the diffuse but not the intestinal type of gastric carcinomas; Scand J Gastroenterol 1991;26 (Suppl 
180):165-169. 
122. Waldum H, Aase S, Kvetnoi I, et aL Neuroendocrine differentiation in human gastric carcinoma. 
Cancer 1998;83:435-444. 
123. Waldum H, Rorvik H, Falkmer S, Kawase S. Neuroendocrine (ECL cell) differentiation of 
spontaneous gastric carcinomas of cotton rats. Lab Anim Sci 1999;49:241-247. 
124. Havu N, Maaroos HI, Sipponen P. Argyrophil cell hyperplasia associated with chronic corpus 
gastritis in gastric ulcer disease. Scand J Gastroenterol1991 ;26:90-94. 
125. Lamberts R, Creutzfeldt W, Struber HG, Brunner G, Solcia E. Long-term omeprazole therapy in 
peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis. GastroenteroI1993;104:1356-1370. 
126. Solcia E, Fiocca R, Havu N, Dalvag A, Carlsson R. Gastric endocrine cells and gastritis in 
patients receiving long-term omeprazole treatment. Digestion 1992;51:82-92. 
127. Solcia E, Villani L, Fiocca R, et aL Effects of eradication of Helicobacter pylori on gastritis in 
duodenal ulcer patients. Scand J Gastroenterol1994;29 (SuppI201):28-34. 
128. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric 
cancer in Mongolian gerbils. GastroenteroI1998;115:642-648. 
129. Hirayama F, Takagi S, Kusuhara H, Iwao E, Yokohama Y, Ikeda Y. Induction of gastric ulcer 
and intestinal metaplasia in Mongolian gerbils infected with Helicobacter pylori. J Gastroenterol 
1996;31:755-757. 
130. Matsumoto S, Washizuka Y, Matsumoto Y, et al. Induction of ulceration and severe gastritis in 
Mongolian gerbils by Helicobacter pylori infection. J Med MicrobioI1997;46:391-397. 
131. Wirth H-P, Beins M, Yang M, Tham K, Blaser M. Experimental infection of Mongolian gerbils 
with wild-type and mutant Helicobacter pylori strains. Infect Immun 1998;66:4856-4866. 
132. Fujioka T, Honda S, Tokieda M, Satoh R. Helicobacter pylori-induced gastric carcinoid in 
Mongolian gerbils. Gut 1998;43 (SuppI2):08/216. 
133. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizon A, Nasu M. Development of Helicobacter 
pylori induced gastric carcinoma. Cancer Res 1998;58:4255-4259. 
134. Wang T, Fox J. Helicobacter pylori and gastric cancer: Koch's postulates fulfilled? 
GastroenteroI1998;1l5:780-783. 
135. Stolte M. Helicobacter pylori and MALT-lymphoma. Lancet 1992;339:745-747. 
L
 l B  
 
CI
,"-,""""'C;I 
Itt : :o tl
199 ;  
l.
\.I."'." ....... ·u<1.1
111 ... ' ... ''''"'''
 
mtl ll  
  ........ IUF,'VU< ...
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
177 
136. Stolte M, Eidt S. Lymphoid follicles in antral mucosa: immune response to Campylobacter 
pylori. J Clin PathoI1989;42:1269-1271. 
137. Eidt S, Stolte M. Prevalence oflymphoid follicles and aggregates in Helicobacter pylori gastritis 
in antral and body mucosa. J Clin PathoI1993;46:832-835. 
138. Wotherspoon A, Ortiz-Hidalgo 0, Falzon M, Isaacson P. Helicobacter pylori-associated gastritis 
and primary B-cell gastric lymphoma. Lancet 1991;338: 1175-1176. 
139. Isaacson P, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathol 
1987;11 :445-462. 
140. Wotherspoon A, Doglioni C, Diss T, et al. Regression of primary low-grade B-celllymphoma of 
the mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 
1993;342:575-577. 
141. Rudolph B, Bayerdorffer E, Ritter M, et at. Is the polymerase chain reaction or cure of 
Helicobacter pylori infection of help in the differential diagnosis of early gastric mucosa-associated 
lymphatic tissue lymphoma? J Clin Oncol 1997;15: 1104-1109. 
142. Roggero E, Zucca E, Cavalli F. Gastric mucosa-associated lymphoid tissue lymphomas: more 
than a fascinating model (editorial). J Natl Cancer Inst 1997;89:1328-1330. 
143. Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of 
mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT 
Lymphoma Study Group. Lancet 1995;345:1591-1594. 
144. Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary 
low-grade lymphoma of the mucosa-associated lymphoid tissue. Ann Intern Med 1995;122:767-769. 
145. Fischbach W, Kolve M, Engemann R, Greiner A, Stolte M. Unexpected success ofHelicobacter 
pylori eradication in low grade lymphoma. GastroenteroI1996;110:A512. 
146. Thiede C, Morgner A, Alpen B, et al. What role does Helicobacter pylori eradication play in 
gastric MALT and gastric MALT lymphoma? GastroenteroI1997;113:S61-S64. 
147. Boot H, de Jong D, van Heerde P, Taal B. Role of Helicobacter pylori eradication in high grade 
MALT lymphoma. Lancet 1995;346:448-449. 
148. Siman J, Forsgren A, Berglund G, Floren C-H. Association between Helicobacter pylori and 
gastric carcinoma in the city ofMalmo, Sweden. Scand J Gastroenterol 1997;32: 1215-1221. 
149. Lin J, Wang L, Wang J, Wang T, Yang C, Chen C. A nested case-control study on the 
association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in 
Taiwan. Anticancer Res 1995;15:603-606. 
150. Aromaa A, Kosunen T, Knekt P, et al. Circulating anti-Helicobacter pylori immunoglobulin A 
antibodies and low serum pepsinogen I levels are associated with increased risk of gastric cancer. Am 
J EpidemioI1996;144:142-149. 
151. Webb P, Yu M, Forman D, et al. An apparent lack of association between Helicobacter pylori 
infection and risk ofgastric cancer in China. Int J Cancer 1996;67:603-607. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
178 
152. Hansen S, Melby K, Aase E, Jellum E, Vollset S. Helicobacter pylori infection and risk of cardia 
cancer and non-cardia gastric cancer. A nested case-control study. Scand J Gastroenterol 
1999;34:353-360. 
153. Howson C, Hiyama T, Wynder E. The decline in gastric cancer: epidemiology of unplanned 
triumph. Epidemiol Rev 1986;8:1-27. 
154. Eliel M, Schaap L. Oncologieboek IKMN. Utrecht, 1997. 
155. Hansen S, Vollset S, Ardill J, et al. Hypergastrinemia is a strong predictor of distal gastric 
adenocarcinoma among Helicobacter pylori infected persons. Gut 1997;41 (Suppll):A45. 
156. Sitas F. Histologically diagnosed cancers in South Africa, 1988. S Afr Med J 1994;84:344-348. 
157. Segal I, Sitas F, Walker A. Helicobacter pylori: the African enigma. Gut 1998;43:300. 
158. van der Merwe C. Helicobacter pylori and gastric cancer. Eur J Gastroenterol Hepatol 
1995;7:589-590. 
159. Tovey F, Tunstall M. Duodenal ulcer in black populations in Africa south of the Sahara. Gut 
1975;16:564-576. 
160. Tovey F. Geographical aspects of peptic ulcer surgery. World J Surg 1977;1:47-53. 
161. Kummer A, Kidd M, Kotze U, Taylor K, Lastovica A, Louw 1. Relation between gastric 
adenocarcinoma (GCA) and H. pylori (HP): a case control study. S Afr Med J 2000; (in press). 
162. The World Health Report, 1996. 
163. Akopyanz N, Bukanov N, Westblom T, Berg D. PCR-based RFLP analysis of DNA sequence 
diversity in the gastric pathogen Helicobacter pylori. Nucleic Acid Res 1992;20:6221-6225. 
164. Kansau L, Raymond J, Bingen E. Genotyping of Helicobacter pylori isolates by sequencing of 
PCR products and comparison with the RAPD technique. Res MicrobioI1996;147:661-669. 
165. Suerbaum S, Maynard Smith J, Bapumia K, et al. Free recombination within Helicobacter pylori. 
Proc Natl Acad Sci USA 1998;95:12619-12624. 
166. Salaun L, Audibert C, Le Lay G, Burucoa C, Fauchere J-L, Picard B. Panmictic structure of 
Helicobacter pylori demonstrated by the comparative study of six genetic markers. FEMS 
Microbiology Letters 1998;161:231-239. 
167. Achtman M, Azuma T, Berg D, et al. Recombination and clonal groupings within Helicobacter 
pylori from different geographical regions. Mol MicrobioI1999;32:459-470. 
168. Covacci A, Telford J, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and 
genetic geography. Science 1999;284:1328-1333. 
169. Yoshimura H, Evans D, Graham D. DNA-DNA hybridization demonstrates apparent genetic 
differences between Helicobacter pylori from patients with duodenal ulcer and asymptomatic 
gastritis. Dig Dis Sci 1993;38: 1128-1131. 
170. Go M, Chan K, Versalovic J, Koeuth T, Graham D, Lupski J. Cluster analysis of Helicobacter 
pylori genomic DNA fingerprints suggests gastroduodenal disease-specific associations. Scand J 
GastroenteroI1995;30:640-646. 
U t
1):
J
;
rn
e(' r~l hllc .... )';".1""
i
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
179 
171. Owen R, Bell G, Desai M, et al. Biotype and molecular fingerprints of metronidazole resistant 
strains ofHelicobacter pylori from antral gastric mucosa. J Med MicrobioI1993;38:6-12. 
172. Akopyanz N, Bukanov N, Westblom T, Kresovich S, Berg D. DNA diversity among clinical 
isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucl Acid Res 
1992;20:5137-5142. 
173. Majewski S, Goodwin C. Restriction endonuclease analysis of the genome of Campylobacter 
pylori with a rapid extraction method: evidence for considerable genomic heterogeneity. J Infect Dis 
1988; 157 :465-71. 
174. Taylor D, Eaton M, Chang N, Salama S. Construction of a Helicobacter pylori genome map and 
demonstration ofdiversity at the genome level. J BacterioI1992;174:6800-6806. 
175. Cover T, Tummuru K, Cao P, Thompson S, Blaser M. Divergence of genetic sequences for the 
vacuolating cytotoxin among Helicobacter pylori strains. J Bioi Chem 1994;269: 10566-10573. 
176. Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes 
type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996;93:14648­
14653. 
177. Jiang Q, Hiratsuka K. Taylor D. Variability of gene order in different Helicobacter pylori strains 
contributes to genome diversity. Mol MicrobioI1996;93: 14648-14653. 
178. Salama S, Jiang Q, Chang N, Sherbaniuk R, Taylor D. Characterization of chromosomal DNA 
profiles from Helicobacter pylori strains isolated from sequential gastric biopsy specimens. J Clin 
MicrobioI1995;33:2496-7. 
179. Marshall D, Chua A, Keeling P, Sullivan D, Coleman D, Smyth C. Molecular analysis of 
Helicobacter pylori populations in antral biopsies from individual patients using randomly 
polymorphic DNA (RAPD) fingerprinting. FEMS Immunol Med MicrobioI1995;10:317-324. 
180. Taylor N, Fox J, Akopyants N, et al. Long term colonization with single and multiple strains of 
Helicobacter pylori assessed by DNA fingerprinting. J Clin MicrobioI1995;33:918-923. 
181. HirschI A, Richter M, Makristathis A, et al. Single and multiple strain colonization in patients 
with Helicobacter pylori-associated gastritis: detection by macrorestriction DNA analysis. J Infect Dis 
1994;170:473-475. 
182. Hua-Xiang H, Kalantar J, Talley N. Metronidazole- and clarithromycin-resistant Helicobacter 
pylori in dyspeptic patients in western Sydney as determined by testing multiple isolates from 
different gastric sites. J Gastroenterol Hepatol1998; 13: 1044-1049. 
183. Jorgensen M, Daskalopoulus G, Warburton V, Mitchell H, Hazell S. Multiple strain colonization 
and metronidazole resistance in Helicobacter pylori-infected patients: identification from sequential 
and multiple biopsy specimens. J Infect Dis 1996;174:631-635. 
184. Fantry G, Zheng Q, Darwin P, Rosenstein A, James S. Mixed infection with cagA-positive and 
cagA-negative strains ofHelicobacter pylori. Helicobacter 1996;1:98-106. 
."',,,,,, .... ,, ..
 1993;3 :
 
  
 
 -
L
i
.... "".""",.LVU
U1U",."",ugast I 1 104 -
Inr,C)'pn;;:pn
'-11lt""''''''''''''   
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
180 
185. van Doom L, Figueiredo C, Sanna R, et al. Clinical relevance of the cagA, vacA and iceA status 
ofHelicobacter pylori. GastroenteroI1998;115:58-66. 
186. Covacci A, Falkow S, Berg D, RappuoH R. Did the inheritance of a pathogenicity island modify 
the virulence ofHelicobacter pylori? Trends MicrobioI1997;5:205-208. 
187. Go M. What are the host factors that place an individual at risk for Helicobacter pylori­
associated disease. Gastroenterol1997;113 (SuppI6):SI5-S20. 
188. Cover T. An intracellular target for Helicobacter pylori vacuolating toxin. Trends Microbiol 
1998;6: 127-128. 
189. Leunk R, Johnson P, David B, Kraft W, Morgan D. Cytotoxic activity in broth-culture filtrates of 
Campylobacter pylori. J Med MicrobioI1988;26:93-99. 
190. Atherton J. CagA, the cag pathogenicity island and Helicobacter pylori virulence. Gut 
1999;44:307-308. 
191. Tompkins L, Falkow S. The new path to preventing ulcers. Science 1995;267:1621-1622. 
192. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiam P. Development of a mouse 
model of Helicobacter pylori infection that mimics human disease. Science 1995;267:1655-1658. 
193. Rudi J, Kolb C, Maiwald M, et at. Diversity of Helicobacter pylori vacA and cagA genes and 
relationship. to VacA and CagA protein expression, cytotoxin production and associated diseases. J 
Clin MicrobioI1998;36:944-948. 
194. van Doom L, Figueiredo C, Rossau R, et at. Typing of Helicobacter pylori vacA gene and 
detection of cagA gene by PCR and reverse hybridization. J Clin MicrobioI1998;36:1271-1276. 
195. Evans D, Queiroz D, Mendes E, Evans D. Helicobacter pylori cagA status and s and m alleles of 
vacA in isolates from individuals with a variety of H. pylori associated gastric diseases. J Clin 
MicrobioI1998;36:3435-3437. 
196. Strobel S, Bereswill S, Balig P, Allgaier P, Sonntag H, Kist M. Identification and analysis of a 
new vacA genotype variant of Helicobacter pylori in different patient groups in Germany. J Clin 
MicrobioI1998;36: 1285-1289. 
197. Ito Y, Azuma T, Ito S, et at. Analysis and typing of the vacA gene from cagA-positive strains of 
Helicobacterpylori isolated in Japan. J Clin Microbiol1997 ;35: 1710-1714. 
198. Maeda S, Ogura K, Yoshida H, et al. Major virulence factors, VacA and CagA, are commonly 
positive in Helicobacter pylori isolates in Japan. Gut 1998;42:338-343. 
199. Miehlke S, Kibler K, Kim J, et aL Allelic variation in the cagA gene of Helicobacter pylori 
obtained from Korea compared to the United States. Am J GastroenteroI1996;91: 1322-1325. 
200. Pan Z, Berg D, van der Hulst R, et aL Prevalence of vacuolating cytotoxin production and 
distribution of distinct vacA alleles in Helicobacter pylori from China. J Infect Dis 1998;178:220-226. 
201. Yamaoka Y, Kodama T, Gutierrez 0, Kim J, Kashima K, Graham D. Relation between 
Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: Studies in four different 
countries. J Clin MicrobioI1999;37:2274-2279. 
 
li
 
-
 
lfi,.,·",l>i",/ 1988;26: - . 
  
l
l
l 
l 
.... "", .. " .. ',,. J li  
K~'e:~\1V1 laent tlcaltlO
V"'1"1.!'! 1" 
, t I"nc" _nn'~ltl,.,e:
l.
l.
........ 'un'"
ll"rnnlnl 1999;37:22 -
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
181 
202. Tummuru M, Cover T, Blaser M. Cloning and expression of a high molecular mass major 
antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production. Infect Immun 
1993;61: 1799-1809. 
203. Lupetti P, Heuser J, Manetti R, et al. Oligomeric and subunit structure ofthe Helicobacter pylori 
vacuolating cytotoxin. J Cell Bioi 1996;133:801-807. 
204. de Bernard M, Papini E, de Filippis V, et al. Low pH activates the vacuolating toxin of 
Helicobacter pylori which becomes acid and pepsin resistant. J Bioi Chem 1995;270:23937-23940. 
I 
205. Gamer J, Cover T. Binding and internalization of the Helicobacter pylori vacuolating cytotoxin 
by epithelial cells. Infect Immun 1996;64:4192-4203. 
206. de Bernard M, Arico B, Papini E, Rizzuto R, Grandi G, Rappuoli R. Helicobacter pylori toxin 
VacA induces vacuole formation by acting in the cell cytosoL Mol MicrobioI1997;26:665-674. 
207. Molinari M, Galli C, Norais N, et al. Vacuoles induced by Helicobacter pylori toxin contain both 
late endosomal and lysosomal markers. J Bioi Chem 1997;272:25339-25344. 
208. Smoot D, Resau J, Earlington M, Simpson M, Cover T. Effects of Helicobacter pylori 
vacuolating cytotoxin on primary cultures ofhuman gastric epithelial cells. Gut 1996;39:795-799. 
209. Tummuru M, Sharma S, Blaser M. Helicobacter pylori picB, a homologue of the Bordetella 
pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol 
MicrobioI1995;18:867-876. 
210. Segal E, Cha J, Lo J, Falkow S, Tompkins L. Altered states: involvement of phosphorylated 
CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci 
1999;96: 14559-14564. 
211. Asahi M, Azuma T, Ito S, et at. Helicobacter pylori CagA protein can be tyrosine 
phosphorylated in gastric epithelial cells. J Exp Med 2000;191:593-602. 
212. Odenbreit S, PuIs J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter 
pylori CagA into gastric epithelial cells by type IV secretion. Science 2000;287:1497-1500. 
213. Meyer-ter-Vehn T, Covacci A, Kist M, Pahl H. Helicobacter pylori activates mitogen-activated 
protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Bioi Chem 
2000;275: 16064-16072. 
214. Akopyants N, Clifton S,. Kersulyte D, et at. Analyses of the cag pathogenicity island of 
Helicobacter pylori. Mol MicrobioI1998;28:37-53. 
215. Covacci A, Rappuoli R. Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host 
cell. J Exp Med 2000;191:587-592. 
216. Jenks P, Megraud F, Labigne A. Clinical outcome after infection with Helicobacter pylori does 
not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island. 
Gut 1998;43:752-758. 
 t
l.
 
tnl
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
182 
217. Takata T, Fujimoto S, Anazai K, et al. Analysis of the expression of CagA and VacA and the 
vacuolating activity in 167 isolates from patients with either peptic ulcers or non-ulcer dyspepsia. Am 
J GastroenteroI1998;93:30-34. 
218. Yamaoka Y, Kodama T, Kashima K, Graham D, Sepulveda A. Variants of the 3' region of the 
cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J 
CUn MicrobioI1998;36:2258-2263. 
219. Rudnicka W, Covacci C, Wadstrom T, Chmiela M. A recombinant fragment of Helicobacter 
pylori CagA affects proliferation ofhuman cells. J Physiol PharmacoI1998;49: 111-119. 
220. Kersulyte D, Akopyants N, Clifton S, Roe B, Berg D. Novel sequence organization and insertion 
specificity of IS605 and IS 606: chimaeric transposable elements of Helicobacter pylori. Gene 
1998;223: 175-186. 
221. Maeda S, Yoshida H, Ikenoue T, et al. Structure of the cag pathogenicity island in Japanese 
HeUcobacter pylori isolates. Gut 1999;44:336-341. 
222. Slater E, Owen R, Williams M, Pounder R. Conservation of the cag pathogenicity island of 
Helicobacter pylori: Associations with vacuolating cytotoxin allele and IS605 diversity. 
GastroenteroI1999;117: 1308-1315. 
223. Peek R, Thompson S, Donahue J, et al. Adherence to gastric epithelial cells induces expression 
of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am 
Physicians 1998;110:531-544. 
224. Figueiredo C, Quint W, Sanna R, et al. Genetic organization and heterogeneity of the iceA locus 
ofHelicobacter pylori. Gene 2000;246:59-68. 
225. van Doorn L, Figueiredo C, Sanna R, Quint W. Genetic organization and molecular typing of the 
Helicobacter pylori iceA gene. GastroenteroI1998;114:A320. 
226. Bauerfeind P, Garner R, Dunn B, Mobley H. Synthesis and activity ofHeUcobacter pylori urease 
and catalase at low pH. Gut 1997;40:25-30. 
227. Hu L, Mobley H. Purification and N-terminal analysis of urease from Helicobacter pylori. Infect 
Immun 1990;58:992-998. 
228. Scott D, Weeks D, Hong C, Postius S, Melchers K, Sachs G. The role of internal urease in acid 
resistance of Helicobacter pylori. GastroenteroI1998;114:58-70. 
229. Clayton C, Pallen M, Kleanthous H, Wren B, Tabaqchali S. Nucleotide sequence of two genes 
from Helicobacter pylori encoding for urease subunits. Nucl Acid Res 1990;18:362. 
230. Labigne A, Cussac V, Courcoux P. Shuttle cloning and nucleotide sequences of Helicobacter 
pylori genes responsible for urease activity. J BacterioI1991;173:1920-1931. 
231. Cussac V, Ferrero R, Labigne A. Expression of Helicobacter pylori urease genes in Escherichia 
coli grown under nitrogen-limiting conditions. J BacterioI1992;174:2466-2473. 
' ... ,' .......... xt)re~;Sl(J,n
}:, :Sla
li
/ i  / 11 
li
l
"-"'-''lL'"'''''''' 1
 
t l'5""U"""''-'U O ll llv
 
l
 li
1
i l ' 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
183 
232. Skouloubis S, Thiberge J, Labigne A, De Reuse H. The Helicobacter pylori UreI protein is not 
involved in urease activity but is essential for bacterial survival in vivo. Infect Immun 1998;66:4517­
4521. 
233. Weeks D, Eskandari S, Scott D, Sachs G. An H+-gated urea channel: the link between 
Helicobacter pylori urease and gastric colonization. Science 2000;287:482-485. 
234. Hawtin P, Stacey A, Newell D. Investigation of the structure and localization of the urease of 
Helicobacter pylori using monoclonal antibodies. J Gen Microbiol 1990;136: 1995-2000. 
235. Bode G, Malfertheiner P, Lenhardt G, Nilius M, Dischuneit H. Ultrastructural localization of 
urease of Helicobacter pylori. Med Microbiol Immun 1993;182:223-242. 
236. Phadnis S, Parlow M, Levy M, et al. Surface localization of Helicobacter pylori urease and heat 
shock protein homolog requires bacterial autolysis. Infect Immun 1996;64:905-912. 
237. Rektorschek M, Weeks D, Sachs G, Melchers K. Influence of pH on metabolism and urease 
activity ofHelicobacter pylori. GastroenteroI1998;115:628-641. 
238. Smoot D, Mobley H, Lewison J, Resau J. Helicobacter pylori urease activity is toxic to human 
gastric epithelial cells. Infect Immun 1990;58: 1992-1994. 
239. Dekigai H, Murakami M, Kita T. Mechanism of Helicobacter pylori associated gastric mucosa 
injury. Dig Dis Sci 1995;40:1332-1339. 
240. Matsui T, Matsukawa Y, Sakai T, Nakamura K, Aoike A, Kawai K. Effect of ammonia on cell 
cycle progression of human gastric cancer cells. Eur J Gastroenterol Hepatol 1995;7 (Suppl 1):S79­
S81. 
241. Matsui T, Matsukawa Y, Sakai T, Nakamura K, Aoike A, Kawai K. Ammonia inhibits 
proliferation and cell cycle progression at S-phase in human gastric cells. Dig Dis Sci 1997;42: 1394­
1399. 
242. Tsuji M, Kawano S, Tsuji S, Fusamoto H, Kamada T, Sato N. Mechanism of gastric mucosal 
damage induced by ammonia. GastroenteroI1992;102:1881-1888. 
243. Karita M, Tsuda M, Nakazawa T. Essential role of urease in vitro and in vivo Helicobacter 
pylori colonization study using a wild-type and isogenic urease mutant strain. J Clin Gastroenterol 
1995;21 (Suppll):SI60-S163. 
244. Eaton K, Krakowka S. Effect of gastric pH on urease-dependent colonization of gnotobiotic 
piglets by Helicobacter pylori. Infect Immun 1994;62:3604-3607. 
245. Eaton K, Krakowka S. Avirulent, urease-deficient Helicobacter pylori colonizes gastric epithelial 
cell explants ex vivo. Scand J GastroenteroI1995;30:434-437. 
246. Geis G, Leying H, Suerbaum S, Mai U, Opferkuch W. Ultrastructure and chemical analysis of 
Campylobacter pylori flagella. J Clin MicrobioI1989;27:436-441. 
247. Lee A, Logan S, Trust T. Demonstration of a flagellar antigen shared by a diverse group of 
spiral-shaped bacteria that colonize intestinal mucus. Infect Immun 1987;55:828-831. 
 , t'nl"l,pt"(l,,·
-
l
n .. nb', HV1HV"Vl'. ""'"111"'>" I nh"",,,, 
:tatl ll
!'If'tIVltv  ; : -64L
 
....,"' ...... "' .....
L
Ina~~I.u'  
 
:S t:l l't
-
rnaJ~
'"_1''U"'''
l
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
184 
248. Newell D. Identification of the outer membrane proteins of Campylobacter pyloridis and 
antigenic cross-reactivity with C. pyloridis and C.jejuni. J Gen MicrobioI1987;133:163-170. 
249. Leying H, Suerbaum S, Geis G, Haas R. Cloning and genetic characterization of a Helicobacter 
pylori flagellin gene. Mol MicrobioI1992;6:2863-2874. 
250. GelS G, Suerbaum S, Forsthoff B, Leying H, Opferkuch W. Ultrastructure and biochemical 
studies of the flagellar sheath ofHelicobacter pylori. J Med MicrobioI1993;38:371-377. 
251. Dunn B, Roop R, Sung C-C, Sharma S, Perez-Perez G, Blaser M. Identification and purification 
ofa cpn60 heat shock protein homolog from Helicobacter pylori. Infect Immun 1992;60:1946-1951. 
252. Evans D, Evans D, Engstrand L, Graham D. Urease-associated heat shock protein of 
Helicobacter pylori. Infect Immun 1992;60:2125-2127. 
253. Figura N, Tabaqchali S. Bacterial pathogenic factors. Curr Opin Gastroenterol 1996;12 (Suppl 
1):11-15. 
254. Kansau I, Labigne A. Heat shock proteins of Helicobacter pylori. Aliment Pharmacol Ther 
1996;10 (Suppll):51-56. 
255. Moran A. The products of Helicobacter pylori that induce inflammation. Eur J Gastroenterol 
Hepato11998;10 (Suppll):S3-S8. 
256. Nikaido H, Vaara M. Outer Membrane. In: Neidhardt F, ed. Escherichia coli and Salmonella 
typhimurium: cellular and molecular biology, 1987: 7-22. 
257. Moran A. The role of lipopolysaccharide in Helicobacter pylori pathogenesis. Aliment 
Pharmacol Ther 1996;10 (Suppll):39-50. 
258. Moran A, Lindner B, Walsh E. Structural characterization of the lipid A component of 
Helicobacter pylori rough- and smooth-from lipopolysaccharides.J BacterioI1997;179:6453-6463. 
259. Aspinall G, Monteiro M, Pang H, Walsh E, Moran A. 0 Antigen chains in the 
lipopolysaccharide ofHelicobacter pylori NCTC 11637. Carbohydr Lett 1995;1: 151-156. 
260. Aspinall G, Monteiro M. Lipopolysaccharide ofthe Helicobacter pylori strains P466 and MOI9: 
structures ofthe 0 antigen and core oligosaccharide regions. Biochem 1996;35:2498-2504. 
261. Boren T, Falk P, Roth K, Larson G, Normark S. Attachment of Helicobacter pylori to human 
gastric epithelium mediated by blood group antigens. Science 1993;262: 1892-1895. 
262. Sherburne R, Taylor D. Helicobacter pylori expresses a complex surface carbohydrate, Lewis X. 
Infect Immun 1995;63:4564-4568. 
263. Chan N, Stangier K, Sherburne R, et al. The biosynthesis of Lewis x in Helicobacter pylori. 
GlycobioI1995;5:683-688. 
264. Negrini R, Lisato L, Zanella I, et al. Helicobacter pylori infection induces antibodies cross 
reacting with human gastric mucosa. GastroenteroI1991;101:437-445. 
265. Mooney C, Keenan J, Munster D, et al. Neutrophil activation by Helicobacter pylori. Gut 
1991;32:853-857. 
  
........ n.''' • ..., 
ll):5 
mtlarrl 2lO
 
m 
I1):
l saccharides. J 
 
01
 
1
.lou ......... "',"',
"'''''''',.':' l
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
185 
266. Mai U, Perez-Perez G, Wahl L, Wahl S, Blaser M, Smith P. Soluble surface proteins from 
Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. 
J CUn Invest 1991;87:894-900. 
267. Crabtree J, Shallcross T, Heatley R, Wyatt 1. Mucosal tumor necrosis factor alpha and 
interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991 ;32: 1473-1477. 
268. Diamond G, Russell J, Bevins C. Inducible expression of an antibiotic peptide gene in 
lipopolysaccharide-challenged tracheal epithelial cells. Proc Natl Acad Sci 1996;93:5156-5160. 
269. Ulevitch R, Tobias P. Recognition of endotoxin by cells leading to transmembrane signalling. 
Curr Opin ImmunoI1994;6: 125-130. 
270. Piotrowski J, Skrodzka D, Slomiany A, Slomiany B. Helicobacter pylori lipopolysaccharide 
induces gastric epithelial apoptosis. Biochem Mol BiolInt 1996;40:597-602. 
271. Piotrowski J, Piotrowski E, Skrodzka D, Slomiany A, Slomiany B. Induction of acute gastritis 
and epithelial apoptosis by Helicobacter pylori lipopolysaccharide. Scand J Gastroenterol 
1997;32:203-211. 
272. Young G, Stemmet N, Lastovica A, et al. Helicobacter pylori lipopolysaccharide stimulates 
gastric mucosal pepsinogen secretion. Aliment Pharmacol Therap 1992;6: 169-179. 
273. Boren T, Normark S, Falk P. Helicobacter pylori: molecular basis for host recognition and 
bacterial adherence. Trends MicrobioI1994;2:221-228. 
274. Gerhard M, Lehn N, Neumayer N, et at. Clinical relevance of the Helicobacter pylori gene for 
blood-group antigen-binding adhesin. Proc Nat! Acad Sci 1999;96: 12778-12783. 
275. Slomiany B, Slomiany A. Mechanism of Helicobacter pylori pathogenesis: focus on mucus. J 
Clin GastroenteroI1992;14 (SuppI1):Sl14-S121. 
276. Sarosiek J, Slomiany A, Slomiany B. Evidence for weakening of gastric mucus integrity by 
Campylobacter pylori. Scand J GastroenteroI1988;23:585-590. 
277. Berstad K, Sjodahl R, Berstad A. Phospholipase A2 activity in gastric juice from patients with 
active and H. pylori-eradicated healed duodenal ulcer. Aliment Pharmacol Ther 1994;8: 175-180. 
278. Mauch F, Bode G, Ditschuneit P, Malfertheiner P. Demonstration of a phospholipid-rich zone in 
the human gastric epithelium damaged by Helicobacter pylori. Gastroenterol 1993;105:1698-1704. 
279. Weitkamp J, Perez-Perez G, Bode G, Malfertheiner P, Blaser M. Identification and 
characterization of Helicobacter pylori phospholipase C activity.Int J Med Microbiol Virol Parasitol 
Infect Dis 1993;280:11-27. 
280. Ottlecz A, Romero J, Hazell S, Graham D, Lichtenberger L. Phospholipase activity of 
Helicobacter pylori and its inhibition by bismuth salts, biochemical and biophysical studies. Dig Dis 
Sci 1993;38:2071-2080. 
281. Cover T, Dooley C, Blaser M. Characterization of and human serologic response to proteins in 
Helicobacter pylori broth culture supernatants with vacuolating cytotoxin activity. Infect Immun 
1990;58:603-610. 
"n1"1"",,''''
'''''''-''''''_1''. ll nl nl r:
i  
C ll IXU',.""". /"',na ' a'£YJ  
ej!lCOOa(~l
l 
t
l cl'JOG!ctE!rpyl  
ll I 
"' ... ''' ... e''' ....  
tivity.  
'a t n:z tl ..... ". ",i,,, .. ,
"' ...... , ....... '" UJ:,errlata
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
186 
282. Vogelstein B, Gillespie D. Preparative and analytical purification of DNA from agarose. Proc 
Natl Acad Sci 1979;76:615-619. 
283. Letley D, Lastovica A, Louw J, Hawkey C, Atherton J. Allelic diversity of Helicobacter pylori 
vacuolating cytotoxin gene in South Africa: rarity of the vac sla genotype and natural occurrence of 
an s2/ml allele. J Clin MicrobioI1999;37: 1203-1205. 
284. Letley D, Lastovica A, Louw J, Hawkey C, Atherton 1. Analysis of vacA diversity among 
Helicobacter pylori isolates from South Africa reveals existence of a vacA s2ml allele. 
Gastroenterology 1998; 113 :A458. 
285. Glupczynski Y, Bordeaux L, De Prez C, et al. Prevalence of Helicobacter pylori in rural Kivu, 
eastern Zaire: a prospective endoscopic study. Eur J Gastroenterol HepatoI1991;3:449-455. 
286. Cook G. Tropical Gastroenterology. Oxford: Oxford University Press, 1980. 
287. Crabtree J, Taylor J, Wyatt J, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa 
protein, peptic ulceration and gastric pathology. Lancet 1991;338:332-335. 
288. Weel J, van der Hulst R, Gerrits Y, et al. The interrelationship between cytotoxin-associated 
gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 1996;173: 1171­
1175. 
289. van der Water N, Williams R, Browett P. Amplification of a 29.7 kb region of the Factor VIII 
gmr using the expand PCR system. Biochemica 1996;2:11-12. 
290. Warnich L, Kotze M, Groenewald I, et al. Identification of three mutations and associated 
haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate 
porphyria. Hum Mol Genet 1996;5:981-984. 
291. Cuff J, Barton G. Evaluation and improvement of multiple sequence methods for protein 
secondary structure prediction. PROTEINS 1999;34:508-519. 
292. Blom N, Gammeltoft S, Brunack S. Sequence- and structure-based prediction of eukaryotic 
protein phosphorylation sites. J Molecular Biology 1999;294: 1351-1362. 
293. von Heijne G. Membrane protein structure prediction, hydrophobicity analysis and the positive­
inside rule. J Molecular Biology 1992;225:487-494. 
294. Cserzo M, Wallin E, Simon I, von Heijne G, Elofsson A. Prediction of transmembrane alpha­
helices in prokaryotic membrane proteins: the dense alignment surface method. Protein Engineering 
1997;10:673-676. 
295. Evans D, Queiroz D, Mendes E, Evans D. Diversity in the variable region of Helicobacter pylori 
cagA gene involves more than simple repetition of a 102-nucleotide sequence. Biochem Biophys Res 
Commun 1998;245:780-784. 
296. Mandour EI-Mahdi A, Pratchett S, Char S, Domizio P, Fedail S, Kumar P. Does CagA contribute 
to ulcer pathogenesis in a developing country such as Sudan? Eur J Gastroenterol Hepatol 
1998;10:313-316. 
      ",,,,.,,nn,.,,,,.  
t
fm
.... ,,,,0."," . .,,, -
 
m t
rn n;:Ol(mOi
 
-
IVl mace T1i'.1pr"it" i  t  
tm m
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
187 
297. Kidd M, Lastovica A, Atherton J, Louw A. Heterogeneity in the Helicobacter pylori genes vacA 
and cagA: Associated with gastroduodenal disease in South Africa? Gut 1999;45:499-503. 
298. Kidd M, Lastovica A, Atherton J, Louw J. Specific genotypes ofHelicobacter pylori vacA and 
cagA but not the presence of cagA, are associated with gastroduodenal disease in South Africa. 
GastroenteroI1999;116:G0928. 
299. Nielsen H, Engelbrecht J, Brunak S, von Heijne G. Identification of prokaryotic and eukaryotic 
signal peptides and prediction of their cleavage sites. Protein Engineering 1997;10:1-6. 
300. Peek R, van Doorn L, Donahue J, Tham K, Blaser M, Miller G. Helicobacter pylori iceA is 
transcribed in vivo and iceAl expression is associated with enhanced mucosal inflammation. 
GastroenteroI1999;116:A279. 
301. Nishiya D, Shimoyama T, Fukuda S, Yoshimura T, Tanaka M, Munakata A. Evaluation of the 
clinical relevance of the iceAl gene in patients with Helicobacter pylori infection in Ja~an. Scand J 
GastroenteroI2000;35:36-39. 
302. Dubois A, Berg D, Incecik E, et at. Transient and persistent experimental infection of nonhuman 
primates with Helicobacter pylori: implications for human disease. Infect Immun 1996;64:2885-2891. 
303. Donahue J, Peek R, van Doorn L-J, et at. Analysis of iceAl transcription in Helicobacter pylori. 
Helicobacter 2000;5: 1-12. 
304. Versalovic J, Koeuth T, Lupski J. Distribution of repetitive DNA sequences in eubacteria and 
application to fingerprinting ofbacterial genomes. Nuc Acid Res 1991 ;19:6823-6831. , 
305. Versalovic J, Kapur V, Mason E, et al. Penicillin-resistant Streptococcus pneumoniae strains 
recovered in Houston: Identification and molecular characterization of multiple clones. J Infect Dis 
1993;167:850-856. 
306. Struelens M, Bax R, Deplano A, Quint W, van Belkum A. Concordant clonal delineation of 
methicillin-resistant Staphylococcus aureus macrorestriction analysis and polymerase chain reaction 
genome fingerprinting. J Clin MicrobioI1993;31: 1964-1970. 
307. Kwon D, EI-Zaatari F, Woo J, Perng C, Graham D, Go M. REP-PCR fragments as biomarkers 
for differentiating gastroduodenal disease-specific Helicobacter pylori strains. Dig Dis Sci 
1998;43:980-987. 
308. da Costa Y, Davids A. Pages from Cape Muslim History. Pietermaritzburg: Shuter and Shooter, 
1994. 
309. van Doorn N, Namavar F, Kusters J, van Rees E, Kuipers E, de Graaf J. Genomic DNA 
fingerprinting of clinical isolates of Helicobacter pylori by REP-PCR and restriction fragment end­
labelling. FEMS Microbiol Lett 1998;160:145-150. 
310. Ward J. Hierarchical grouping to optimize an objective function. J Am Statist Assoc 
1963;58:236-244. 
311. Humphreys H, Bourke S, Dooley C, et at. Effect of therapy on Campylobacter pylori in peptic 
disease: A randomized prospective trial. Gut 1988;29:279-283. 
 .. ·rl .....  
:lI'oo ()o Ol s;
 
l as;
 
l 
.  , ~'''''''''J 
l 
I ll CIlO p .
l n",r.;,,.;:tt .. X1Jerl cmtit
.... ",.", .. ,...,.
l trj;j (!(',r1r.h .... ,    . 
 
..... "',."" ... ,." C() :a
VlOjrJOCCUS aCU()ll
0''''rnr 1~ 1 I0' 
v ...... ll' .. "'~J..,
 L l
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
188 
312. Chittajulla R, Ardill J, McColl K. The degree of hypergastrinemia induced by Helicobacter 
pylori is the same in duodenal ulcer patients and asymptomatic volunteers. Eur J Gastroenterol 
1992;4:49-53. 
313. Chittajulla R, Doman C, Neithercut W, Daghill S, McColl K. Is Helicobacter pylori associated 
hypergastrinemia due to the bacterium's urease activity or the antral gastritis? Gut 1991;32:1286­
1290. 
314. EI-Omar E, Penman I, Doman C, Ardill J, McColl K. Eradicating Helicobacter pylori infection 
lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 
1993 ;34: 1060-1065. 
315. McGowan C, Cover T, Blaser M. Helicobacter pylori and Gastric acid: Biological and 
therapeutic implications. GastroenteroI1996;1l0:926-938. 
316. Hakanson R, Bottcher G, Ekblad E, et a1. Histamine in the endocrine cells in the stomach. A 
survey of several species using a panel ofhistamine antibodies. Histochemistry 1986;86:5-17. 
317. Prinz C, Scott D, Herwitz D, Helander HF, Sachs G. Gastrin effects on isolated rat 
enterochromaffin-like cells in primary culture. Am J PhysioI1994;267:G663-G676. 
318. Hakanson R, Sundler F. Proposed mechanism ofgastric carcinoids: The gastrin hypothesis. Eur J 
Clin Invest 1990;20:S65-S71. 
319. Sandor A, Kidd M, Lawton G, Tang L, Miu K, Modlin I. Neurohormonal modulation of rat 
Enterochromaffin-like (ECL) cell histamine .secretion. Gastroenterol 1996;110: 1 084-1 092. 
320. Perez-Perez G, Shepherd V, Morrow J, Blaser M. Activation ofhuman THP-l cells and rat bone 
marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect Immun 
1995;63:1183-1187. 
32l. Wyllie J, Limbosch J, Nyhus L. Inhibition of gastric acid secretion by bacterial 
lipopolysaccharide. Nature 1967;215:879. 
322. Kidd M, Tang L, Miu K, Lawton G, Sandor A, Modlin I. Autoregulation of Enterochromaffin­
like cell histamine secretion via the histamine 3 receptor subtype. YaleJ Bioi and Med 1996;69:9-19. 
323. Piotrowski J, Majka J, Slomiarty A, Slomiany B. H. pylori lipopolysaccharide inhibition of 
gastric mucosal somatostatin receptor. GastroenteroI1995;108:A998. 
324. Prinz C, Sachs G, Walsh JH, Coy DH, Wu SV. The somatostatin receptor subtype on rat 
enterochromaffin-like cells. GastroenteroI1994;107: 1067 -1074. 
325. Borin J, Tang L, Kidd M, et al. Somatostatin receptor (SSTR) regulation of gastric 
Enterochromaffin-like cell transformation to gastric carcinoid. Surgery 1996;120:1026-1032. 
326. Kirkland T, Viriyakosol V, Perez-Perez G, Blaser M. Helicobacter pylori lipopolysaccharide can 
activate 70Zl3 cells via CD14. Infect Immun 1997;65:604-608. 
327. Modlin I, Tang L, Lawton G, Darr U, Zhu Z, Soroka C. Enterochromaffin-like Cell Pathobiology 
ofMastomys. Ann NYAcad Sci 1994;733:365-379. 
I  li t  l i "''''.'V''J''''t",U 
 -
..., ... "' ...... "8
; 1
l
  
 
·
1.
 
 -1
1
-
/
/ 1994;  
m :"oOnrnll"!l
  
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
189 
328. Modlin 1M, Lawton GP, Tang LH, Geibel J, Abraham R, Darr U. The mastomys gastric 
carcinoid: Aspects ofECL cell function. Digestion 1994;55 (Supp13):31-37. 
329. Modlin 1M, Kumar RR, Soroka C, Ahlman H, Nilsson 0, Goldenring JR. Histamine as an 
intermediate growth factor in the genesis of gastric ECLomas associated with hypergastrinemia in 
Mastomys. Dig Dis & Sci 1994;39:1446-1453. 
330. Modlin I, Zhu Z, Tang L, et al. Evidence for a regulatory role for Histamine in gastric 
enterochromaffin-like cell proliferation induced by hypergastrinemia. Digestion 1996;57 :31 0-321. 
331. Modlin I, Miu K, Kidd M, Luque E, Tang L. Identification of Histamine-l receptor subtype and 
determination of its function in Enterochromaffin-like (ECL) cells. GastroenteroI1996;110:AII01. 
332. Lamberts R, Creutzfeldt W, Stockman F, Jacubaschke U, Maas S, Brunner G. Long term 
omeprazole treatment (in man: effects on gastric endocrine cell populations. Digestion. 1988;39:126­
135. 
333. Logan R, Walker M, Misiewicz J, Gummet P, Karim Q, Baron J. Changes in intragastric 
distribution ofHelicobacter pylori during treatment with omeprazole. Gut 1995;36:12-16. 
334. Kuipers E, Lundell L, Klinkenberg-Knol E, et al. Atrophic gastritis and Helicobacter pylori 
infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 
1996;334: 1018-1022. 
335. Eisse1e R, Brunner G, Simon B, Solcia E, Arnold R. Gastric mucosa during treatment with 
Lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterol 
1997;112:707-717. 
336. Peterson W. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991;324:1043-1048. 
337. Kames WJ, SamloffI, Siurala M, et aL Positive serum antibody and negative tissue staining for 
Helicobacter pylon in subjects with atrophic body gastritis. Gastroenterol 1991; 1 01: 167-174. 
338. Seiler N. Polyamine metabolism. Digestion 1990;46 (Supp12):319-330. 
339. Luk G, Baylin S. Ornithine decarboxylase as a biological marker in familial colonic polyposis. N 
Engl J Med 1984;311:80-83. 
340. Okuzurni J, Yamane T, Kitao Y, et at. Increased mucosal ornithine decarboxylase activity in 
human gastric cancer. Cancer Res 1991:1448-1451. 
341. Alam K, Arlow F, Ma C, Schubert T. Decrease in ornithine decarboxylase activity after 
eradication ofHelicobacter pylori. Am J GastroenteroI1994;89:888-893. 
342. Pratchett S, Alstead E, Butruk L, Przytulski K, Farthing M. Ornithine decarboxylase as a marker 
forpremalignancy in the stomach. Gut 1995;37:13-16. 
343. Pratchett S, Katelaris P, Zhang Z, Alstead E, Domizio P, Farthing M. Ornithine decarboxylase 
activity is a marker ofpremalignancy in longstanding Helicobacter pylon infection. Gut 1996;39: 807­
810. 
344. Kidd M, Miu K, Schmid S, Tang L, Modlin 1. Abolition of ECL cell tumor DNA synthesis by 
DFMO - A critical role for polyamines. GastroenteroI1997;112:A591. 
r i i : £1"""',,","'" l 1-
 t I 996;110:A11Ol
 -
 
l
l.
l ri
J 1 -
rlPI·~"lh{\ .... ·U 
m l 11"I(,."p~<;lprl 
 
c: tlox'vla:>;
HIW"' .. '"  l ri -
I
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
190 
345. Tang L, Modlin I, Lawton G, Kidd M, Chinnery R. The Role of TGF-alpha in the 
Enterochromaffin-like (ECL) Cell Tumor Autonomy in an African Rodent Mastomys. Gastroenterol 
1996;111: 1212-1223. 
346. Janne J, Williams-Ashman H. On the purification ofL-ornithine decarboxylase from rat prostate 
and effects ofthiol compounds on the enzyme. J Bioi Chem 1971 ;246: 1725-1732. 
347. Kidd M, Miu K, Tang L, et al. Helicobacter pylori lipopolysaccharide stimulates histamine 
release and DNA synthesis in rat enterochromaffin-like cells. GastroenteroI1997;113:1110-1117. 
348. Basu H, Feuerstein B, Deen D, et al. Correlation between the effects of polyamine analogs on 
DNA conformation and cell growth. Cancer Res 1989;49:5591-5597. 
349. Colson P, Houssier C. Polyamine addition to preparation media induces chromatin condensation, 
irreversibly at low ionic strength. FEBS Lett 1989;257:141-144. 
350. Evers B, Townsend C, Upp J, et al. Establishment and characterisation of a human carcinoid in 
" " 
nude mice and effect of various agents on tumor growth. Gastroenterol1991 ;101 :303-311. 
351. Fitzpatrick L, Wang P, Johnson L. Effect of epidermal growth factor on polyamine synthesising 
enzymes in rat enterocytes. Am J PhysioI1987;252:G818-G821. 
352. Pohjanpelto P. Putrescine transport is greatly increased in human fibroblasts initiated to 
proliferate. J Cell Bioi 1976;68:512-520. 
353. Seiler N, Dezeure F. Polyamine transport in mammalian cells. Int J Biochem 1990;22:211-218. 
354. Hovis J, Stumpo D, Halsey D, Blackshear P. Effects of mitogens on ornithine decarboxylase 
activity and messenger RNA levels in normal and PKC deficient NIH-3T3 fibroblasts. JBC 
1986;261: 10380-10386. 
355. Kielian T, Blecha F. CD14 and other recognition molecules for lipopolysaccharide: a review. 
Immunopharmaco/1995;29: 187-205. 
356. Ziegler-Heitbrock H, Schraut W, Wendelgass P, et at Distinct patterns of differentiation induced 
in the monocytic cell line Mono Mac 6. J Leukocyte Bioi 1994;55:73-80. 
357. Weber C, Erl W, Weber P. Lovostatin induces differentiation of Mono Mac 6 cells. Cell Biochem 
Function 1995;13:273-277. 
358. Smith JP, Solomon TE. Effects of gastrin, proglumide, and somatostatin on growth of human 
colon cancer. GastroenteroI1988;149:35-39. 
359. Koper J, Markstein R, Kohler C, et at Somatostatin inhibits the activity of adenylate cyclase in 
cultured human meningioma cells and stimulates their growth. J Clin Endocrinol Metab 1992;74:543­
547. 
360. Ishizuka J, Beauchamp R, Evers B, Townsend C, Thompson J. Unexpected growth-stimulatory 
effect of the somatostatin analog on cultured human pancreatic carcinoid celllines. Biochem Biophys 
Res Comm 1992;185:577-581. 
361. Westphal 0, Jann K. Bacterial lipopolysaccharides: Extraction with phenol-water and further 
applications of the procedure. Methods in Carbohydr Chem 1965;5:83-91. 
lst
 
 
I
 
""',.,.,, ...... 1T""n"' .... n l rrl Wm
I
l.
-
l li
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
191 
362. Inzana T. A microadaptation of the phenol/water procedure of Westphal ~nd Jann for the 
isolation ofLPS from small amounts ofbacteria. J Infect Dis 1983;148:492-499. 
363. Morrison D, Kline L. Activation of the classical and properidin pathways of complement by 
bacterial1ipopolysaccharides (LPS). J Immuno/1977;118:362-369. 
364. Kidd M, Michie J, Young G, O'Keefe S. Flow cytometry - applications in gastroenterology. S Afr 
Med J 1994;84:440. 
365. Stefanova I, Horejsi V, Ansotegui I, Knapp W, Stockinger H. GPI-anchored cell-surface 
molecules complexed to protein tyrosine kinases. Science 1991;254:1016-1019. 
366. Han J, Lee J, Tobias P, Ulevitch R. Endotoxin induces rapid protein tyrosine phosphorylation in 
70Z/3 cells expressing CD14. J BioI Chem 1993;268:25009-25014. 
367. Yasui K, Backer E, Sha'afi R. Lipopolysaccharide and serum cause the translocation ofG-protein 
to the membrane and prime neutrophils via CDI4. Biochem Biophys Res Commun 1992;183:1280­
1286. 
368. Kinoshita Y, Nakata H, Kishi K, Kawanami C, Sawada M, Chiba T. Comparison of the signal 
transduction pathways activated by gastrin in Enterochromaffin-like and Parietal cells. Gastroenterol 
1998;115:93-100. 
369. Straub S, Sharp G. A wortmannin-sensitive signal transduction pathway is involved in the 
stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenyl ate cyclase­
activating peptide. J BioI Chem 1996;3: 1660-1668. 
370. Jones N, Day A, Jennings H, Sherman P. Helicobacter pylori induces gastric epithelial cell 
apoptosis in association with increased Fas receptor expression. Infect Immun 1999;67:4237-4242. 
371. Muotiola A, Helander I, Pyhala L, Kosunen T, Moran A. Low biological activity of Helicobacter 
pylori lipopolysaccharide. Infect Immun 1992;60: 1714-1716. 
372. Kidd M, Tang L, Modlin I, et al. Gastrin-mediated alterations in gastric epithelial apoptosis and 
proliferation in a mastomys rodent model of gastric neoplasia. Digestion 2000;(in press). 
373. Peek R, Moss S, Tham K, et al. Helicobacter pylori cagA+ strains and dissociation of gastric 
epithelial cell proliferation from apoptosis. J Natl Cancer Inst 1997;89:863-868. 
374. Zhu G, Yang X, Lai K, et al. Nonsteroidal anti-inflammatory drugs could reverse Helicobacter 
pylori-induced apoptosis and proliferation in gastric epithelial cells. Dig Dis Sci 1998;43: 1957 -1963. 
375. Moss S, Cal am J, Agarwal B, Wang S, Holt P. Induction of epithelial apoptosis by Helicobacter 
pylori. Gut 1996;38:498-501. 
376. Fraser A, Sim R, Sankey E, Dhillon A, Pounder R. Effect of eradication of Helicobacter pylori 
on gastric epithelial cell proliferation. Aliment Pharmacol Ther 1994;8: 167 -173. 
377. Chow K, Banks S, Ahn J, Roberts J, Blumstein M, Kranz V. Helicobacter pylori infection does 
not increase gastric antrum mucosal cell proliferation. Am J GastroenteroI1995;90:64-66. 
a
 
li l I
i
-
b-Y-~'
-
i
"I-"U'"''''''
ast t ; : ~ .
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
192 
378. Aspinall G, Mainkar A, Moran A. A structural comparison of lipopolysaccharides from two 
strains of Helicobacter pylori, of which one strain (442) does and the other strain (471) does not 
stimulate pepsinogen secretion. Glycobiology 1999;9: 1235-1245. 
379. Monteiro M, Appelmelk B, Rasko D, et al. Lipopolysaccharide structures of Helicobacter pylori 
genomic strains 26695 and J99, mouse model H. pylori Sydney strain, H. pylori P466 carrying sialyl 
Lewis X, and H. pylori UA915 expressing Lewis B classification ofH. pylori Jipopolysaccharides into 
glycotype families. Eur J Biochem 2000;267:305-320. 
380. Young G, Brown S, Lastovica A, Louw J, Marks I. Guinea pig gastric mucosal pepsinogen 
release is greater with H. pylori lipopolysaccharide from duodenal ulcer patients than from non-ulcer 
subjects. S Afr Med J 1992;82. 
381. Schromm A, Brandenburg K, Loppnow H, et al. Biological activities of lipopolysaccharides are 
determined by the shape of their lipid A portion. Eur J Biochem 2000;267:2008-2013. 
~"I-'U''''U OIln nSC)fl HI-''-'I-'v.ysa ctlan
C)flt(:lr L
 li
